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Abstract
Sulfated carbohydrates play key roles in a wide range of biological processes such
as blood clotting, viral entry into cells, amyloidogenesis, neurite outgrowth, tumor growth
and metastasis.  However, their synthesis still remains a considerable challenge.  A
general approach to the synthesis of sulfated carbohydrates was examined in which
sulfate group is incorporated at the beginning of the syntheses as a protected sulfodiester.
Towards this end, a series of sulfuryl imidazolium salts (SIS), a new class of sulfating
agents, was prepared and examined as reagents for incorporating 2,2,2-trichloroethyl-
protected sulfate esters into monosaccharides.  The SIS that contained a 1,2-
dimethylimidazolium moiety proved to be a superior sulfating agent compared to SIS
bearing no alkyl groups or bulkier alkyl groups on the imidazolium ring.  Difficult O- and
N- sulfations that required prolonged reaction times and a large excess of the SIS bearing
a 1-methylimidazolium group were achieved in high yield and in less time when
employing less than half the 1,2-dimethylimidazolium derivative.  Efforts were then
made to apply the sulfate protecting group strategy to the total synthesis of a class of
chondroitin sulfate glycosaminoglycans.  These studies revealed some of the limitations
of the sulfate protecting group approach to the synthesis of sulfated oligosaccharides.
Studies on the selective introduction and isomerization of the carbobenzyloxy protecting
group into 2,3-diols of 4,6-O-benzylidene galactose derivatives are also reported.
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Chapter 1  - Introduction
1.1 Sulfated Carbohydrates
One of the unique features of carbohydrates is the limitless number of distinct
structures that can be obtained from combining individual monosaccharide building
blocks. Oligosaccharides are naturally assembled from monosaccharides in pyranose and
furanose configurations, with different types of linkages, at varying positions in the
carbohydrate ring, forming straight chain or branched polymers. Further modifications
such as alkylation, phosphorylation, and sulfation provide additional structural
complexity to the already diverse compounds.
The high degree of variability among biologically relevant sulfated carbohydrates
is attributed to a number of factors. There is variability with respect to monosaccharides
which are sulfated (i.e. glucose (Glc), galactose (Gal), the corresponding N-acetyl (NAc)
amines GlcNAc, GalNAc, and mannose (Man) among others); the total number of sulfate
moieties, and hydroxyl(s) to which the sulfate group(s) are linked (i.e. 2-O, 3-O, 4-O, 6-O
sulfates, and any resulting combination from multiple sulfations); and also the varied
structure of the underlying oligosaccharide moiety.  An important consequence of this
structural diversity is that each unique structure has the potential to be recognized by an
individual receptor, making sulfated oligosaccharides ideal for carrying information in
complex biological systems.
Sulfated carbohydrates are of extreme biological importance.  The
oligosaccharides play key roles in modulating bioactive proteins and peptides, and thus
2
are responsible for controlling many physiological events.  Despite their widespread
occurrence, a clear comprehension of the specific roles of these compounds is limited.
Research to develop an understanding of the molecular-level function of many different
oligosaccharides is hampered, mainly because these compounds are isolated as complex
mixtures from natural sources, and the chemical synthesis of pure, well defined sulfated
















































































































Figure 1.1. Typical fragments from heparin degradation.1
Some of the most well-known sulfated carbohydrates are heparin oligosaccharides
(Figure 1.1).1  Heparin is a highly sulfated glycosaminoglycan that has been clinically
applied as an injected anticoagulant-antithrombotic agent since the early 1940’s.  It is one
3
of the oldest pharmaceutical drugs still currently in use, and is the only sulfated
carbohydrate-based drug on the market.
The negatively charged, unbranched carbohydrate polymers were originally
isolated from animal tissues as complex mixtures of sulfated oligosaccharides.
Degradation of naturally occurring heparin yields a wide variety of oligosaccharides that
consist predominantly of α-(1,4)-linked L-iduronic acid and N-, O-di-sulfated
glucosamine residues (1.1 – 1.3 Figure 1.1).    Heparin binds and activates antithrombin
III (AT-III), a serine protease inhibitor that blocks thrombin and factor Xa in the blood
coagulation cascade.2 In clinical use, natural heparin has several drawbacks, including a
very short half life (t1/2 = 1 h) and a lack of selectivity, which can lead to abnormal
bleeding in patients.3
In the early 1980’s, it was discovered that the interaction between heparin and
AT-III was mediated by a unique pentasaccharide sequence (denoted in parenthesis in
Figure 1.1, 1.4 in Figure 1.2), now called the antithrombin III binding domain (ABD).4
The discovery and characterization of the active pentasaccharide 1.4 lead to a widespread
drug development program lasting more than 20 years.  The primary goals of this
program were to establish a specific heparin structure-function relationship and create
synthetic AT-III inhibitors with the heparin pentasaccharide 1.4 as a vantage point.1
Research efforts eventually lead to the synthesis of active heparin analogs such as
pentasaccharide 1.5, first synthesized in over 60 steps with low yield and purity, and its
stabilized methyl glycoside 1.6 in over 55 synthetic steps. These pentasaccharides contain
4














































































Figure 1.2. Heparin pentasaccharide and synthetic analogs.
In 1989 over 20 g of highly purified pentasaccharide 1.6 was prepared; and in
2001 after successes in toxicology testing and clinical studies, 1.6 was registered in the
USA and Europe as a new antithrombotic drug under the name Arixtra (fondaparinux).7
Even though it comprises almost 60 steps and a low overall yield, the multi-kg synthesis
of highly pure 1.6 is still performed successfully in the pharmaceutical industry.  Arixtra
is superior to natural Heparin in that it requires a lower dosage, has a much longer half
life (t1/2 = 17 h) and is uncompromised by the adverse side effects.7  As outlined in
5
Scheme 1.1, the key approach to the synthesis of the pentasaccharide is the application of
an orthogonal protecting group strategy to differentiate the location of the sulfate group













































































1.7 (Prepared in 30+  Steps) 1.8 (Prepared in 20+ Steps)
1.9
Scheme 1.1. Synthesis of Arixtra
The fully protected pentasaccharide 1.9 is prepared by coupling trisaccharide
donor 1.7 with disaccharide 1.8 (prepared in over 50 combined synthetic steps).1,8 The
positions that will carry sulfate groups are protected as acetate esters, whereas the
hydroxyl groups in the product are masked as benzyl ether groups. The locations that
bear the sulfates are deprotected and then O-sulfated.  The remaining benzyl and azido
groups are subjected to hydrogenolysis, and selective N-sulfation affords the desired
pentasaccharide 1.6.  Through extensive structure-activity relationship (SAR) studies,
6
almost all of the sulfate groups (as indicated in Figure 1.3) on pentasaccharide 1.6 were

























Figure 1.3. Essential sulfate groups in Arixtra
Further structure-activity studies of heparin-like pentasaccharides have lead to the
development of simplified pentasaccharides such as Idraparinux 1 .101 and

























































Figure 1.4. Idraparinux and Idrabiotaparinux
7
As a result of the simplified chemical structure of the pentasaccharide in 1.10 and
1.11, the need for orthogonal protecting groups is eliminated, and the total synthesis of
1.10 is achieved in ‘only’ 25-30 steps (outlined in Scheme 1.2).5,10,11 The synthesis
utilizes disaccharide 1.12 which can be converted into, and then coupled to 1.13 to
provide access to an intermediate tetrasaccharide.  This tetrasaccharide is then coupled
with donor 1.14 to give fully protected pentasaccharide 1.15.  Removal of the benzyl














































































Scheme 1.2. Synthesis of Idraparinux
Idraparinux displayed higher activity and higher bio-availability than both heparin
and Arixtra, (t1/2 = 120 h), and by 2003 had reached phase III clinical trials.
Unfortunately, the compound was found to be too active, and caused major bleeding
8
events in greater than 18% of the clinical trials.9  To counteract this, a biotin moiety was
tethered to the non-reducing end of 1.10 to give Idrabiotaparinux 1.11 (Figure 1.4).  It is
anticipated that the activity of Idrabiotaparinux can be controlled by the addition of
Avidin, and this process is currently in phase III clinical trials.9
Similar to the heparin family of oligosaccharides, the chondroitin sulfate family of
glycosaminoglycans is a very important class of naturally occurring sulfated
oligosaccharides. In 2004, Hsieh-Wilson and coworkers reported that tetrasaccharide
1.16, a fragment of a chondroitin sulfate glycoaminoglycan, stimulates neuronal
growth.12 The presence of the four sulfate residues was absolutely essential for the
stimulatory activity.12 Chondroitin sulfate glycosaminoglycans will be covered in more
detail in chapter 3.
Other sulfated carbohydrates of interest include disaccharide 1.17 (Figure 1.5),
known as sulfolipid-1 (SL-1), which is a virulence factor in strains of Mycobacterium
tuberculosis.13,14 SL-1 contains a trehalose core modified with four lipid chains, and a
sulfate group at C2 of the first monomer.  The sulfate group is critical for virulence of the
bacterium.13,14
In 2004, Schroeder and co-workers isolated and identified a family of unusual
sulfated nucleoside derivatives, such as the known compound 1.18 and previously
unknown sulfated nucleosides such as 1.1915 and from the venom of the grass spider
Hololena curta.16 These neurotoxins are unique mono- or disulfated glyconucleosides
that are found to have an uncommon ability to effectively block kainate receptors in
9
addition to weakly blocking calcium channels. Interestingly, these authors summarize
their article by commenting on the fact that a literature search revealed very little
synthetic information about these molecules, which results in very little evaluation of
their biological properties.  They concluded that the synthesis and subsequent biological


































































Figure 1.5. Biologically relevant sulfated carbohydrates
1.2 Synthesis of Sulfated Carbohydrates
Although sulfated carbohydrates have been obtained synthetically for several
decades, their synthesis still remains a considerable challenge. In the current approach, as
outlined in Scheme 1.3, monosaccharide or disaccharide building blocks are fully
protected, with the hydroxyls that will ultimately bear the sulfate groups protected in an
orthogonal manner to those that will not be sulfated.  After assembly of the
oligosaccharide, the locations that are to be sulfated are selectively deprotected. The
sulfate moiety is introduced using a conventional sulfation method such as a sulfur
10



























































Scheme 1.3. Orthogonal protection strategy
An alternate approach to the conventional synthesis of sulfated carbohydrates is
being advocated in this thesis.  In this approach, the sulfate groups are introduced at the
monosaccharide stage as protected sulfate diesters.  This method reduces the required
protecting group manipulations, and provides products which are less polar, and easier to
manipulate.  Once the fully protected oligosaccharide is assembled, the hydroxyl and









































Scheme 1.4. Incorporation of a protected sulfate moiety
1.3 Protecting Groups for the Sulfate Moiety
The idea of protecting the sulfate group during sulfocarbohydrate synthesis has
been around for some time; however, applications of this approach have been very
limited.  The reason for this has to do with the number of sulfate protecting groups that
are available as well as the ease by which they can be incorporated into the carbohydrate
building blocks and then removed to provide the free sulfate.  The limited number of
protecting groups is a direct consequence of the chemical reactivity of sulfate mono- and
diesters.  Acid labile protecting groups cannot be used due to the well-known instability
of sulfate monoesters to acid.17 Furthermore, sulfate diesters are highly susceptible to
nucleophilic attack, which can occur at either the sulfur atom or carbon atoms of the C-O-







Figure 1.6. Nucleophilic attack on a sulfate ester – 3 possible routes
When R is a carbohydrate, substitution by path (a) is generally slow, especially so
for the sulfate esters of secondary alcohols.  The idea of protected carbohydrate sulfate
diesters focuses on disfavouring attack by route (a) (Figure 1.6), with the strategic design
of R’ in a manner which favours attack by route (b) without rendering the protecting
group ineffective, as it is expected to be stable to many different chemical manipulations.
The reactivity properties of sulfate diesters eliminates the possibility of using
protecting groups that are removed by hydrogenolysis or photolysis, since these are
usually benzylic moieties, and so are very susceptible to nucleophilic displacement.  If
base labile protecting groups are used, they would have to be designed such that they are
stable enough to nucleophiles while being removed under conditions that are not too
harsh.  In light of these difficulties, it is not surprising that, until recently, only a few
protecting groups for sulfate esters have ever been reported.
1.3.1  Phenyl Protection for Sulfate Monoesters
In 1981, Penney and Perlin were the first to propose and demonstrate the
introduction of the sulfate group to a carbohydrate in the form of its protected
organosulfate.19 Employing monosaccharides as model systems, the authors showed that
phenyl chlorosulfate 1.21 could be reacted with partially protected carbohydrates 1.20
13
and 1.24 to afford the corresponding phenyl sulfocarbohydrates 1.22  in a 77 % yield, and




































































Scheme 1.5.  Incorporation and deprotection of phenyl sulfates
The authors studied the stability of the phenyl protected sulfate esters, and
reported that 1.22 was stable to various conditions including NaOMe at room
temperature; 2:1 NH4OH in pyridine; CsF in acetonitrile or methanol; KF and 18-Crown-
6; but formed unidentifiable products when reacted with TBAF in oxolane.  Stability
studies with 1.25 showed that the 5,6-isopropylidine group could be hydrolyzed in the
presence of the protected sulfate using TFA in CHCl3; the phenyl sulfate moiety was
stable to cationic resin in water/oxolane at room temperature but not at elevated
temperatures; and that the acetals could be removed using 1:1 Ac2O/H2SO4 without
affecting the phenyl sulfate.
Removal of the phenyl protecting group to provide the free sulfate was achieved
by subjecting 1.22 and 1.25 to a solution of excess potassium carbonate and cat. platinum
oxide / H2 in ethanol-water.  This resulted in the hydrogenation of the phenyl ring to a
14
cyclohexyl group, which was removed to give the desired sulfated carbohydrates 1.23
and 1.26 (Scheme 1.5 a,b).19   The authors did not comment on the yield of the
deprotections, but did suggest that 10 % of desulfation had taken place during the
reaction.
Perlin and co-workers further examined use of the phenyl protecting group in the
synthesis of sulfated monosaccharides in the preparation of mono-and disulfated
compounds;20,21 however, the approach exhibited a number of limitations.  Cleavage of
the sulfate diester required conditions that are not compatible with protecting groups that
are sensitive to base and hydrogenolysis.  The deprotected products required tedious
purifications involving anion exchange resins, and removing the phenyl protecting group
was found to result in partial desulfation leading to poor yields of the desired products.
Because of these limiting factors, Penney and Perlin’s method was not widely applied to
the synthesis of sulfated carbohydrates.
1.3.2  Trifluoroethyl Protection for Sulfate Monoesters
The idea of protected sulfates in carbohydrate chemistry did not resurface until
sixteen years later, when Proud et al. offered an alternative to the phenyl group.18  In
1997, the authors proposed the use of trihaloethyl sulfate esters, suggesting that these
moieties would be stable to nucleophilic attack (as indicated in Figure 1.6) for both steric
and electronic reasons, and could offer versatile protection in many aspects of
carbohydrate chemistry.  Their initial attempts focused on the 2,2,2-trichloroethyl (TCE)
group, since it had previously been used for phosphate and carboxyl protection.22 This
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appeared to be an unusual first choice, since these authors anticipated that the TCE group
could be successfully removed from the protected sulfocarbohydrate without the loss of
the sulfate group using Zn/AcOH, which is unlikely due to the poor stability of the sulfate
monoesters to acid.  Nevertheless, they never got the opportunity to test their hypothesis,
since they were unable to prepare the TCE-protected sulfocarbohydrates.  The authors
stated that the reaction of 2,2,2-trichloroethyl chlorosulfate with carbohydrate
nucleophiles proceeded in yields that were too low to be of use, attributing this to steric
reasons.  They therefore decided to examine the trifluoroethyl (TFE) group instead.
Again, reacting 2,2,2-trifluoroethyl chlorosulfate with carbohydrates proceeded in poor
yields.  They were, however, able to develop a two step approach in which conventional
sulfation methods such as sulfur trioxide / amine complexes were first used to prepare a
sulfated carbohydrate such as 1 .27 , which was then treated with 2,2,2-
























Scheme 1.6. Preparation of TFE-protected carbohydrate sulfates
Proud et al. extended the chemistry to synthesize a number of sulfated






















1.30   93%1.29   75%




Figure 1.7. Formation of trifluoroethyl esters of carbohydrate sulfates
The TFE protecting group was reported to be stable to a variety of conditions such
as TFA in EtOH, TBAF, hydrogenation, and NaOMe in MeOH at room temperature and
reflux. This stability unfortunately, affected the ease with which the protecting group was
removed; this transformation required refluxing the protected carbohydrate in potassium
t-butoxide in t-butanol.  The yields of deprotected products ranged from 82-96 %. In
certain cases such as 1.29 in Figure 1.7, migration of the sulfate ester occurred during
deprotection.18
Despite the apparent potential that Proud et al.’s chemistry had for the synthesis
of sulfated carbohydrates, it was another six years before it was examined in more detail.
In 2003, Linhardt and coworkers published extensive studies on the use of the TFE group
in the synthesis of fully differentiated hexosamine monosaccharides.23 For example,
selective 6-O-sulfation of carbohydrate 1.33 with sulfur trioxide-trimethyl amine
followed by treatment with trifluorodiazoethane gave the TFE-protected












1. Me3N.SO3, DMF, 50 oC
2. CF3CHN2, MeCN, citric acid
1.34  68%1.33
Scheme 1.7. Selective incorporation of a TFE sulfate
Linhardt’s group also prepared disulfo-derivative 1.38 (Scheme 1.8)
demonstrating that the TFE-sulfate moiety was compatible with the acidic conditions















1. Me3N.SO3, DMF, 50 oC




1. Me3N.SO3, DMF, 50 oC






1.36   68%
1.38  67% 1.37   94%
Scheme 1.8. Preparation of a TFE-protected disulfated acceptor
Monosaccharide building blocks employing p-methoxybenzylidene (PMB)
protection at the 4,6-position such as glucosamine derivative 1.39 were subjected to
regioselective opening of the benzylidene ring to unmask the 6-position for sulfation
without affecting the TFE-protected sulfate.  The PMB group was then selectively


























1. Me3N.SO3, DMF, 50 oC
2. CF3CHN2, MeCN, citric acid
1.40   85%
1.41   71%1.42   87%
Scheme 1.9. PMB removal from TFE-protected carbohydrate sulfate
Linhardt and coworkers then studied the preparation of activatable carbohydrates
bearing the TFE sulfate moiety.  Both fluoride and trichloroacetimidate species were
prepared (Scheme 1.10).  It was reported that when present at the 6-position, the
trifluoroethylsulfate moiety acted as a good leaving group when using only TBAF to
remove the anomeric thexyldisilyl (TDS) group on carbohydrate 1.41, as 1,6-anhydro
sugars were recovered as side products for the reaction. This was corrected when excess
acetic acid was added to TBAF, or by applying a milder reagent such as triethylamine
trihydrofluoride (Scheme 1.10a,b).  It was also noted that partial loss of the sulfate
protecting group was observed under the basic conditions required to prepare








































1. TBAF, AcOH, THF





1.44 1.45  53%




Scheme 1.10. Glycosyl donors bearing TFE sulfates
Finally, preliminary glycosylation attempts via the coupling of fluoride 1.45 and
imidate 1.47 with the 6-OH acceptor of 1.48 were reported (Scheme 1.11).23 Despite the
electron-withdrawing character of the trifluoroethyl sulfonate, encouraging yields for the
















































1.45 1.48 1.49  64%




Scheme 1.11. Glycosylation with sulfated donors
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In July of 2004, a second publication from Linhardt and co-workers further
described the synthesis of a variety of sulfo-protected monosaccharide donors and
acceptors.24 A wide variety of glycosylation reactions were studied, demonstrating the
TFE sulfate group was compatible with a range of activation conditions commonly used
with fluoride, imidate, and sulfoxide donors.  Despite the extensive TFE-sulfate
chemistry presented in the first publication, it was not until this second paper that
Linhardt addressed the deprotection of the sulfate group (Scheme 1.12), demonstrating





















































































1.52 1.53  60%
1.54 1.55  90%





Scheme 1.12. Deprotection of TFE-protected sulfates
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The standard conditions of t-BuOK/t-BuOH first reported for TFE-sulfate
deprotection18 were found to be too harsh for disaccharide 1.50 resulting in substrate
decomposition. Instead, it was demonstrated that the TFE group could be removed using
NaOMe/MeOH, conditions which Proud et al. reported that the TFE group was stable
to,18 affording the deprotected product 1.51 in a 70 % yield (Scheme 1.12a).24
Deprotection of the 6-O-sulfate 1.52 (Scheme 1.12b) presented an even greater challenge,
as the tBuOK/tBuOH conditions lead to almost complete desulfation.  It was found that
the TFE protecting group could be removed under standard conditions only after the
complete removal of the benzoyl esters in 1.52, a method which resulted in minor loss of
the sulfate group, compromising the final yield of 1.53.  Furthermore, for the 2,4-
disulfate 1.54 (Scheme 1.12c) a stepwise deprotection was required.  The 4-O-position
sulfate was removed with NaOMe/MeOH to afford 1.55, which was then subjected to
tBuOK/tBuOH to deprotect the 2-O-position sulfate, providing 1.56 (Scheme 1.12d).
Partial decomposition was also observed using this method, resulting in loss of the 6-
OTBDMS and anomeric OMP protecting groups; therefore, the deprotected product 1.56
was obtained in only a 45% overall yield.24
The TFE protecting group has allowed for the synthesis of protected carbohydrate
sulfate diesters, and has proved to be stable to a number of synthetic conditions for
complex carbohydrates; however, this strategy has not been widely applied to the
synthesis of these compounds as the approach exhibits some strong limitations. The
method relies on conventional sulfation techniques that can be unreliable. Introducing the
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TFE group involves the use of trifluorodiazoethane, which is toxic and potentially
explosive, and often proceeds in variable yields. Finally, and most significantly,
removing the TFE group is difficult, and deprotection yields tend to be low when the
substrate is more complex than a simple monosaccharide.  While the approach is an
excellent idea, alternative protecting groups and new methods for their introduction are
required before this strategy becomes effective.
1.3.3  Neopentyl and Isobutyl Protection for Sulfate Monoesters
In 2006, Simpson and Widlanski published an article describing a comprehensive
approach to the synthesis of sulfate esters.25 Noting that there is no broadly useful method
for the introduction of a protected sulfate monoester in the synthesis of complex
molecules, the authors sought methodology to incorporate transient sulfate diesters that
permit access to the target sulfates.  In their approach, Simpson and Widlanski described
the synthesis of sulfate esters employing neopentyl and isobutyl protecting groups for the
protection of aromatic and aliphatic sulfate monoesters, basing their protecting group
selection on the idea that the neopentyl and isobutyl groups are known to serve as good
protecting groups for sulfonates.25
By treating an alkyl or aryl alcohol with a strong base, followed by the addition of
neopentyl or isobutyl chlorosulfates 1.57 and 1.58, respectively, a selection of protected
sulfate diesters was prepared, with results summarized below in table 1.1.
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Table 1.1. Preparation of Neopentyl and Isobutyl Sulfate Diesters
ROH
1. NaHMDS or NaH
2. ClSO2OR'
ROSO3R'
Where R' = nP 1.57 or R' = iBu 1.58
Entry       Product* Protecting Group* Yield (%)
1
1.59 R = nP




1.61 R = nP
1.62 R = iBu
98
82
3 1.63 R = nP 99
4
1.64 R = nP
1.65 R = iBu
95
95
5 1.66 R = iBu 86
* E = Estrone; nP = neopentyl; iBu = isobutyl
The neopentyl protected sulfate monoesters were prepared by subjecting the
corresponding alcohols and phenols to sodium hydride or sodium bis
(trimethylsilyl)amide (NaHMDS) in THF (20% DMPU) at –75 oC, followed by treatment































neopentyl protected sulfated monoesters including phenolic derivative 1.59, estrone
sulfate 1.61, protected tyrosine sulfate 1.63, as well as the sulfocarbohydrate 1.64 were
readily prepared from their hydroxyl substrates in excellent yields.
Simpson and Widlanski examined the isobutyl group as an alternative to the
neopentyl group anticipating that it would be significantly more labile as the neopentyl
protecting group is known to be extremely stable.25 To prepare the isobutyl protected
sulfate monoesters, the reaction conditions required slight adjustments to eliminate
isobutyl ether side products which were assumed to arise form the attack of the sodium













Scheme 1.13. Isobutyl ether side products
The modifications for the introduction of the isobutyl sulfate monoesters included
discontinuing the use of DMPU, lowering the concentration, increasing the temperature,
and using a larger excess of isobutyl chlorosulfate (5-10 eq.).  Under the optimized
conditions, the isobutyl protected sulfate esters of 1,2:5,6-di-O-isopropylidene-α-D-
glucofuranose 1.65  and 3,5-di-O-benzyl-1,2-di-O-isopropylidene-α-D-glucofuranose
1.66 were obtained in 95 % and 86 % yields, respectively.
The stability of the neopentyl and isobutyl protected sulfate esters were studied
using NMR assays by subjecting protected phenyl sulfates 1.59 and 1.60 to different
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concentrations of TFA and piperidine.  Both the isobutyl and neopentyl sulfate esters
were found to be stable to 50% TFA, with less than 10% degradation observed after 48 h.
The neopentyl sulfate ester was stable to 20% piperidine in chloroform, but the isobutyl
sulfate ester was less tolerant, showing evidence of nucleophilic cleavage, even at 6%
piperidine solution.  From these studies, the authors concluded that both the neopentyl
and isobutyl groups for sulfate esters offer viable protection in highly acidic reactions,
with the isobutyl protecting group being much less effective under basic or nucleophilic
conditions. The stability of the alkyl sulfates was not investigated under the TFA or
piperidine conditions; however, carbohydrate sulfates 1.64, 1.65, and 1.66 were subjected



































1.64 1.67  94%
1.65 1.68  92%
1. Pd/C
2. H2SO4











Scheme 1.14. Stability of alkyl protected carbohydrate sulfates
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The stability of the neopentyl and isobutyl protecting groups towards
hydrogenolysis and brief treatment with strong acids was demonstrated by removing the
isopropylidene groups from protected carbohydrates 1.64, and 1.65 using H2SO4 in THF
/H2O, and removal of the benzyl groups in 1.66 by hydrogenolysis with Pd/C and H2,
followed by treatment with aqueous H2SO4 in THF, with yields of the deprotected
hexoses ranging from 92 – 96%.
To study the deprotection conditions required to cleave the neopentyl moiety, the
protected sulfate esters were reacted with nucleophiles in polar solvents.  The reaction of
sodium iodide with phenyl neopentyl sulfate 1.59 (Scheme 1.15a) yielded the desulfated
phenol rather than cleavage of the neopentyl group, and did not result in any reaction
with the neopentyl protected glucose sulfate 1.64 (Scheme 1.15b).  Other small
nucleophiles such as azide and cyanide in DMF (60-70 oC) were reported to be effective
for removing the neopentyl protecting group in protected aryl sulfates 1.59, 1.61, and
1.63, as well as the protected sulfate of diacetone-D-glucose 1.65 (Scheme 1.15c) in near
quantitative yields.  Treating the unprotected glucopyranose neopentyl diester 1.67 with
sodium azide in DMF, however, led to the displacement of the entire protected sulfate
group providing 3-azido-3-deoxy D-allose 1.72 (Scheme 1.15d).  This result strongly
suggests that the neopentyl group is not useful for the protection for sulfates of primary

























































Scheme 1.15. Deprotection of neopentyl protected sulfate groups
Because nucleophilic substitution is significantly faster at isobutyl centers than at
the more hindered neopentyl counterpart, a variety of nucleophiles were expected to
cleave the isobutyl protecting group.  The isobutyl protected sulfate esters of unprotected
hexoses 1.68 and 1.69 were effectively cleaved with sodium iodide in acetone at 55 °C to
provide the target sulfates 1.73 and 1.74 in excellent yields (Scheme 1.16).  As was the
case with the neopentyl aryl sulfates, iodide was able to displace phenoxides from the
aryl alkyl sulfate esters; thus the isobutyl protecting group in sulfoestrone derivative 1.62
was cleaved using sodium thiocyanate and triethylamine in acetone at 55 oC to provide


































Scheme 1.16. Deprotection of isobutyl protected sulfate groups
The chemistry presented by Simpson and Widlanski does offer a unique approach
for the synthesis of sulfated compounds; however, like other sulfation methods it is more
successful for aryl sulfates.  The neopentyl protected aryl sulfate monoesters could be
highly effective for the synthesis of complex molecules but cleavage of the protecting
group requires somewhat harsh conditions, to which other functionalities may not be
tolerant.  The isobutyl protected sulfate monoesters, designed to provide an alternative to
the highly stable neopentyl counterparts, were much more sensitive to nucleophilic and
basic conditions, which in turn limits their potential applications towards the synthesis of
complex molecules.  The authors also indicated that the isobutyl chlorosulfate approach
would be effective for introducing sulfate monoesters at the last step in a synthesis.
Although the method could be useful for increased yields of sulfation, it does not
eliminate the unnecessary protecting group manipulations that are avoided by introducing
the sulfate group at the beginning of a synthetic sequence, and therefore does not provide
a significant alternative to conventional sulfation methods.
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1.3.4  2,2,2-trichloroethyl Protection for Sulfate Monoesters
Although the 1997 paper by Proud et al. focused on the TFE moiety, this was not
the starting point for their research.18 As previously stated, initial attempts involved the
use of the 2,2,2-trichloroethyl ester, a group that is used for phosphate and carboxyl
protection.18 Proud and coworkers had concluded that the TCE-sulfate moiety could not
be incorporated into carbohydrates in good yields, and would not be useful for the
synthesis of these compounds. The TCE group has an advantage over the TFE group in
that it can be cleaved under very mild conditions (such as Zn/AcOH).  In order for this
group to be used, however, methodology would have to be developed for its introduction
into sulfated carbohydrates in high yields without the use of toxic and explosive diazo
derivatives, and a mild alternative for Zn/AcOH would have to be developed for it’s
removal.
In 2004, the Taylor group reported the use of the TCE moiety as the first group
for the protection of aryl sulfates.26 They demonstrated that 2,2,2-trichloroethyl




















1.75 1.76 1.77  74-95% 1.78  81-94%
Scheme 1.17. Preparation of aryl sulfates
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The TCE protecting group was easily removed in excellent yields under mild
conditions by catalytic transfer hydrogenolysis using Pd/C and ammonium formate, or by
using Zn and ammonium formate in methanol to obtain aryl sulfates 1.78.26  This success
prompted further investigation into the use of the TCE group for protecting alkyl sulfates,
specifically carbohydrate sulfates.
The methodology reported by the Taylor group was expanded to show that TCE
chlorosulfate 1.76 can be reacted with diacetone glucose 1.24 to give the sulfated 1.79 in
82% yield, according to Scheme 1.18.  This was an important development, since it
contradicted Proud’s previous conclusions that incorporation of the TCE group in high




















Scheme 1.18. TCE protected sulfate moiety
Attempts to extend the chemistry to other carbohydrates were found to be more
difficult than expected.  For example, we found that reacting 1,2:3,4-di-O-isopropylidene
galactose 1.48 with the TCE chlorosulfate 1.76 gave carbohydrate 1.80 in only a 51%
yield (Scheme 1.19a).  Analysis of the reaction products revealed that displacement of the
TCE sulfate moiety by the liberated chloride ion to give chlorosugar 1.81 was a
competing reaction.  Attempts to repeat this chemistry to include benzyl-protected
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carbohydrates 1.81 and 1.83 (Scheme 1.19b,c) were less successful, as the reactions




























































Scheme 1.19. Formation of chlorosugar by-products
The unexpected side reactions described in Scheme 1.19 led to the investigation
of alternative approaches.  In January of 2006, we introduced the 2,2,2-trichloroethyl
protecting group for sulfated carbohydrates.27 To achieve this, an entirely new class of
sulfating agents capable of introducing the TCE-protected sulfates to monosaccharide
building blocks was reported.  In search of a sulfating agent that did not liberate a
nucleophilic species such as a chloride ion, we prepared the sulfuryl imidazolium triflate
salt 1.87, according to Scheme 1.20. Although sulfuryl imidazolium salts have never been
reported, 2,2,2-trichloroethoxysulfuryl imidazole 1.86 was easily constructed (Scheme
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1.20). 2,2,2-Trichloroethylsulfuryl chloride 1.76 was treated with an excess of imidazole
to give TCE sulfuryl imidazole 1.86 in 86% yield.  Treatment of 1.86 with methyl triflate
(1.0 eq.) in dry diethyl ether provided the activated imidazolium triflate species 1.87.  As
this reaction progressed, 1.87 was found to precipitate out of solution, and was isolated
by simple filtration in near-quantitative yields, with no further purification required.
Reagent 1.87 was found to be very stable and can be stored for months at room





















0oC, THF 0oC, Et2O
1.87  96%1.86 86%
isolable and stable solid
1.76
Scheme 1.20. TCE-Sulfuryl imidazolium triflate reagent
We then demonstrated that the TCE-sulfurylimidazolium triflate salt 1.87 could
be reacted with a variety of monosaccharide building blocks (R in Scheme 1.21) in the
presence of N-methylimidazole (NMI) in THF to provide the corresponding TCE-
protected sulfocarbohydrates.  The sulfated products could be transformed under other
conditions to modified products, and at the end of the sequence, the TCE protecting































Scheme 1.21. TCE Sulfate protection and deprotection
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1.4 Summary and Thesis Outline
It is widely known that the chemical synthesis of complex carbohydrates is
extremely challenging. The reluctance of the pharmaceutical industry to target molecules
in this field is not surprising, as the industry depends on the ability to bring innovative
products to the market in a quick and cost-effective matter, a difficult feat for
oligosaccharide total synthesis.   Research in the last 10 years, however, has
demonstrated that carbohydrate-based compounds have immense therapeutic
possibilities.  Because of this, there are great efforts being conducted toward probing the
functions and synthesis of oligosaccharides with interesting biological profiles.
Sulfated carbohydrates are included in the group of biologically relevant
oligosaccharides, as they are implicated in a variety of biological processes; many of
which depend solely on the ‘sulfation code’ of a particular oligosaccharide.  There
remains, however, no simple and efficient route to obtain pure, well-defined fragments of
naturally occurring sulfated oligosaccharides
The remainder of this thesis focuses on my research contributions to the synthesis
of sulfated carbohydrates.  The ultimate goal was to devise an efficient and reliable
method by which such compounds can be prepared, providing a viable alternative to the
conventional methods currently in use.  Chapter 2 describes the development and
applications of 2,2,2-trichloroethyl (TCE) sulfuryl imidazolium salts for the preparation
of TCE-protected sulfated carbohydrates.  This methodology, unlike those currently in
use, allows for the incorporation of a protected sulfate diester at the monosaccharide
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building block stage.  Notable advantages of this approach include higher yields of
sulfation, and products that are non-polar and easy to purify and handle for subsequent
manipulations. Chapter 3 describes the efforts towards the total synthesis of chondroitin-
based sulfated oligosaccharides. These targets, which are known to be extremely difficult
to prepare synthetically, are ideal targets to further evaluate the scope of our TCE-
protecting group strategy.  The successes and shortfalls in the synthesis of a selection of
chondroitin sulfate oligosaccharides are discussed. Chapter 4 covers the development of
methodology that allows for selective 3-O-carbobenzoxylation of carbohydrate diols, and
the formation of the 2-O-Cbz migrated products.  This methodology will be applied
towards the total synthesis of a disulfated SB1A tetrasaccharide.
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Chapter 2 - 2,2,2-trichloroethyl-protected Carbohydrate
Sulfates
2.1  Background on the use of 2,2,2-Trichloroethoxysulfuryl
Imidazolium Triflate in the Preparation of Sulfated Carbohydrates
As mentioned in Chapter 1, in 2006 we reported the synthesis of a 2,2,2-
trichloroethoxysulfuryl-N-methylimidazolium triflate, (compound 1.87, Figure 2.1) the
first example of a sulfuryl imidazolium salt (SIS).27 This reagent represented the first of a
new class of potent sulfating agents, capable of reacting with nucleophilic substrates










Figure 2.1.  2,2,2-Trichloroethoxysulfuryl-N-methylimidazolium triflate (1.87)
It was also mentioned in chapter 1 (Scheme 1.21) that carbohydrates containing
TCE-protected sulfate groups could be prepared in good yields by subjecting partially
protected carbohydrates containing a free hydroxyl group to 1.87 and 1-methylimidazole
(1-MeIm).27,28  A selection of the prepared sulfated carbohydrates is shown in Table 2.1.
The target nucleophile substrates were designed with a number of factors in mind:  (1)
that the TCE sulfate group could be incorporated at the 2-O, 3-O, 4-O, and 6-O positions,
(2) a variety of commonly used protecting groups are employed, including acetate and
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benzoyl groups, benzyl ethers, as well as substituted acetals, and (3) the target TCE-
protected sulfocarbohydrates should provide ready access to both glycosyl donors and
acceptors.  In most cases, primary and secondary hydroxyl groups were sulfated in good
to excellent yields by subjecting them to 1.87 (2.0 – 5.0 eq.) and N-methylimidazole (1-
MeIm) in THF (2.5 – 6.0 eq.) in THF for 16-46 hours.  A select few sulfation reactions
were found to be more difficult than others.  In the case of 2.11, 11.6 eq. of 1-MeIm 10.5
eq. of 1.87 and 72 hours were required to achieve a 90 % yield of the sulfated product
2.12.  Similarly, carbohydrate 2.19 was obtained in only a 76% yield, even after 2.17 was
treated with 6 eq. of 1.87 over a 72 h period.  For all reactions, the presence of 1-MeIm
was essential, as other bases (NEt3, Hunig’s base, pyridine, 2,6-lutidine, and piperidine)
were considerably less effective.
37















Entry       Monosaccharide Sulfated Product Yield (%)














































































































a) 2.5 eq. 1-MeIm, 2.0 eq. 1.87; b) 5.3 eq. 1-MeIm, 4.7 eq. 1.87; c) 11.6 eq. 1-MeIm, 10.5 eq.












When a new protecting group is introduced, one of the most important factors to
demonstrate is that the group can be removed without difficulty, and in respectable yields
when required.  The TCE group was easily removed in high yields from the sulfated
carbohydrates by subjecting the compounds to zinc and ammonium formate in methanol
(Table 2.2).  Apart from the presence of ZnCl2, Zn(HCO2)2 and NH4Cl, the crude sulfates
were essentially pure.  These side products were easily removed by passing the
carbohydrate through a short column of silica with CH2Cl2/MeOH/NH4OH (20:4:1) as
eluent. Deprotection studies were also performed with Pd/C–ammonium formate;


















































































































In order for the TCE-protected sulfate methodology to be applied to carbohydrate
chemistry, it was essential to demonstrate that the TCE sulfates are stable to a wide
variety of conditions commonly encountered in the synthesis of higher order
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oligosaccharides.  The TCESO3 moiety should remain intact during routine protecting
group manipulations, as this is one of the major components in the synthesis of complex
carbohydrates. The protected sulfates must also tolerate conditions for anomeric
activation; and survive conditions required for the coupling of monosaccharides, which
often involve nucleophilic acceptors as well as strong promoters.  Table 2.3 demonstrates
that, for the most part, the TCE-protected sulfates are stable to many conditions
commonly encountered in carbohydrate chemistry, and could offer a viable approach
towards the synthesis of sulfated carbohydrates.  Selective 6-O-debenzylation and
acetylation of 2.8 with ZnCl2/AcOH/Ac2O gave 2.26, which could be treated with
catalytic NaOMe in MeOH to give the deacetylated product 2.27 in 85% yield.
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Table 2.3.  Manipulations of TCE-protected carbohydrate sulfates29
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Unfortunately, the ease with which the primary acetate in 2.26 was removed could
not be extended successfully to other carbohydrates.  Attempts to deacetylate 2.18, which
bears secondary acetate groups, under the same Zemplén conditions resulted in both de-
acetylation and loss of the TCE-sulfate.  This issue is easily overcome by stirring an
acetylated carbohydrate (such as 2.18) in acidic methanol to get the corresponding de-
esterified compound (2.28 for example) in good yields.
Benzylidene acetals are key protecting groups in carbohydrate chemistry, as they
protect two hydroxyl groups with high regioselectivity.  The TCESO3 was found to be
tolerant of the conditions required for the regioselective reductive opening of the
benzylidene acetal.  Sulfated carbohydrate 2.10 bearing a benzylidene acetal can be
treated with PhBCl2 or TfOH in the presence of Et3SiH to access 2.29 with a free 6-OH,
or 2.30 with a free 4-OH in good yields.  The benzylidene acetal in 2.10 was also
completely removed under acidic conditions to provide 2.31, the corresponding 4,6-diol.
No detectable loss of the TCESO3 group was observed in any of these reactions.
Difficulties were initially encountered when attempting to selectively cleave a
benzyl ether in the presence of the TCE-protected sulfate in 2.14 using hydrogenolysis, as
the TCE protecting group is known to be removed under the standard hydrogenolysis (Pd,
H2) conditions.  Photochemically initiated debenzylation was first documented by
Binkley and Hehemann in 1990,30 and was developed further by Riley and Grindley in
2001.31 In this approach, sterically hindered benzyl ethers that could not be removed by
hydrogenolysis, or those that progressed slowly, were readily removed by applying N-
bromosuccinimide (NBS) and light in the presence of aqueous calcium carbonate.
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Subjecting benzylated 2.14 to these conditions (table 2.3, entry 10) resulted in the
selective 4-O-debenzylation to give easy access to the corresponding alcohol 2.34 in a
91% yield.
The stability of the TCE protecting group was further examined in the preparation
of activatable carbohydrate donors and disaccharide formation.  Thioglycoside 2.16,
bearing a TCE-protected sulfate group at C-4 was subjected to NBS in acetone/water to
give the corresponding hemiacetal 2.32  in a 74 % yield.  Reacting 2.32  with
trichloroacetonitrile in the presence of a catalytic amount of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) at low temperature, provided the
trichloroacetimidate 2.33 in 80 % yield (entry 9, table 2.3)
As mentioned in Chapter 1, Karst et al. removed the TFE moiety from sulfate
groups in fully protected disaccharides in low to moderate yields.24  It was anticipated
that this would not be an issue with the TCE group, as it is removed under very mild
conditions. To illustrate this, trichloroacetimidate donor 2.33 was coupled to glycosyl
acceptor 2.29 in the presence of TMSOTf to give disaccharide 2.35 in 81 % yield
(Scheme 2.1).  Deprotection of 2.35 with zinc and ammonium formate gave the sulfo-










































Scheme 2.1.   Synthesis of a disulfated disaccharide
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2.2  Objectives
One of the limitations of reagent 1.87 is that the sulfations need to be run in THF
due to the low solubility of the triflate salt in other solvents, such as dichloromethane.
This is a hindering factor for the reactions involving poorly nucleophilic substrates, as
these reactions tend to proceed very slowly. It is suspected that for the slower reactions,
reagent 1.87 begins to break down in THF before the sulfation occurs, thus the reaction
requires additional aliquots over extended periods of time. For example, from table 2.1,
the sulfation reaction with the 4-OH substrate 2.17 proceeded very slowly, and required
up to 6 equivalents of 1.87 to reach completion over two days.  Also, for the 2-O-
sulfation of 2.11, over 10 eq. of 1.87 were required over 72 hours.  So although this new
sulfation methodology gives the desired products in good yields, there is clearly room for
improvement.  The primary objective of the work described in this chapter is to develop
an SIS with stability, solubility and sulfation properties that are superior to that of reagent
1.87.  Additional objectives are to examine the sulfate protecting group strategy as a
means of preparing N-sulfated compounds including N-sulfated carbohydrates and to
examine alternative means of removing the TCE groups from TCE-protected sulfate
groups in carbohydrates.
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2.3 Results and Discussion
2.3.1  Derivatives of 2,2,2-Trichloroethoxysulfuryl Imidazolium Triflate (1.87)
2.3.1.1  Synthesis of Derivatives of 2,2,2-Trichloroethoxysulfuryl Imidazolium Triflate
(1.87)
In conjunction with Dr. Ahmed M. Ali and Ahmed Desoky of the Taylor group,
we set out to modify the imidazolium moiety in reagent 1.87 anticipating that the
reactivity and/or stability of the sulfating agents could be tuned based on substitution on
the imidazole ring. In doing so, we prepared a series of sulfuryl imidazolium triflates, all
of which contained the TCE group, with different alkyl groups at the 2- and 3- positions
of the imidazolium ring.32  It was anticipated that modifying the imidazole moiety of
reagent 1.87 with alkyl groups could potentially change the solubility enough such that
the sulfation reactions could be performed in solvents that are less polar than THF such
as dichloromethane. The tetrafluoroborate counterion was also examined.  In most cases,
the synthesis of these compounds was readily achieved by reacting 2,2,2-
trichloroethylchlorosulfate 1.76 with an excess of the appropriate imidazole to give the
corresponding TCE sulfuryl imidazole (compounds 2.37-2.39).  The sulfuryl imidazole
compounds were then reacted with 1.0 eq. of methyl triflate, or trimethyl- or
triethyloxonium tetrafluoroborate to give the sulfuryl imidazolium salts (table 2.4).
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2.37 R' = Me (88%)
2.38 R' = Et (84%)
2.39 R' = iPr (68%)
2.40 - 2.48
Table 2.4
Product R R’ X- Yield (%)
2.40 Me Me TfO- 99
2.41 Et Me TfO- 98
2.42 iPr Me TfO- 85
2.43 Me Me BF4- 85
2.44 Et Me BF4- 79
2.45 iPr Me BF4- ND
2.46 Me Et BF4- 81
2.47 Et Et BF4- ND
2.48 iPr Et BF4- ND
Upon formation, most of the modified imidazolium salts precipitated out of
solution, and were easily isolated by filtration. It is likely that the precipitation of the
product is required to drive the formation of the sulfuryl imidazolium salts. Compounds
2.45, 2.47, and 2.48 did not precipitate out of the reaction mixture irrespective of the
solvent used (diethyl ether, THF, CH2Cl2), and the reaction did not go to completion even
with extended reaction times.  Attempts to selectively precipitate the products using non-
polar solvents such as hexane or pentane were not successful, and semisolids consisting
of both the starting material and product were obtained.
In general, sulfuryl imidazolium salts having the triflate counterion were obtained
in higher yields than those having the tetrafluoroborate counterion. For example,
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compound 2.42 was easily isolated in good yield, whereas the identical tetrafluoroborate
salt 2.45 could not be isolated at all. In the preparation and isolation of derivatives 2.46,
2.47, and 2.48, a few people encountered strong allergic reactions to the compounds, so
these salts were not pursued any further.  All of the isolated sulfuryl imidazolium salts
were obtained in pure form, were white powders, and were stored at 4 °C for months
without any detectable decomposition.
2.3.1.2  Sulfating Abilities of TCE Sulfuryl Imidazolium Salts 2.40-2.46
Carbohydrate 2.17 was chosen as a model compound to evaluate the sulfating
abilities of each of the TCE sulfuryl imidazolium salts 2.40 to 2.46, as it had previously
been noted as being challenging to sulfate under the original optimized sulfating
conditions (i.e. 2.5 eq. of 1.87 with 2.0 eq. 1-MeIm in THF, 0 °C).  As previously
mentioned in table 2.1, for the 4-O-sulfation of 2.17, over 6 eq. of 1.87 was required over
a 72 hour period to obtain sulfated 2.18 in a 76 % yield (table 2.1, entry 9). The yield of
2.18 was even lower when the reaction was performed in CH2Cl2, likely due to the very
limited solubility of 1.87 in this solvent.  To evaluate the new sulfuryl imidazolium salts,
compound 2.17 was reacted with 2 eq. of the sulfating agents 2.40 to 2.46 in various
solvents for 20 h.  The results are shown in table 2.5.  To have a direct comparison of
each of the new reagents, the reaction was halted at 20 h, whether or not it had reached
completion, and the isolated yield of 2.18 was determined after purification.   This work
was done in conjunction with Ahmed Desoky of the Taylor group.
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Reagent 2.40 - 2.46 (2.0 eq.)
Base (2.5 eq.), Solvent







Entry Reagent Base Solvent Yield (%)
1 1.87 1-MeIm THF 70
2 1.87 1-MeIm CH2Cl2 56
3 1.87 1-MeIm DMF 35
4 2.40 1,2-DiMeIm THF 65
5 2.40 1,2-DiMeIm CH2Cl2 80
6 2.40 1-Me-2-iPrIM CH2Cl2 53
7 2.40 1,2-DiMeIm DMF 40
8 2.41 1-Me-2-EtIm THF 18
9 2.41 1,2-DiMeIm THF 58
10 2.41 1-Me-2-EtIm CH2Cl2 21
11 2.41 1,2-DiMeIm CH2Cl2 68
12 2.42 1-Me-2-iPrIm THF 18
13 2.42 1,2-DiMeIm THF 54
14 2.42 1-Me-2-iPrIm CH2Cl2 30
15 2.42 1,2-DiMeIm CH2Cl2 60
16 2.43 1,2-DiMeIm CH2Cl2 79
17 2.44 1-Me-2-Et CH2Cl2 38
18 2.44 1,2-DiMeIm CH2Cl2 78
19 2.46 1-Et-2-MeIm CH2Cl2 45
20 2.46 1,2-DiMeIm CH2Cl2 75
For sulfating agents 2.40 – 2.42, CH2Cl2 proved to be a better reaction solvent
than THF, as 2.18 was obtained in higher yields when the two solvents were compared
under identical reaction conditions (for example, table 2.5 entry 1 vs. 2, and entry 4 vs.
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5).  Reagents 2.43 to 2.46 had very limited solubility in THF, thus were not evaluated in
that reaction medium.
The use of sulfuryl imidazolium salts 2.40  and 2.43 , which bear a 1,2-
dimethylimidazolium group, resulted in good yields when the sulfations were performed
in CH2Cl2 using 1,2-dimethylimidazole (1,2-diMeIm) as the base (table 2.5, entries 5 and
16).  The counterion (TfO- or BF4-) had no effect on the isolated yield of 2.18.  Lower
yields were obtained when the sulfating agents contained an ethyl or isopropyl group at
the 2-position of the imidazole ring (2.41, 2.42, 2.44) if the base used was the same as the
leaving group of the sulfating agent (1-methyl-2-ethylimidazole (1-Me-2-EtIm) for 2.41
and 2.44; 1-methyl-2-isopropylimidazole (1-Me-2-iPrIm) for 2.42, as shown by entries
10 and 17 in table 2.5.  The yield of 2.18 increased considerably when the same sulfating
reagents (2.41 and 2.44) were used in conjunction with 1,2-dimethylimidazole (entries 11
and 18, table 2.5) under the same reaction conditions.
To understand why 1,2-dimethylimidazole was a superior base to the others (i.e.
1-Me-2-EtIm, and 1-Me-2-iPrIm), nuclear magnetic resonance (NMR) investigations
were performed on a selection of the sulfating agents and the corresponding bases. 1H
NMR studies in CDCl3 revealed that just 1 eq. of 1,2-dimethylimidazole rapidly
displaced the 1-methyl-2-ethylimidazole or the 1-methyl-2-isopropylimidazole from
sulfating reagents 2.41 and 2.42 in less than five minutes, forming 2.40 in situ (Scheme
2.2), which has proven to be the better sulfating agent.  Even after several hours, 1H
NMR provided no evidence that the reverse reaction to the original compound was
occurring.  This indicates that reagent 2.40 is more stable than 2.41 and 2.42, possibly
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due to steric hindrance between the ethyl or isopropyl group at the 2-position of the













































2.40 (generated in situ)
N N
Scheme 2.2.  In situ imidazolium exchange
Reduced yields of 2.18 were also observed using reagent 2.40 and 1-Me-2-iPrIm
as a base in CH2Cl2 (table 2.5, entry 6).  This suggests that the low yields encountered
with sulfating agents 2.41, 2.42, and 2.44 could in part be due to the added imidazole
itself, which is likely acting as a general base during the reaction.  It is possible that there
is greater steric crowding at the transition state of the reaction with reagents 2.41, 2.42,
and 2.44 and the sterically hindered imidazole groups 1-Me-2-iPrIm and 1-Me-2-EtIm.
Sulfating reagent 2.46, which differs from 2.43 only by the presence of an ethyl instead
of a methyl group on the alkylated nitrogen atom, gave lower yields than 2.43 when 1-
ethyl-2-methylimidazole (1-Et-2-MeIm) was used a base (entry 16), but gave a similar
yield when 1,2-DiMeIm was added (entries 19 and 20).  These results again suggest that
the 1-Et-2-MeIM group in 2.46 is exchanging in situ with 1,2-DiMeIm, forming a more
reactive sulfating species.
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Overall, sulfuryl imidazolium salt 2.40 was prepared in the highest yield, and
provided the desired sulfated carbohydrate 2.18 in the highest yields. In light of this,
reagent 2.40 was chosen for further study. Additional studies with reagent 2.40 and
carbohydrate 2.17 revealed that 2.18 could be prepared in an 88 % yield in 24 h, using
just 3 eq. of 2.40 and 4.3 eq. of 1,2-DiMeIm in CH2Cl2 (Scheme 2.3a).  Furthermore,
carbohydrate 2.12, previously prepared in 90 % yield by subjecting 2.11 to 10.5 eq. of
1.87 in THF over 72 h (table 2.1) could be prepared using only 4 eq. of 2.40, in a 96 %
yield after just 24 h (Scheme 2.3b).  Performing the reaction under the same conditions in
THF gave only a 40 % of 2.12, with unreacted starting material 2.11 still remaining after
24 h. This result demonstrates that these reactions can be subject to a significant solvent
effect.  Surprisingly, a complex mixture of products was obtained when 2.49, the
thioglycoside analogue of 2.11 was subjected to the optimized sulfating conditions
(Scheme 2.3c).  Despite numerous efforts, the target sulfated thioglycoside 2.50 could not
be isolated.  This was unexpected, as the sulfation of the 4-OH on thioglycoside 2.15
(table 2.1) progressed very smoothly to provide 2.16 in a 91 % yield.  In the case of 2.49,
it is possible that upon 2-O-sulfation, an intramolecular displacement of the TCE sulfate
by the sulfur atom occurs, resulting in the formation of a reactive episulfonium ion.
Alternatively, it is possible that the thioglycoside is activated by the imidazolium triflate








































































Scheme 2.3. Improved Sulfation Reactions
2.3.2  TCE-Protected N-Sulfate Moieties in Amines
Glucosamine monomers are one of the most abundant sugars, found primarily in
carbohydrate-based biomolecules.  In naturally occurring polymers the residues can exist
in the free amine form, but are most commonly found as the N-sulfated and N-acetylated
derivatives.  The scope and application of our TCE-protected sulfate chemistry was
examined in the synthesis of both N- and O- sulfated glucosamine residues; and the
compatibility of TCE protected sulfates with N-acetyl glucosamine donors was examined.
2.3.2.1  Sulfation of Simple Amines
The sulfation of simple amines was first examined as described in Table 2.6.
Several primary and secondary commercially available amines were selected as
substrates to examine sulfating abilities of reagents 1.87 and 2.40.  Table 2.6 summarizes
the results of these studies.
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1.87 R = H


































a THF (0.23 M), 2.5 eq. 1,2-dimethylimidazole, 2.0 eq 1.87, 8-14 h.
b THF (0.23 M), 2.5 eq. 1-methylimidazole, 2.0 eq. 2.40, 8-14h
Sulfation of cyclohexylamine (2.51) and benzylamine (2.53) using reagent 2.40 gave
the desired sulfated products 2.52 and 2.54 in excellent yields, whereas very poor yields
were obtained using sulfating agent 1.87.32 N-Sulfation of secondary amines 2.55 and
2.57 with reagent 2.40 progressed smoothly affording the corresponding N-sulfates 2.56
and 2.58 in high yields. The sulfation of 2.55 and 2.56 with 1.87 was not examined.  We
do not have a clear explanation as to why SISs 1.87 and 2.40 behave so differently under
identical conditions when amine nucleophiles are used, but demonstrate in the next
section that this observation is not limited to simple aliphatic amines.
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2.3.2.2   Sulfation of 1,3,4,5-tetra-O-acetyl-β-D-glucosamine hydrochloride
As our laboratory was investigating the sulfation of carbohydrate-based amines,
Chen and Yu published the first literature example of N-sulfate protection with the TCE
protecting group.33 The authors demonstrated that readily available 1,3,4,6-tetra- O-
acetyl-β-D-glucosamine hydrochloride (2.59) could be treated with our original sulfating
agent, TCE-chlorosulfate 1.76, in the presence of DMAP and NEt3 to access the TCE-
protected glucosamine-N-sulfate derivative 2.60  in an 82 % yield (Scheme 2.4).
Unfortunately, very little experimental details (such as the required amount of





















Scheme 2.4. TCE-protected N-Sulfate
Our initial attempts to repeat the literature sulfation of 2.59 published by Chen
and Yu were unsuccessful, likely due to the lack of experimental details on the
preparation of the compound.  Yu was contacted to obtain the details of his synthesis, and
it was learned that 2.60 was prepared by the addition of a solution of 2.59 and 3.0 eq. of
NEt3 in DMF over 1 h to a solution of 1.76 (6.0 eq) and DMAP (1.0 eq) in DMF.  Under
identical conditions, the best yield of 2.60 that could be obtained was 45 % (table 2.7,
entry 1).  The reaction produced two major products, one of which was the desired
sulfated 2.60, and second product was determined to be dimer 2.61, a byproduct that was
not mentioned in Chen and Yu’s original report. This sulfation reaction was performed
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numerous times under the literature conditions, and in each instance, 2.60 and 2.61 were
formed in 40-45 % yields.  Alternative reaction conditions were examined with hopes to
increase the yield of 2.60, while minimizing the formation of dimer 2.61 and the results
are summarized in table 2.7.  Adding 1.1 eq. reagent 1.76 to a solution of Et3N and 2.59
in DMF at 0 oC resulted in only the formation of dimer 2.61 in low yield (entry 2).
Performing the reaction under the same conditions described by Chen and Yu except
CH2Cl2 was used in place of DMF (table 2.7, entry 3) gave exclusively dimer 2.61 in a 70
% yield.
Attempts to prepare compound 2.60 using reagent 2.40 also gave disappointing
results with the best yield of 2.60 being only 29 % when the reaction was performed with
6.0 eq. of 2.40 in the presence of 3.5 eq. of 1,2-diMeIm (entry 7).  In some instances we
were able to isolate (TCEO)2SO2 (2.62).  Performing the same reaction in DMF (entry 9,
table 2.7) gave an even lower yield of 2.60 (18 %); however in neither case was dimer
2.61 formed.  It was assumed that a stronger base such as NEt3 is required for elimination
of trichloroethanol from 2.60, which would lead to dimer formation.  Attempts to access
2.60 using 4.0 eq. of 2.40 and 1,2-diMeIm in the presence of NEt3 or pyridine gave only
trace amounts of the desired product (entries 10 and 11).
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Entry Reagent (eq) Solvent Base (Eq.) 2.60 2.61
1a 1.76 (6.0 eq) DMF NEt3 (3.5)
DMAP (1.0)
40% 45%
2b 1.76 (1.1 eq) DMF NEt3 (3.5)
DMAP (1.0)
0% 20%
3a 1.76 (6.0 eq) DCM NEt3 (3.5)
DMAP (1.0)
0% 70%
4b 2.40 (1.1 eq) DMF NEt3 (3.5)
DMAP (1.0)
0% 0%
5b 2.40 (3.0 eq) DCM NEt3 (3.5)
DMAP (1.0)
0% 68%
6b,c 2.40 (2.0 eq) DCM 1,2-DiMeIm (4.0) 0% 0%
7b,c 2.40 (6.0 eq) DCM 1,2-DiMeIm (3.5) 29% 0%
8a,c 2.40 (6.0 eq) DCM 1,2-DiMeIm (3.5) 23% 0%
9a 2.40 (6.0 eq) DMF 1,2-DiMeIm (3.5) 18% 0%
10a 2.40 (4.0 eq) DCM NEt3 (1.0)
1,2-DiMeIm (4.0)
trace Trace
11a 2.40 (4.0 eq) pyridine NEt3 (1.0) trace Trace
a2.59 and base in solvent (0.1 M wrt 2.59) added at 0 °C over 1 h to a solution of 1.76 or 2.40 and
DMAP in solvent (2.0 M wrt 1.76 or 2.40).
b2.59 in solvent (0.05M) at 0 °C, add base then reagent 1.76 or 2.40
c Isolated significant quantities of 2.62
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2.3.2.3  N-Sulfation of Glucosamine Derivatives as their Free bases
After encountering limitations when attempting to introduce the TCESO3 moiety
to per-acetylated glucosamine hydrochloride 2.61, we turned our attention to glucosamine
monomers bearing amino groups as their free bases.  Two model substrates, 2.64 and
2.67, were prepared as stable free amines, and were subjected to reagents 1.76, 1.87 or
2.40 under a variety of conditions.  The results are summarized in table 2.8.
Sulfation of 2.64 with reagent 1.76 using the conditions of Chen and Yu did not
result in the formation of the N-sulfated product 2.65; however dimer 2.66 was isolated in
a 70 % yield (table 2.8, entry 1). Sulfation of 2.64 using reagent 1.76 in the presence of
1,2-DiMeIm gave 2.65 in a 60% yield (entry 2).  Sulfation reactions using amine 2.64,
reagent 1.87 and 1-MeIm were  unsuccessful or very low yielding as complex mixtures of
products were formed (determined by TLC), and only trace quantities of the sulfated
amine 2.65 were obtained (table 2.8, entries 3-5).
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2.64 R1 = STol, R2 = H



















2.65 R1 = STol, R2 = H












Solvent Base (Eq.) 2.65 or
2.68
2.66
1 2.64 1.76 (6.0) DMF NEt3 (3.5), DMAP (1.0) 0% 70%
2 2.67 1.76 (2.0) THF 1,2-DiMeIm (4.0) 60% N/A
3 2.64 1.87 (2.0) THF 1-MeIm (2.5) Trace 0%
4 2.64 1.87 (6.0) THF 1-MeIm (4.0) Trace 0%
5 2.64 1.87 (6.0) CH2Cl2 1-MeIm (4.0) Trace 0%
6 2.64 2.40 (6.0) THF 1,2-DiMeIm (4.0) 94% 0%
7 2.64 2.40 (6.0) CH2Cl2 1,2-DiMeIm (4.0) 95% 0%
8 2.67 2.40 (4.0) THF 1,2-DiMeIm (3.5) 94% N/A
9 2.67 1.87 (6.0) THF 1-MeIm (3.5) 9% N/A
However, subjecting 2.64 to 6.0 eq. of 2.40 and 4.0 eq. of 1,2-DiMeIm in either
THF or CH2Cl2 (entries 6 and 7) gave N-sulfated glucosamine 2.65 in 94-95% yield.
Similarly, the sulfation of 2.67, which bears an anomeric allyl protecting group in place
of the thioglycoside, was readily achieved under the same conditions using reagent 2.40
and 1,2-DiMeIm to give N-sulfated product 2.68 in a 94 % yield (table 2.8, entry 8) while
reagent 1.87 gave only a 9% yield of 2.68 (entry 9).  Thus, the difference in reactivity
between sulfating agents 1.87 and 2.40 that was observed during the sulfation of simple
amines (table 2.6) was also observed in the sulfations of carbohydrate-based amines in
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that little or none of the desired product was obtained with reagent 1.87. We do not yet
have a clear understanding as to why sulfating agents 1.87 and 2.40 behave so differently
with amines.  One possible explanation could be that a free amine may deprotonate the 2-
position of the imidazole ring in 1.87, forming a reactive imidazolium carbene species; a
side reaction that could not occur with 2.40.  Alternatively, attack of the amine at the 2-
position of the imidazolium ring of 1.87 may also occur.  These hypotheses could not be
investigated by NMR, however, as 1.87 is poorly soluble in CDCl3.
The N-sulfated thioglycoside 2.65 was subjected to the standard zinc and
ammonium formate deprotection conditions to provide the unmasked N-sulfamate 2.69 in













Scheme 2.5. Deprotection of the TCE-protected N-sulfate
2.3.2.4  Attempted Synthesis of a Heparin Based Monosaccharide
While exploring the synthesis of N-sulfated monosaccharide residues, we turned











Figure 2.2. Heparin disaccharide fragment
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It was anticipated that the trisulfated glucosamine residue could easily be
prepared using the TCE-protection chemistry, with the sulfate groups being introduced in
































Scheme 2.6. Retrosynthesis of a trisulfated heparin monosaccharide
The synthesis of the trisulfated heparin acceptor was designed such that the per-
acetylated glucosamine hydrochloride 2.70 could be modified to obtain amino-alcohol
2.71 , which could be subjected to a simultaneous di-sulfation to obtain 2.72 .
Regioselective reductive opening of the benzylidene acetal in 2.72 would lead to a free 6-
OH, which can then be sulfated to provide the fully protected trisulfated monomer 2.73.
Scheme 2.7 describes the completed synthetic steps towards the synthesis of the
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2.78   75% 2.71   97%
NaOMe
Scheme 2.7.  Synthesis of amino-alcohol 2.71
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Compound 2.71 was prepared from 2.70 using literature procedures.34 Fully
protected glucosamine residue 2.75, was easily converted into methyl glycoside 2.76 with
an anomeric protecting group exchange using methanol and the boron trifluoride diethyl
etherate promoter.  Selective removal of the acetate esters in 2.76 under Zemplén
conditions yields triol 2.77, which was subjected to 4,6-O-benzylidenation with
dimethoxybenzaldehyde under acid catalyzed conditions to give partially protected 2.78
in moderate yields.  Finally, alkaline hydrolysis of the trifluoroacetamide group provided
the target amino-alcohol 2.71.
Unfortunately, the N- and O- disulfation did not proceed as expected.  The
reaction progressed very slowly, and required a considerable excess of 2.40 to push the
reaction to completion (as determined by consumption of starting material).  More
significantly, as shown in Scheme 2.8, none of the desired disulfated compound 2.72 was
obtained.  Instead, the only identifiable product was the sulfated aziridine 2.79, isolated

























Scheme 2.8.  Formation of N-sulfated aziridine product 2.79
Despite subjecting 2.71 to a variety of conditions to introduce the TCE-protected
sulfate groups, the formation of the N-sulfated aziridine product 2.79 could not be
avoided.35  This highlights one of the limitations of the TCE-protecting group chemistry,
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as it cannot be used to introduce TCE-protected sulfates to a 1,2-trans amino-alcohol
functionality.
2.3.3  Alternative Conditions for the Deprotection of TCE-protected sulfates
Naturally occurring glucosamine residues are most commonly found in the form
of a 2-acetamido-2-deoxyglucopyranoside. These monosaccharides are constituents of
biologically significant peptidoglycans, proteoglycans, glycosaminoglycans,
glycoproteins including milk oligosaccharides, as well as the blood group glycolipids.36
Because of this prevalence, chemical synthesis of naturally occurring oligosaccharides
can often require the use of a 2-acetamido-2-deoxyglucopyranoside glycosyl donor.
N-acetylated glucosamine donors (depicted by 2.80) are not commonly used for
difficult glycosylation reactions, as oxazoline compounds (such as 2.81) can readily form
upon donor activation (Scheme 2.9).  In certain cases, these oxazoline compounds are










Scheme 2.9. Stable oxazoline formation
In 1994, Blatter, Beau and Jacquinet provided a possible solution to this
problem.37  They proposed the use of a trichloroacetamide at the 2-position of the
glycosyl donor, suggesting that upon activation the corresponding 2-
(trichloromethyl)oxazolinium ion would form.  This intramolecular trichloroacetimidate
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species would prove to be a reactive glycosyl donor for the synthesis of 1,2-trans-2-
aminodeoxyglycosides. Using N-trichloroacetylated amines such as 2.82 in Scheme 2.10,
the authors demonstrated that the compounds could be effective donors for incorporating
the 2-deoxy-2-trichloroacetamido-β-D-glucopyranosyl units into disaccharides such as
2.84 (Scheme 2.10), in good yields and high 1,2-trans selectivity.  The main advantage of
their method over other 2-amino protection strategies is that the conversion of N-
trichloroacetyl in 2.84 to the required N-acetyl counterpart 2.85 (Scheme 2.10) is
achieved in a single step using tributylstannane and AIBN, affecting very few other
























































Scheme 2.10.  2-Trichloroacetamido-2-deoxyglucopyranosyl glycosyl donors37
2.3.3.1  Deprotection of TCE-protected sulfates using tributylstannane and AIBN
2-Trichloroacetamido-2-deoxyglucopyranosyl donors such as 2.82 presented a
potential complication to our TCE-sulfate protecting strategy.  Reduction of the
trichloroacetamide using tributylstannane and AIBN could possibly result in some or
complete reduction of the TCE sulfate moiety to a di- or monochloroethyl-protected
sulfate or even to an ethyl-protected sulfate as shown in Scheme 2.11.  This would not be
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a problem as long as the sulfate group can eventually be completely deprotected at the
































Scheme 2.11.  TCE and TCA co-reduction using tributylstannane and AIBN
To determine how tributylstannane/AIBN would affect a TCE-protected sulfate
group we subjected a model monosaccharide (2.18) to the literature reaction conditions (3
eq. tributylstannane, AIBN, benzene, 80 oC, 1 h) for the reduction of the N-
trichloroacetamide.  This resulted in a mixture containing mostly starting material, with
traces of mono- and didechlorinated products (entry 1, table 2.9).  Ideally, we wished to
develop conditions that would result in the complete reduction of the 2,2,2-trichloroethyl
group to the ethyl group.  Increasing the amount of reducing agent as well as the reaction
time lead to mixtures of the mono- di- and fully dechlorinated product, and in one
instance (entry 4), the desired completely dechlorinated product 2.86 was isolated in a 91
% yield. Unfortunately, these reaction conditions could not be easily reproduced, and
mixtures of partially and fully dechlorinated products were often obtained.  The
execution of these reductions required tedious work-ups because of the large excess of tin
reagents; and the dechlorinated products were very difficult to purify, often requiring 3 to
4 purifications by flash column chromatography.  It was then reasoned that it would take
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at least 12 equivalents of tributylstannane to co-reduce one TCE group along with one
trichloroacetamide, and the required work-up and purification would not be favourable
for products more complicated than simple monosaccharides.















Entry Bu3SnH Time Work-Up / Purification Result
1 3.0 eq. 1 h H2O Wash / 3 columns Mostly 2.18, trace mono, di-
dechlorinated products
2 6.0 eq. 1 h H2O Wash / 4 columns Mixture of mono-, di- and tri-
dechlorinated product
3 6.0 eq. 2 h CH3CN-Hexanes / 2 columns ~95 % contaminated with trace
didechlorinated
4 6.0 eq. 4 h CH3CN-Hexanes / 3 columns 91%
2.3.3.2   Deprotection of TCE-protected sulfates using polymethylhydrosiloxane,
aqueous KF and catalytic Bu3SnCl.
In 1990, Terstiege and Maleczka reported a radical dehalogenation pathway that
was performed under catalytic tin conditions as described by Scheme 2.12.38 In this
reaction, the organotin hydride is generated in situ, using polymethylhydrosiloxane











Scheme 2.12. Catalytic tributyltin chloride reduction
The TCE-protected monosaccharide 2.18 was subjected to the catalytic reduction
conditions developed by Terstiege and Maleczka with the intent to effectively convert the
TCE moiety to the corresponding ethyl group. The results are summarized in table 2.10.
Unfortunately, the desired compound was never obtained under the above conditions.
Several variables were examined, including amount of tributyltin chloride, aliquots of
PMHS with aqueous KF, solvent, and reaction time; but at best, only 2:1 mixtures of tri-
di dechlorinated products were obtained (table 2.10, entries 5 and 6).  Attempts to force
the reaction to completion with excess KF and PMHS resulted in a complex mixture of
products as determined by TLC.  This approach was not pursued any further.














Entry Bu3SnCl PMHS / aq. KF Conditions Result
1 0.1 eq 1.5 eq  (x3, 2h) PhCH3, 8h N.R.
2 0.1 eq 1.5 eq  (x3, 2h) PhH, 8h Trace product
3 0.25 eq 1.5 eq  (x3, 2h) PhH, 8h Trace product
4 0.5 eq 1.5 eq  (x3, 2h) PhH, 8h Trace product
5 1.0 eq 3.0 eq (X2, 1h) PhH, 2h 2:1 tri:di dechlorinated
6 1.0 eq 3.0 eq (x3, 1h) PhH, 3h 2:1 tri:di dechlorinated
7 1.0 eq 3.0 eq (x6, 1h) PhH, 6h Complex mixture
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2.3.3.3  Deprotection of TCE-protected sulfates using Catalytic Hydrogenolysis in Basic
Media
We then turned our attention to other dehalogenation conditions that, in theory,
would be more mild for the carbohydrate starting material.  Since the TCE group is easily
removed using zinc and ammonium formate, it was reasoned that similar conditions
might in fact reduce the trichloroacetamide moiety as well.  As shown in Scheme 2.13, N-
trichloroacetylated glucosamine derivative 2.87 was subjected to varying amounts of zinc
and ammonium formate in methanol.  Unfortunately, only mixtures of the mono- and di-
dechlorinated products 2.90 and 2.91 were observed, with no evidence of the completely























Scheme 2.13.   Zinc and ammonium formate mediated dechlorination
In 2000, Mulard and Ughetto-Monfin reported that during debenzylation of a
protected pentasaccharide under catalytic hydrogenation conditions (Pd/H2), the N-
trichloroacetamide group was partially reduced to a monochloroacetate.39 The authors
took advantage of this and found that the N-trichloroacetate moiety could be efficiently
transformed to the required N-acetamide group when the debenzylation was performed











Scheme 2.14. Hydrogenation conditions for trichloroacetamide reduction
TCE-protected carbohydrate sulfate 2.92 was subjected to the basic catalytic
hydrogenation conditions described by Scheme 2.13, to determine if the TCE protecting
group could be removed without subsequent loss of the sulfate moiety (table 2.11).  The
literature procedure describes the use of “2 drops” of triethylamine; thus some
optimization was required to obtain the reduced product in good yields.  Initial attempts
using the literature conditions resulted in desulfated product (table 2.11, entries 1-3).
Presumably, HCl is formed as the deprotection progresses, and sulfate groups are known
to be unstable in acidic media. Increasing the amount of triethylamine to 5 eq. allowed
for the isolation of the desired sulfated carbohydrate 2.93 in an excellent yield (entry 4),
and decreasing the amount of palladium catalyst from 50 wt % to 10 wt % increased the
reaction time slightly, but had no effect on the yield of the desired product (entry 5).
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Entry NEt3 (eq.) 10 % Pd/C Time Result
1 5 drops 50 wt % 30 min Desulfated product
2 1 eq 50 wt % 30 min Desulfated product
3 2 eq 50 wt % 30 min Desulfated product
4 5 eq 50 wt % 30 min 97 %
5 5 eq 10 wt % 90 min 98 %
To determine if the TCE and trichloroacetamide groups could be reduced
simultaneously, TCE-protected sulfated monosaccharide 2.94 was subjected to the
optimized conditions from table 2.9. Compound 2.95 was easily prepared in a 91% yield
by subjecting 2.94 to catalytic hydrogenation conditions in the presence of triethylamine










OBn10% Pd/C (25 wt%)





Scheme 2.15.   Co-reduction and deprotection of trichloroacetamide and TCE groups
2.4  Summary and Future Work
In 2004, we reported the first synthesis of a sulfuryl imidazolium salt.  Compound
1.87  was effective for introducing the TCE-protected sulfates into simple
monosaccharides in good yields.  The resulting TCE-protected sulfocarbohydrates were
found to be stable to various manipulations often encountered in carbohydrate synthesis;
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and yet the sulfate groups could easily be deprotected as required in excellent yields.
However, reagent 1.87 was not without its limitations.  To circumvent some of the
limitations of 1.87 a series of modified sulfuryl imidazolium salts were prepared and
studied.  We demonstrated that by incorporating a methyl group at the 2-position of the
imidazolium ring of 1.87 a more efficient sulfating agent, 2.40, was obtained.  O-
Sulfations that required prolonged reaction times and a large excess of the original
reagent 1.87, were more readily achieved using reagent 2.40.  Attempts to incorporate a
TCE-protected sulfate at the 2-position of a thioglycoside failed revealing a limitation of
our sulfate protecting group approach.  Furthermore, we expanded the scope of the
chemistry to include the synthesis of selected N-sulfated glucosamine derivatives.
Certain N-sulfated compounds that that were practically inaccessible using 1.87 could be
obtained in excellent yield using SIS 2.40. However, shortcomings were observed as a
target 2-N, 3-O-disulfated product could not be prepared.  The compatibility of the TCE-
protected sulfate groups with the reduction of N-trichloroacetylated glucosamine donors
was also resolved, as it was demonstrated that the N-trichloroacetamide and TCE-
protected sulfate could be simultaneously reduced and deprotected under the same
conditions.  These successes suggest that the TCE-protection strategy could be
considered a viable approach to the synthesis of complex sulfated oligosaccharides.
Clearly the next step in this work is the application of our sulfate protecting group
strategy to the total synthesis of a multisulfated oligosaccharide.  Our efforts towards this
goal are discussed in Chapters 3 and 4.
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2.5  Experimental
2.5.1  General Information
All reactions were carried out using freshly distilled solvents unless otherwise
noted.  Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium metal
in the presence of benzophenone under argon.  CH2Cl2 was distilled from calcium
hydride under nitrogen.  Flash chromatography was performed using silica gel 60 Å (234-
400 mesh).  Chemical shifts (δ) for 1H NMR spectra are reported in parts per million
(ppm) relative to Me4Si (0.0 ppm) or DMSO-d6 (2.49 ppm) and are reported as follows:
chemical shift (ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet;
br, broadened), integration, coupling constant in Hz, and assignment.   Chemical shifts
(δ) for 13C spectra are reported in ppm relative to CDCl3 (δ 77.0, central peak) or DMSO-
d6 (δ 39.5, central peak).  Chemical shifts (δ) for 19F spectra are reported in ppm relative
to an external standard (δ 0.0, CFCl3).  All peak assignments were confirmed using 2D-
NMR (COSY, HMQC) techniques. Optical rotations were measured at the sodium D line
at ambient temperature in cells with 1 dm path length. All melting points are uncorrected.
High resolution mass spectra were obtained at the University of Waterloo Mass
Spectrometry Facility.  HRMS data for chlorine containing compounds is reported for
35Cl. Compounds 2.38, 2.39, and 2.41-2.48 were prepared by Dr. Ahmed Ali and Ahmed
Desoky.
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2.5.2  Experimental Syntheses
2,2,2-Trichloroethoxysulfuryl chloride (1.76). Procedure modified from
the original synthesis.40 Distilled sulfuryl chloride (20.0 mL, 0.250 mol)
was added dropwise via syringe pump over 1 h to a solution of pyridine (20.5 mL, 0.250
mol) and 2,2,2-trichloroethanol (24.0 mL, 0.250 mol) in distilled Et2O at –78 °C.  The
resulting slurry was stirred for an additional 1 h at –78 °C, then stirred for 3 h at room
temperature.  The precipitate was removed by suction filtration and the filtrate was
concentrate to a crude oil.  Purification by vacuum distillation afforded 1.76 as a clear
colourless oil (54.4 g, 88%). Boiling point 71 °C/ 8 mm Hg. 1H NMR (300 MHz, CDCl3)
δ 4.90 (s, 2H, CH2).
General procedure for the synthesis of 1-(2,2,2-Trichloroethoxysulfuryl) 2-
substituted imidazoles (2.37, 2.38, 2.39).  To a solution of appropriately 2-substituted
imidazole (0.072 mol, 3.60 eq.) in dry THF (40 mL) at 0 oC was added dropwise a
solution of 2,2,2-trichloroethoxysulfuryl chloride (1.76) (5.0 g, 0.02 mol, 1.00 eq.) in
THF (50 mL). The reaction was stirred at 0 oC for 1 h, warmed to room temperature and
stirred for an additional hour. The reaction mixture was filtered; residue washed with
THF and the combined filtrate was concentrated under vacuum. The crude residue was








2,2,2-Trichloroethoxysulfuryl-(2-methyl)imidazole (2.37). To 2-
methyl imidazole (0.493 g 6.0 mmol) in CH2Cl2 (1 mL) at 0 0C was
added a solution of 2,2,2-trichloroethyl chlorosulfate 1.76 (0.5 g 2.0 mmol) in CH2Cl2
(1.5 mL).  The reaction was gradually warmed to room temperature, and allowed to stir
for 24 h.  The crude material was concentrated, then purified by flash chromatography
(33:67 EtOAc/hexanes) to provide 2.37 as a white solid (0.464 g, 75%). 1H NMR (300
MHz, CDCl3) δ 2.68 (s, 3H, CH3), 4.66 (s, 2H, CH2), 6.96 (d, 1H, J = 1.5 Hz, ImH), 7.33
(d, 1H, J = 1.5 Hz, ImH); 13C NMR (75 MHz, CDCl3) δ  14.8, 79.9, 91.6, 120.0, 128.2,
146.4. Melting point 53-55 °C.
2,2,2-Trichloroethoxysulfuryl-(2-methyl)-N-methylimidazolium
triflate (2.40). To a solution of 2,2,2-trichloroethoxysulfuryl-(2-
methyl)imidazole 2.37 (5.0 g, 17.0 mmol) in Et2O (65 mL) at 0 oC was added dropwise
methyl triflate (2.1 mL, 18.7 mmol).  The reaction was stirred for 3 h at 0 oC during
which time a white precipitate formed.  The desired product was isolated by suction
filtration, in which the first filtrate was cooled to re-precipitate any remaining product
(1x) and washed with cold Et2O to afford 2.40 as a fluffy white solid (6.32 g, 81%). 1H
NMR (300 MHz, MeOD) δ 2.96 (s, 3H, CH3), 3.96 (s, 3H, CH3), 5.38, (s, 2H, CH2), 7.77
(d, 1H, J = 1.6 Hz, ImH), 8.10 (d, 1H, J = 1.6 Hz, ImH); 13C NMR (75 MHz, MeOD) δ




















carbohydrate 2.11 (0.200 g, 0.431 mmol) in freshly distilled dichloromethane (2.7 mL) at
0 °C was added 1,2-dimethylimidazole (0.100 g, 1.0 mmol) followed by sulfating agent
2.40 (0.400 g, 0.874 mmol). The reaction was gradually brought to room temperature by
allowing the ice bath to melt, and then stirred for 16 hours.  Analysis by TLC indicated
remaining starting material, thus additional 1,2-dimethylimidazole (0.100 g, 1.0 mmol)
and sulfating agent 2.40 (0.4 g, 0.874 mmol) were added at room temperature.  The
reaction was stirred for an additional 8 hours, at which point no starting material was
detected by TLC.  The reaction was diluted with dichloromethane (1.0 mL) and quenched
with water (1.0 mL).  The organic layer was separated and dried over MgSO4, and
concentrated to a brown crude oil.  Purification by flash chromatography (25:75
EtOAc/hexanes) afforded 2.12 as an amorphous white solid (0.278 g, 96%).  1H NMR
(300 MHz, CDCl3) δ 3.57 (ddd, 1H, J5,6ax = 9.7, J5,4 = 9.5, J5,6eq = 5.0 Hz, H5), 3.80 (s,
3H, CH3), 3.86 (tapp, 1H, J6eq,6ax =  J6ax,5 = 10.4 Hz, H6ax), 3.88 (tapp,  1H, J4,5 = J4,3 = 9.2
Hz, H4), 3.98 (tapp, 1H, J3,4 = J3,2 = 9.1 Hz, H3), 4.43 (dd, 1H, J6eq,6ax = 10.5, J6eq,5 = 5.0
Hz, H6eq), 4.68, 4.71 (AB, 2H, J = 11.1 Hz, CH2CCl3), 4.85 (m, 1H, H2), 4.87, 5.01 (AB,
2H, J = 11.2 Hz, CH2Ph), 5.02 (d, 1H, J1,2 = 7.8 Hz, H1), 5.61 (s, 1H, CHPh), 6.85-6.88
(m, 2H, ArH), 7.06-7.09 (m, 2H, ArH), 7.33-7.50 (m, 10H, ArH); 13C NMR (75 MHz,
CDCl3) δ 55.5, 66.2, 66.3, 74.6, 77.9, 79.9, 81.2, 83.9, 92.6, 99.9, 101.4, 114.6, 118.8,













To carbohydrate 2.17 (0.25 g, 0.54 mmol) in CH2Cl2 (2.2 mL, 0.25 M) at 0 oC was added
1,2-dimethylimidazole (0.130 g, 1.35 mmol) followed by the sulfating agent 2.40 (0.48 g,
0.104 mmol). The reaction was stirred at 0 oC, allowed to warm to room temperature by
allowing the ice bath to melt.  After 12 h, additional 1,2-dimethylimidazole (0.104 g, 1.08
mmol) and 2.40 (0.24 g, 0.524 mmoL) were added, and the reaction was stirred for an
additional 12 h at rt.  The solvent was removed under vacuum and the crude oil was
immediately applied to a silica gel column. Flash chromatography (27:75
EtOAc/hexanes) yielded 2.18 as a white amorphous solid. 1H NMR (300 MHz, CDCl3) δ
1H NMR (300 MHz, CDCl3) δ 2.08 (s, 3H, CH3), 2.13 (s, 3H, CH3), 3.77 (s, 3H, OCH3),
3.77-3.81 (m, 3H, H5, H6, H6’), 4.59, 4.62 (AB, 2H, J = 11.8 Hz, CH2Ph), 4.68, 4.73
(AB, 2H, J = 11.1 Hz, CH2CCl3), 4.97 (d, 1H, J1,2 = 7.9 Hz, H1), 5.00 (tapp, 1H, J4,5 = J4,3
= 9.3 Hz, H4), 5.22 (dd, 1H, J2,3 = 9.3 Hz, J2,1 = 7.9 Hz, H2), 5.42 (tapp, 1H, J3,4 = J3,2 =
9.3 Hz, H3), 6.78 – 6.81 (m, 2H, ArH), 6.94 – 6.97 (m, 2H, ArH), 7.26 – 7.34 (m, 5H,
ArH); 13C NMR (75 MHz, CDCl3) δ 20.6, 20.7, 55.6, 67.9, 71.4, 73.2, 73.8, 79.3, 80.2,
92.5, 100.2, 114.6, 118.8, 127.8, 127.8, 128.4, 137.5, 150.8, 155.9, 169.3, 170.3; [α]D25








General procedure for preparation of sulfated amines 2.51-2.57.  To the appropriate
amine (1.0 eq) in THF (0.23 M) at 0 °C was added 1,2-dimethylimidazole or 1-
methylimidazole (2.5 eq) followed by sulfating agent 2.40 or 1.87 (2.0 eq).  The reactions
were gradually brought to room temperature, and stirred for 8-14 hours.  The crude
material was applied directly to a silica gel column, and purified by flash chromatography
(33:67 EtOAc/hexanes).
2,2,2-Trichloroethyl cyclohexylsulfamate (2.52): 99% as a white solid.
1H NMR (300 MHz, CDCl3) δ  1.22-1.41 (m, 5H, CH2), 1.61-1.79 (m,
3H, CH2), 2.06-2.11 (m, 2H, CH2), 3.44-3.48 (m, 1H, CHN), 4.59 (d, 1H, J = 12.4 Hz,
NH), 4.64 (s, 2H, CH2CCl3); 13C NMR (75 MHz, CDCl3) δ 24.59, 25.06, 33.59, 54.17,
78.15, 93.50; Melting point 80-82 °C; HRMS (EI) m/z = 308.9756, C8H14Cl3NO3S
requires 308.9760.
2,2,2-Trichloroethyl benzylsulfamate (2.54): 95% as a white solid.
1H NMR (300 MHz, CDCl3) δ 4.38 (d, 2H, J = 5.8 Hz, CH2Ph), 4.56
(s, 2H, CH2CCl3), 4.92 (br-s, 1H, NH), 7.32-7.35 (m, 5H, ArH); 13C NMR (75 MHz,
CDCl3) δ 48.12, 78.27, 93.40, 128.41, 128.50, 129.01, 135.52; Melting point 87-89 °C;





2,2,2-Trichloroethyl butyl(methyl)sulfamate (2.56): 90% as a clear
colourless oil. 1H NMR (300 MHz, CDCl3) δ 0.92 (t, 3H, J = 7.3 Hz,
CH3CH2CH2CH2N), 1.34 (tq, 2H, J1 = J2 = 7.4 Hz, CH3CH2CH2CH2N), 1.60 (tt, 2H, J1 =
J2 =7.3 Hz, CH3CH2CH2CH2N), 2.93 (s, 3H, CH3), 3.27 (t, 2H, J  = 7.4 Hz,
CH3CH2CH2CH2N), 4.57 (s, 2H, CH2CCl3); 13C NMR (75 MHz, CDCl3) δ 13.62, 19.59,
29.17, 35.49, 51.16, 77.67, 93.79; HRMS (EI) m/z = 296.9753, C7H14Cl3NO3S requires
296.9760.
2,2,2-Trichloroethyl piperidine-1-sulfonate (2.58): 98% as a white solid.
1H NMR (300 MHz, CDCl3) δ 1.57-1.70 (m, 6H, CH2), 3.35 (t, 4H, J = 5.3
Hz, CH2N), 4.58 (s, 2H, CH2CCl3); 13C NMR (75 MHz, CDCl3) δ 23.38, 24.77, 47.86,




and dimeric by-product (2.61): A solution containing
carbohydrate 2.59 (0.200 g, 0.521 mmol) and NEt3 (0.25 mL,
1.78 mmol) in dry DMF (10.0 mL) was added dropwise via
syringe pump over 1.5 hours to a solution of reagent 1.76 (0.41 mL, 3.13 mmol) and


























an additional 30 minutes at 0 °C, then diluted with dichloromethane (10 mL) and
quenched with ice water (5 mL).  The organic phase was separated, and the remaining
aqueous phase was extracted with dichloromethane (2x5 mL).  The combined organics
were dried over MgSO4 and concentrated to a crude yellow oil.  Purification by flash
chromatography (1:1 EtOAc/Hexanes) provided N-sulfated product 2.60 as a white foam
(0.132 g, 45%) and the dimeric by product 2.61 as a yellow solid (0.088 g, 45%).
Compound 2.60: 1H NMR (300 MHz, CDCl3) δ  2.04 (s, 3H, CH3), 2.08 (s, 3H, CH3),
2.14 (s, 3H, CH3), 2.20 (s, 3H, CH3), 3.78 (m, 1H, H2), 3.87 (m, 1H, H5), 4.11 (dd, 1H,
J6,6’ =  12.5 Hz, J6,5 = 1.8 Hz, H6), 4.28 (dd, 1H, J6’,6 =  12.5 Hz, J6’,5 = 4.4 Hz, H6’), 4.61
(s, 2H, CH2), 5.08 (tapp, 1H, J4,5 = J4,3 = 9.6 Hz, H4), 5.22 (tapp, 1H, J3,4+J3,2 = 19.8 Hz,
H3), 5.72 (d, 1H, J1,2 = 8.6 Hz, H1), 5.99 (d, 1H, JNH,2 = 8.0 Hz, NH); 13C NMR (75
MHz, CDCl3) δ 20.5, 20.7, 20.8, 21.0, 58.0, 61.5, 67.9, 72.4, 72.7, 78.8, 92.0, 93.2,
169.4, 169.7, 170.7, 171.8; HRMS (ESI) m/z = 575.0275, C16H26N2O12SCl3 (M+NH4)+
requires 575.0272.  Dimer 2.61: 1H NMR (300 MHz, CDCl3) δ  2.00 (s, 3H, CH3), 2.03
(s, 3H, CH3), 2.09 (s, 3H, CH3), 2.15 (s, 3H, CH3), 3.50-3.59 (m, 1H, H2), 3.84-3.86 (m,
1H, H5), 4.06 (br-d, 1H, J6,6’ =  10.9 Hz, H6), 4.25 (dd, 1H, J6’,6 =  12.5 Hz, J6’,5 = 3.9
Hz, H6’), 4.98-5.06 (m, 2H, H4, H3), 5.42 (d, 1H, JNH,2 = 9.8 Hz, NH), 5.56 (d, 1H, J1,2 =
8.8 Hz, H1);  13C NMR (75 MHz, CDCl3) δ 20.5, 20.6, 20.8, 21.0, 56.9, 61.3, 68.1, 72.4,





(2.65): To 2.6428 (0.50 g, 1.08 mmol) in THF (5.0 mL, 0.23 M) at
0 oC was added 1,2-dimethylimidazole (0.43 g, 2.7 mmol) followed by 2.40 (2.0 g, 4.32
mmol).  The reaction was stirred at 0 oC, gradually warmed to room temperature by
allowing the ice bath to melt, and then stirred overnight.  After 14 h, additional 2.42 (1.0
g, 2.16 mmol) was added and after 10 h the system applied directly to silica gel column.
Flash chromatography (33:67 EtOAc/hexanes) gave pure 2.65 as a white solid (0.68 g,
94%). 1H NMR (300 MHz, CDCl3) δ 2.37 (s, 3H, CH3), 3.37 (dt, 1H, J2,3+ J2,1 = 20.1,
J2,NH  = 7.1 Hz, H2), 3.52 (dt, 1H, J5,6ax+J5,4 = 19.4 Hz, J5,6eq = 5.0 Hz, H5), 3.70 (t 1H, J4,5
= J4,3 = 9.2 Hz, H4), 3.81 (tapp, 1H, J6ax,6eq = J6ax,5 = 10.3 Hz, H6ax), 3.99 (tapp, 1H, J3,4 =
J3,2 = 9.3 Hz, H3), 4.41 (dd, 1H, J6eq,6ax = 10.5, J6eq,5 = 5.0 Hz, H6eq), 4.79, 4.83 (AB, 2H,
J = 11.0 Hz, CH2CCl3), 4.83 (d, 1H, J = 11.0 Hz, 1/2 CH2Ph), 4.90 (d, 1H, J = 10.4 Hz,
H1), 4.95 (d, 1H, JNH,2 = 7.1 Hz, NH), 5.00 (d, 1H, J = 11.0 Hz, 1/2 CH2Ph), 5.55 (s, 1H,
CHPh), 7.16 (d, 2H, J = 8.0 Hz, ArH), 7.35-7.46 (m, 12H, ArH); 13C NMR (75 MHz,
CDCl3) δ 21.2, 59.3, 68.5, 70.1, 74.1, 78.5, 78.8, 82.3, 86.4, 93.4, 101.3, 126.0, 127.2,
128.1, 128.4, 128.56, 128.59, 129.2, 130.0, 133.7, 137.0, 137.6, 139.0; HRMS (EI) m/z =







1-thio-ß-D-glucopyranoside dimer (2.66): A solution
containing carbohydrate 2.64 (0.135 g, 0.300 mmol) and NEt3
(0.14 mL, 1.00 mmol) in dry DMF (3.0 mL) was added dropwise
via syringe pump over 1.0 hour to a solution of reagent 1.76 (0.24
mL, 1.83 mmol) and DMAP (0.037 g, 0.300 mmol) in dry DMF (1.0 mL) at 0 °C.  The
reaction was stirred for an additional 30 minutes at 0 °C, then diluted with
dichloromethane (10 mL) and quenched with ice water (5 mL).  The organic phase was
separated, and the remaining aqueous phase was extracted with dichloromethane (2x5
mL).  The combined organics were dried over MgSO4 and concentrated to a crude yellow
oil.  Purification by flash chromatography (1:1 EtOAc/Hexanes) provided 2.66 as a white
solid (0.104 g, 70%).  1H NMR (300 MHz, CDCl3) δ 2.38 (s, 3H, CH3), 3.15 (ddd, 1H,
J5,6ax = 10.3 Hz, J5,4 = 9.2 Hz, J5,6eq= 5.0 Hz, H5), 3.30 (tapp, 1H, J3,4= J3,2= 9.2 Hz, H3),
3.52 (dt, 1H, J2,1 = 10.3 Hz, J2,3= J2,NH = 9.2 Hz, H2), 3.62 (tapp, 1H, J4,5 = J4,3 = 9.2 Hz,
H4), 3.71 (d, 1H, J1,2  = 10.3 Hz, H1), 3.74 (tapp, 1H, J6ax,6eq = J6ax,5  = 10.3 Hz, H6ax), 4.34
(dd, 1H, J6eq,6ax = 10.3, J6eq,5 = 5.0 Hz, H6eq), 4.57 (d, 1H, JNH,2 = 9.2 Hz, NH), 4.59 (d,
1H, J = 11.0 Hz, 1/2 CH2Ph), 5.17 (d, 1H, J = 11.0 Hz, 1/2 CH2Ph), 5.52 (s, 1H, CHPh),
7.14-7.48 (m, 14H, ArH); 13C NMR (75 MHz, CDCl3) δ 21.2, 58.2, 68.6, 69.8, 73.9,
81.6, 87.3, 101.1, 126.0, 127.8, 128.3, 129.0, 129.1, 129.6, 133.6, 137.1, 138.0, 138.2;





















ethoxysulfoxyamino)-ß-D-glucopyranoside (2.68): To 2.67 (0.10 g,
0.252 mmol) in THF (1.1 mL, 0.23 M) at 0 oC was added 1,2-dimethylimidazole (0.06 g,
0.62 mmol) followed by 2.40 (0.460 g, 1.01 mmol).  The reaction was stirred at 0 oC,
gradually warmed to room temperature by allowing the ice bath to melt, and then stirred
overnight.  After 14 h no starting material was detected by TLC, and the system was
applied directly to silica gel column.  Flash chromatography (33:67 EtOAc/hexanes) gave
pure 2.68 as an amorphous white solid (0.144 g, 94%).  1H NMR (300 MHz, CDCl3) δ
3.68 (br-ddd, 1H, J2,NH = J2,3 = 8.8 Hz, J2,1 = 3.4 Hz, H2), 3.73-3.94 (m, 4H, H3, H4, H5,
H6ax), 4.08 (dd, 1H, JH,H = 12.6, 6.4 Hz, OCH2CHCH2), 4.25 (dd, 1H, JH,H = 12.6, 5.5
Hz, OCH2CHCH2), 4.32 (dd, 1H, J6eq,6ax = 9.9 Hz, J6eq,5 = 4.3 Hz, H6eq), 4.58, 4.62 (AB,
2H, J =  10.8 Hz, CH2CCl3), 4.76, 4.99 (AB, 2H, J = 11.5 Hz, CH2Ph), 5.00 (br-d, JNH,2 =
8.8 Hz, NH), 5.15 (d, 1H, J1,2 = 3.7 Hz, H1), 5.27-5.37 (m, 2H, OCH2CHCH2), 5.62 (s,
1H, CHPh), 5.88-6.01 (m, 1H, OCH2CHCH2), 7.28-7.52 (m, 10H, ArH); 13C NMR (75
MHz, CDCl3) δ  57.8, 62.7, 68.8, 69.0, 75.0, 75.5, 78.3, 82.8, 92.9, 96.9, 101.4, 118.8,
126.0, 128.0, 128.2, 128.3, 128.6, 129.1, 132.9, 137.1, 137.7; HRMS (ESI) m/z =
608.0665, C25H29NO8Cl3S (M+H) requires 608.0679.
p-Tolyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-
sulfoxyamino-1-thio-ß-D-glucopyranoside (2.69).   To a
suspension of ammonium formate (0.083 g, 1.3 mmol) in MeOH











(0.1 g, 1.55 mmol).  The reaction was stirred for 7 h at room temperature, at which point
no starting material was detected using TLC.  The reaction was filtered through celite,
and concentrated to crude product.  Flash chromatography (20:4:1
CH2Cl2/MeOH/NH4OH) afforded a white solid, which was lyophilized (3x) from water to
yield 2.69 as a light fluffy white product (0.105 g, 84%). 1H NMR (500 MHz, DMSO-d6)
δ 2.29 (s, 3H, CH3), 3.01 (tapp, 1H, J2,3+J2,1 = 17.1 Hz, H2), 3.39-3.46 (m, 1H, H5), 3.65
(tapp, 1H, J6ax,6eq = J6ax,5 = 10.2 Hz, H6ax), 3.71 (tapp, J4,5+J4,3 = 18.3 Hz, H4), 4.20 (dd, 1H,
J6eq,6ax = 10.2, J6eq,5 = 5.1 Hz, H6eq), 4.39 (tapp, J3,4 = J3,2 = 8.5 Hz, H3), 4.74 (d, 1H, J =
11.5 Hz, 1/2 CH2Ph), 4.97 (d, 1H, J = 11.5 Hz, 1/2 CH2Ph), 5.59 (d, 1H, J = 9.1 Hz, H1),
5.66 (s, 1H, CHPh), 5.76 (s, 1H, NH), 7.14-7.40 (m, 18 H, 14 ArH + NH4); 13C NMR
(125 MHz, DMSO-d6) δ  21.1, 59.8, 68.5. 68.6, 74.0, 78.9, 81.7, 87.0, 100.6, 126.4,
126.5, 127.4, 128.2, 128.3, 128.5, 130.0, 131.2, 131.8, 138.3, 140.1; HRMS (ESI) m/z =
542.1306, C27H28NO7S2 requires 542.1307.
Methyl 4,6-O-benzylidene-2,3-dideoxy-2,3-imino-N-
(2,2,2-trichloroethoxysulfonyl)-β-D-glucopyranoside (2.79):
To carbohydrate 2.71 (0.200 g, 0.716 mmol) in THF (4.0 mL,
0.18 M) at 0 oC was added 1,2-dMeIm (0.35 g, 3.64 mmol) followed by 2.40 (1.3 g, 2.86
mmol).  The reaction was stirred at 0 oC, gradually warmed to room temperature by
allowing the ice bath to melt. After 8 h, additional 2.40 (1.3 g, 2.86 mmol), and 1,2-
dMeIm (0.35 g, 3.64 mmol) were added, and the reaction was allowed to stir for 16 h.








(100% dichloromethane) gave pure 2.79 as a white foam.  1H NMR (300 MHz, CDCl3) δ
3.42 (d, 1H, J6ax,6eq = 7.3 Hz, H6ax), 3.49 (dd, 1H, J6eq,6ax = 7.3 Hz, J6eq,5 = 2.2 Hz, H6eq),
3.55 (s, 3H, CH3), 3.62-3.79 (m, 2H, H3,H4), 4.08 (dd, 1H, J4,5 = 8.7 Hz, J4,3 = 2.4 Hz,
H4), 4.30 (dd, 1H, J5,4 = 8.8 Hz, J5,6eq = 2.9 Hz, H5), 4.86, 4.90 (AB, 2H, J = 10.6 Hz,
CH2CCl3), 5.28 (s, 1H, H1), 5.59 (s, 1H, CHPh), 7.41-7.46 (m, 2H, ArH), 7.33-7.36 (m,
3H, ArH); 13C NMR (75 MHz, CDCl3) δ 41.3, 44.3, 57.0, 61.8, 68.9, 74.3, 79.9, 92.5,
97.7, 102.6, 126.1, 128.3, 129.3, 136.6; [α]D25 =-2.0 (c 0.5, CHCl3); HRMS (ESI) m/z =
473.9960, C16H19Cl3NO7S (M+H) requires 473.9948.
4-Methoxyphenyl 2,3-Di-O-acetyl-4-O-ethylsulfo-6-O-benzyl-β-
D-glucopyranoside (2.86): To Carbohydrate 2.18 (0.201 g, 0.299
mmol) in benzene (6.5 mL, 0.05 M) was added AIBN (0.01 g, 0.061 mmol) followed by
tributyltin hydride (0.48 mL, 1.78 mmol).  The reaction mixture was stirred under argon
for 1h, then heated at 80 °C for 3 h. Upon cooling, the solvent was removed in vacuo, and
the remaining residue was stirred in a 1:1 mixture of CH3CN:hexanes for 1h.  The
organic layers were separated, and the CH3CN layer was concentrated to a clear
colourless syrup.  Flash chromatography (1:1 EtOAc/hexanes, performed twice) gave
nearly pure 2.86 as a clear colourless glassy compound (0.154 g, 91%). 1H NMR (300
MHz, CDCl3) δ  1.35 (t, 3H, J = 7.1 Hz, CH3), 2.05 (s, 3H, COCH3), 2.08 (s, 3H,
COCH3), 3.63-3.79 (m, 5H, OCH3, H6, H5), 3.86 (d, 1H, J6,6’ = 10.6 Hz, H6’), 4.23-4.35
(m, 2H, CH2), 4.55, 4.60 (AB, 2H, J = 11.8 Hz, CH2Ph), 4.83 (tapp, 1H, J4,3 = J4,5 = 9.3







(tapp, 1H, J3,2 + J3,4 = 18.5 Hz, H3), 6.76 (d, 2H, J = 9.0 Hz, ArH), 6.95 (d, 2H, J = 9.0
Hz, ArH), 7.28-7.32 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 14.6, 20.6, 20.7, 55.6,
68.1, 71.0, 71.4, 72.2, 73.5, 73.7, 76.5, 100.5, 114.5, 118.7, 127.8, 128.4, 137.7, 150.9,
155.8, 169.3, 170.3.
Methyl 2,3 Di-O-acetyl-6-O-benzyl-4-O-sulfo-α-D-
glucopyranoside (2.93). A solution of 2.92 (0.200 g, 0.345 mmol)
and triethylamine (0.24 mL, 1.72 mmol), and 10% Pd/C (0.02 g, 10% w/w) in methanol
(5.0 mL) was stirred under H2 (1 atm, balloon) for 90 min, until no starting material was
detected using TLC.  The reaction mixture was filtered through a pad of celite, and
concentrated to a crude solid.  Flash chromatography (20:4:1 CH2Cl2/MeOH/NH4OH)
provided a white solid, which was lyophilized (3x) from H2O to yield 2.93 as a light
white solid. 1H NMR (300 MHz, DMSO-d6) δ 1.18 (t, 9H, J = 7.3 Hz, 3xCH3), 1.92 (s,
3H, COCH3), 2.00 (s, 3H, COCH3), 3.10 (q, 6H, J = 7.3 Hz, 3xCH2), 3.32 (s, 3H, OCH3),
3.52 (dd, 1H, J6,6’ = 11.0 Hz, J6,5 = 7.2 Hz, H6), 3.69 (tapp, 1H, J5,6 + J5,4 = 16.6 Hz, H5),
3.96 (d, 1H, J6',6 = 11.0 Hz, H6'), 4.05 (tapp, 1H, J4,5 = J4,3 = 9.6 Hz, H4), 4.50 (s, 2H,
CH2Ph), 4.71 (dd, 1H, J2,3 = 10.4, J2,1 = 3.6 Hz, H2), 4.85 (d, 1H, J1,2 = 3.6 Hz, H1),  5.23
(tapp, 1H, J3,2 +J3,4 = 19.6 Hz, H3), 7.24-7.35 (m, 5H, ArH), 8.82 (br-s, 1H, NH); 13C
NMR (75 MHz, DMSO-d6) δ 9.1, 20.9, 21.3, 46.5, 54.9, 69.7, 70.3, 70.5, 70.9, 72.7,







Chapter 3 - Target Based Synthesis of Sulfated Carbohydrates
using a Sulfate Protecting Group Strategy
3.1 Introduction
In chapter 2 and in our previous reports27,32 we demonstrated that 2,2,2-
trichloroethyl-protected sulfates could be introduced into monosaccharides in good yield
using sulfuryl imidazolium salts.  We also demonstrated that the TCE group withstood
many of the conditions that are commonly encountered in carbohydrate chemistry and a
simple disaccharide containing TCE-protected sulfates could be prepared.  Finally, we
demonstrated that the TCE group can be removed under mild conditions usually in
excellent yield.  However the true test of our methodology will be in the synthesis of
complex multisulfated oligosacharides.  In this chapter we present our studies on the
application of our sulfate protecting group strategy towards the synthesis of di- and
tetrasaccharides derived from chondroitin sulfates C and D, which are two glycosamino
glycans (GAG’s) that have been implicated in a number of physiological processes.
3.1.1  Chondroitin Sulfate
Chondroitin sulfate (CS) glycosaminoglycans (GAGs) are unbranched
polysaccharides of variable lengths that contain two alternating monosaccharide residues:
D-glucuronic acid (GlcA) and N-Acetyl-D-galactosamine (GalNAc).  There are several
characterized CS compounds (Figure 3.1), each of which carries a different sulfation
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code.  CS-A and CS-C bear sulfate groups at the 4-O- and 6-O-positions, respectively;
CS-D and CS-E are described as oversulfated chondroitin sulfates.  CS-D contains a
sulfate group at the 2-O-position of the GlcA monomer along with a 6-O-sulfate on the
GalNAc residue.  CS-E bears a 4,6-di-O-sulftaed GalNAc residue.  CS-K and CS-L have
a 3-O-sulfate on the glucuronic acid residue, and differ by being 4-O-sulfated and 6-O-
sulfated on the GalNAc monomer, respectively.  CS-M is heavily sulfated, with groups at







































































Figure 3.1. Chondroitin Sulfates A,C,D,E,K,L,M
The specific biological functions of these compounds are a subject of intense
investigation.  It is now known that the roles of these oligosaccharides are intimately
related to the distinctive sulfation pattern each GAG carries; and that these diverse
patterns of sulfation are highly regulated in vivo. The CS GAGs are implicated in a
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number of physiological processes including viral invasion.,41 brain development and
regeneration,42 cell-cell recognition, 43 and spinal cord injuries, 44 as well as numerous
other processes.
It is widely known that the synthesis of naturally occurring glycosaminoglycans is
extremely challenging, and is even more so when the targets are modified with sulfation
patterns.  In order to better study the structure and activity of these compounds, pure
oligosaccharide fragments of defined length and sulfation pattern are required. Isolation
of well-defined CS fragments from natural sources is difficult due to the inherent
microheterogeneity of the polymers, thus progress in this field must rely on chemical
oligosaccharide synthesis.  The groups of Jean-Claude Jacquinet and Linda Hsieh-Wilson
are the leading researchers in the chemical synthesis of chondroitin sulfate
oligosaccharides. The research efforts of each group are summarized below.
3.1.1.1  Research Efforts by the Jacquinet Group
Over 2000 to 2002, Karst and Jacquinet reported the first stereocontrolled total
synthesis of CS-D based oligosaccharides.45,46 In an admirable synthetic achievement,
Karst and Jacquinet successfully prepared the CS-D related tetra- and hexasaccharides















































Figure 3.2. Synthetic CS-D Oligosaccharides 3.1 and 3.2
Their initial syntheses of CS-D fragments 3.1 and 3.2 are presented in Schemes
3.1 to 3.3.  In the synthesis, benzyl ethers were selected as permanent protection for the
hydroxyl groups to be free in the final product, and benzoate esters were used as
temporary protecting groups for the hydroxyl groups to ultimately be sulfated.  The
synthesis of the targets focused on the preparation of disaccharide 3.7 (Scheme 3.1),
which could be used in an iterative fashion to provide access to 3.1 and 3.2.
To access the key disaccharide 3.7, glycosyl donor 3.3 (prepared in 13 steps), and
acceptor 3.4 (prepared in 15 steps) were coupled in the presence of TMSOTf to obtain
disaccharide 3.5 in a 71 % yield.  The primary silyl ether in 3.5 was exchanged for a
benzoate ester, giving 3.6.  Oxidative hydrolysis of the anomeric OMP group in 3.6
followed by installation of the trichloroacetimidate moiety provided target disaccharide
3.7 as an α,β-mixture in 67% yield.  Disaccharide 3.7 was then condensed with methanol
in the presence of TMSOTf and then treated with thiourea to afford the reducing
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1) AcOH/THF  91%
2) BzCl, Py, CH2Cl2  89%
71%
64% (2 steps)
1) TMSOTf (15%) CH2Cl2 , 
    MeOH  86%
















Scheme 3.1. Preparation of target disaccharides 3.7 and 3.845
With disaccharide donor 3.7 and acceptor 3.8 in hand, the authors examined an
iterative approach for the preparation of the target oligosaccharides. Coupling of imidate
3.7  with the 4-OH in acceptor 3.8  followed by O-dechloroacetylation provided
tetrasaccharide 3.9 in a 44 % yield (Scheme 3.2).  This tetrasaccharide bearing a free 4-
OH at the non-reducing end served as the glycosyl acceptor when condensed a second
time with key disaccharide donor 3.7.  The resulting free 4-OH positions of the
glucuronic acid residues at the non-reducing ends of the tetra- and hexasaccharides 3.9
and 3.11 were then protected with hydrogenolyzable PMB (4-Methoxybenzyl) ethers
using 4-methoxybenzyl trichloroacetimidate to give the fully protected oligosaccharides
3.10 and 3.12 (Scheme 3.2).
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1) TMSOTf (15%)










































1) 3.7, TMSOTf (15%)



















































































Scheme 3.2. Preparation of fully protected tetra- and hexasaccharides 3.10 and 3.1245
Before the sulfate esters could be introduced to the oligosaccharides, several
modifications first had to be performed (Scheme 3.3). The N-trichloroacetate groups were
transformed into N-acetyl groups using tributylstannane and AIBN; and the benzoate and
methyl esters were saponified with treatment of lithium hydroperoxide followed by
methanolic sodium hydroxide to give 3.13 and 3.14 in good yields.  The partially
protected 3.13 and 3.14 were then O-sulfated using the sulfur trioxide-trimethylamine
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complex in DMF to give their sulfated counterparts 3.15 and 3.16 in 67% and 54% yields
(Scheme 3.3).  Final deprotection of 3.15 and 3.16 was achieved under catalytic
hydrogenation conditions using 10% palladium on carbon to afford the target tetra- and



















3.10 n = 1
3.12 n = 2
n
1) Bu3SnH, AIBN, 
    N,N-dimethylacetamide, 95 oC
2) LiOH/H2O2, THF 0 oC to RT  

















3.13 n = 1 46 %
3.14 n = 2 64 %
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3.15 n = 1 67 %
3.16 n = 2 54 %



















3.1  n = 1 93 %






Scheme 3.3. Access to CS-D tetra- and hexasaccharides 3.1 and 3.245
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In 2006, a publication by Lopin and Jacquinet provided an alternate approach to
the preparation of structurally defined CS polymers.47  In this publication, the authors
made note of the fact that for all of the previous preparations of chondroitin sulfate
molecules, each synthesis started from chemically prepared monomeric units.  Since each
synthesis required a GalNAc monomer, a rare and expensive starting material, the
derivatives were generally prepared via long synthetic routes.  Taking advantage of the
abundance of the naturally occurring GAGs, the authors sought to isolate and modify the
basic CS disaccharide unit 3.17, which is obtained from chemical hydrolysis of the CS
oligosaccharides.48,49 From pure 3.17 Lopin and Jacquinet prepared the functionalized
disaccharide 3.18 and related derivatives in a series of protecting group manipulations
over 10 steps and an overall 8.5 % yield from the CS-polymer.
CS 
Oligosaccharide
IR-120 [H+] Resin, H2O
then 0.5 M H2SO4, 100 oC, 6h



















Scheme 3.4. Modified CS fragments obtained from natural sources47
In 2009, a two-part publication by Jacquinet and co-workers further elaborated on
the synthesis of structurally defined chondroitin sulfate polymers using starting materials
obtained from chemical degradation of the natural polymer.50,51 The authors designed a
highly divergent chemical synthesis of all known variants (A, C, D, E, K, L, M) of
chondroitin sulfate GAGs starting from the key disaccharide 3.18 (Scheme 3.5).  The
protecting group pattern in 3.18 allows for elongation at the reducing end through
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oxidative removal of the anomeric NAP group; as well as modification at the non-
reducing end through selective removal of the Lev protecting moiety.  All hydroxyl
groups in the synthesis requiring permanent protection were masked as benzyl ethers, and
then easily regenerated at the end of the synthesis.  The required CS variants were
organized into two structural classes: those that have a sulfate moiety on the GalNAc
monomer (CS-A, -C, -E), and those that are sulfated on both the GalNAc and GlcA
monomers (CS-D, -K, -L, -M).  To access all of the possible sulfation motifs, 3.18 was
converted into 3.19 to ultimately produce CS-A, -C, and –E; 3.20 to provide access to














































Scheme 3.5. Divergent approach to all CS variants51
CS-A, -C, and –E oligosaccharides were prepared from disaccharide 3.19 as
described by Scheme 3.6.  Disaccharide 3.22 was converted into acceptor 3.23 (89 %
95
yield) and glycosyl donor 3.24 (61 %, 2 steps), which were then coupled to give
tetrasaccharide 3.25 in 71 % yield.  After removing the 4-O-Lev group at the non-
reducing end, tetrasaccharide 3.25 was coupled to donor 3.24 in a second glycosylation
reaction.  Removal of the chloroacetate protecting groups with thiourea, followed by
tributylstannane mediated reduction of the N-trichloroacetate moiety provided access to
modified tetra- and hexasaccharides 3.26 and 3.27 (Scheme 3.6).
The fully protected tetra- and hexasaccharides 3.26  and 3.27  were then
transformed into the target CS fragments (Scheme 3.6).  Selective benzoylation with
benzoyl cyanide gave the 6-O-Bz derivatives, which were sulfated using an excess of
sulfur trioxide/trimethylamine complex in DMF to provide the 4-sulfated
oligosaccharides 3.28 and 3.29 for the CS-A derivatives in 72% and 85% yields.
Controlled regioselective sulfation of 3.26 and 3.27 followed by 4-O-acetylation gave the
6-sulfated derivatives 3.30 and 3.31 (83% and 81% yield) required for the CS-C
fragments.  Finally, total O-sulfation of 3.26 and 3.27 provided the 4,6-disulfated
configuration in 3.36  and 3.37 (in 86% and 82%) required for CS-E. Complete
deprotection of the oligosaccharides was achieved through a 2-step saponification with
lithium hydroperoxide and sodium hydroxide, followed by catalytic hydrogenolysis to
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n = 2 3.33
n = 1 3.34
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n = 1 3.38
n = 2 3.39
HNAc
Scheme 3.6. CS-A, -C, -E tetra- and hexasaccharides of defined lengths51
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CS-D based di- and tetrasaccharides were prepared starting from disaccharide
3.20 as shown in Scheme 3.7.  Fully protected 3.20 was subjected to standard protecting
group manipulations to give differentiated derivative 3.40.  Oxidative cleavage of the
anomeric NAP ether with installation of the imidate moiety; and removal of the 4-O-Lev
group in 3.40 provided access to donor 3.41 and acceptor 3.42 which were coupled in the
presence of TMSOTf.  The resulting tetrasaccharide was then de-chloroacetylated and the
N-trichloroacetate group was reduced to give partially protected 3.43, which was then
completely O-sulfated using sulfur trioxide/trimethylamine.  Tetrasaccharide 3.44 was
then saponified and hydrogenated under the previously described conditions to provide






























































































Scheme 3.7. Synthesis of a CS-D reducing tetrasaccharide51
Synthesis of the less common CS-K, -L, and -M sulfoforms commenced with the
synthesis of the basic reducing disaccharides starting from 3.21.  Radical reduction of the
N-trichloroacetyl group followed by hydrolysis of the benzylidene acetal provided triol
3.46, which served as a precursor to the required CS variants (Scheme 3.8).  CS-K was
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accessed through selective primary benzoylation followed by disulfation in 80% to give
the fully protected 3.47.  Conversely, controlled selective sulfation of triol 3.46 gave the
6,3’-disulfated CS-L disaccharide 3.48 in 75 % yield (with approximately 10% of the
trisulfated disaccharide).  Finally, exhaustive O-sulfation of 3.46 gave the CS-M
precursor 3.49.  The disaccharides were then subjected to saponification conditions
followed by catalytic hydrogenolysis to provide the CS-K 3.50, -L 3.51, and -M 3.52






































































Scheme 3.8. Synthesis of CS-K, -L, and –M disaccharides51
3.1.1.2  Synthesis of Chondroitin Sulfates by the Hsieh-Wilson Group
Over 2004 to 2006, the Hsieh-Wilson group also addressed the idea that chemical
synthesis of these CS glycosaminoglycans could provide a powerful means to access well
defined structures, and further enable systematic investigations into the biological roles of
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specific sulfation patterns.52,53 In two publications, the authors designed an efficient and
modular approach to obtain target tetrasaccharides derived from CS-A, CS-C, CS-E, and
the relatively rare CS-R sulfation sequences, while attempting to minimize the number of
synthetic steps and maximize isolation quantities of the target oligosaccharides.
Similar to Jacquinet’s approach (albeit from chemically prepared starting
materials as opposed to those obtained from natural sources) the Hsieh-Wilson group
employed N-trichloroacetamide or O-benzoyl groups to provide stereocontrol for the
required β-glycoside synthesis; and an orthogonal protecting group strategy was
developed to allow for the installation of specific sulfate sequences.
Starting from donor 3.53 (prepared in 11 steps) and acceptor 3.54 (prepared in 10
steps) disaccharide 3.55 was prepared in a 77% yield.  This key disaccharide intermediate
was readily converted into glycosyl acceptor 3.56 and trichloroacetimidate donor 3.57,
which were coupled in the presence of TMSOTf to give tetrasaccharide 3.58 in a 44 %
yield with good stereoselectivity (Scheme 3.9).  Conversion of the N-trichloroacetamide
moiety to the corresponding N-acetamide followed by oxidative cleavage of the p-



























































































Scheme 3.9. Preparation of key tetrasaccharide intermediate 3.5952,53
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With the functionalized tetrasaccharide 3.59 in hand, the CS structures with
specific sulfation motifs were then assembled (Scheme 3.10).  Vigorous sulfation of 3.59
provided the 4,6-O-tetrasulfated tetrasaccharide required to access CS-E.  A selective
primary di-O-sulfation of 3.59 provided the precursor to CS-C.  To obtain the precursor
to CS-A, the primary hydroxyl groups in 3.59 were selectively benzoylated with benzoyl
cyanide, and the remaining free 4-OH positions were then sulfated.  To obtain the CS-R
sulfation code, a benzylidene acetal was introduced to tetrasaccharide 3.59, the ester
protecting groups were saponified and the resulting free hydroxyl groups were then
sulfated.  The target CS-E, CS-C, and CS-A tetrasaccharides 3.60, 3.61, and 3.62 were
obtained after removal of the silyl- and benzoate-protecting groups.  The unique CS-R















































































1) SO3.TMA (50 eq). DMF, 84%
2) HF.Py, 91%
3) 1M LiOH, 30% H2O2
4) NaOH, MeOH, H2O 70% (2 steps)
1) SO3.TMA (5 eq). DMF, 61%
2) HF.Py, 89%
3) 1M LiOH, 30% H2O2
4) NaOH, MeOH, H2O quant. (2 steps)
3.60 CS-E 3.61
3.62 CS-A 3.63 CS-R
1) BzCN, Py, 93%
2) SO3.TMA (20 eq). DMF, 84%
3) HF.Py, 90%
4) 1M LiOH, 30% H2O2
5) NaOH, MeOH, H2O 70% (2 steps)
1) PhCH(OMe)2, cat. CSA, CH3CN 96% 
2) 1M LiOH, 30% H2O2
3) NaOH, MeOH, H2O 56% (2 steps)
4) SO3.TEA (20 eq), DMF
5) 0.01 M aq. AcOH 17% (2 steps)
CS-C
Scheme 3.10. Hsieh-Wilson’s approach to defined CS variants53
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The work completed by Jacquinet, Hsieh-Wilson and respective research groups
is an outstanding synthetic achievement.  For the first time, two highly divergent
approaches to the preparation of all known CS-oligosaccharides have been developed and
executed.  These oligosaccharides are currently in high demand, and access to polymers
of defined length and sulfation patterns will allow for in-depth study of these intriguing
polysaccharides.
3.2  Objectives
The objectives of the work described in this chapter is to further evaluate the
scope of our TCE-protecting group strategy by applying it to the synthesis of di- and
tetrasaccharides derived from CS-C and CS-D (3.64-3.66, Figure 3.3).  In the approaches
of both Jacquinet and Hsieh-Wilson, the sulfate groups are incorporated late in the
synthetic sequence, which necessitates the use of an orthogonal protecting group strategy.
Because of this, almost all of the protecting group manipulations are performed on the di-
, tetra- and hexasaccharide targets, often resulting in less than favourable yields, and
products that are very difficult to characterize due to their complex nature.  Furthermore,
multiple sulfations on large targets can sometimes be low yielding (for example, 54% for
the sulfation of 3.14 or 17% for the sulfation of 3.62), and the sulfated products can be
very difficult to isolate and purify.  The yields of sulfate-incorporation into
monosaccharides using the sulfuryl imidazolium salts described in chapter 2 are often





































Figure 3.3. Target CS based molecules
Each target (3.64-3.66) presents unique synthetic challenges that will allow for
further exploration of the scope and limitations of the protected sulfate approach.  In each
target we wished to demonstrate that a synthesis could be achieved whereby all of the
protecting groups could be removed in a single step at the end of the syntheses by
catalytic hydrogenolysis.  The CS-C disaccharide 3.64, the simplest of the three, provides
a relatively simple model system to test this.  The CS-D disaccharide 3.65 was chosen to
investigate the reactivity of 2-O-sulfated glycosyl donors, as well as the effect of the
TCE-protected sulfate moiety on the stereochemical outcome of the glycosylation
reactions.  The CS-C tetrasaccharide target 3.66 was chosen to demonstrate the TCE-
protection strategy in the synthesis of higher order oligosaccharides.  The synthesis of
these CS-based targets is still very much a work in progress, and this section presents our
preliminary developments in this area.  Nevertheless, it is our hope that the chemistry
developed in the preparation of these compounds will be applicable in the synthesis of
higher order sulfated oligosaccharides.
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3.3  Results and Discussion
3.3.1  Towards the Synthesis of CS-C Disaccharide 3.64
The retrosynthetic analysis of 3.64 is shown in Figure 3.4.  We envisioned target
3.64 being obtained from its fully protected precursor 3.67 in a one-pot global
deprotection, as all of the protecting groups in 3.67 can be removed and reduced under
catalytic hydrogenolysis conditions.  Disaccharide 3.67 was to be prepared from
thioglycoside donor 3.68 and galactosamine acceptor 3.69. The key features of this
synthesis include the preparation of a GalNTCA monomer bearing a TCE-protected
sulfate group at the 6-O-position, as well as the use of a carboxybenzyl (Cbz) group at the
2-O-position of the GlcA monomer. The Cbz group was an attractive choice for the
synthesis of the CS-C target, as it has been shown that it can be readily introduced into
carbohydrates, can provide the anchimeric assistance required to direct the β-glycosidic
linkage and, unlike traditional esters, could be removed by catalytic
hydrogenolysis.54,55,56  The only potential problem in using the Cbz group is that under
certain glycosidation conditions the benzyl group (derived from a Cbz group at the 2-
position of the donor) can be transferred to the acceptor.54 This issue will be discussed in
more detail in a subsequent section in this chapter.  Furthermore, the synthesis also
employs a NAP ether at the 4-O-position of the glucuronic acid ring in 3.67, and an OMP
group at the reducing end of the molecule.  This protecting group strategy can, based on
literature precedence,57 allow for chain elongation at the anomeric position of the
reducing end by independent removal of the OMP protecting group; or elongation at the

































Figure 3.4. Retrosynthesis of CS-C disaccharide 3.64
3.3.1.1  Synthesis of the GlcA Thioglycoside Donor 3.68
The challenge in the preparation of donor 3.68 was that by the end of the
synthesis, each position in the carbohydrate ring had to be orthogonally protected from
the others.  The anomeric position required reliable protection, yet had to be easily
activated for glycosylation when required.  The 2-O -, and 3-O-positions required
permanent protection; thus a benzyl protecting group was selected for the 3-O- position,
and as mentioned above, a Cbz group was selected for the 2-position.  Further
manipulations of the target disaccharide would require selective access to a free 4-OH
group, thus that position was protected with a NAP ether that can be removed in the
presence of other benzyl groups.57 Lastly, the 6-OH had to be oxidized to provide the
corresponding glucuronic acid which required subsequent esterification.  The synthesis of



















































CBzCl (3.0 eq). 






















1. BF3OEt2 (1.0 eq)
2. cat. NaOMe/MeOH








Scheme 3.11. Synthesis of thioglycoside donor 3.68
The synthesis of donor 3.68 began with the preparation of the tetrasilylated
thioglycoside 3.72 in three steps from commercially available acetyl 2,3,4,6-tetra-O-
acetyl-β-D-glucopyranoside (3.70).59 After an anomeric protecting group exchange and
ester saponification under Zemplén conditions, tetraol 3.71 was silylated with
chlorotrimethylsilane (TMSCl) in the presence of pyridine.  Persilylated 3.72 served as
the substrate for a regioselective one-pot protection reaction.  The reaction concept was
originally developed by Wang and co-workers,58 however, we found that particular
reaction protocol was very involved, and we were unable to repeat the literature yields.
Instead, we applied a very elegant tandem catalysis reaction developed by Francais,
Urban, and Beau.59 In this reaction, 3.72 is treated with 1 mol% of CuOTf in the presence
of benzaldehyde forming a di-benzylidenated intermediate (not shown).  Addition of
triethylsilane (TES) regioselectively opens the less stable 5-membered acetal to provide
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the free 2-OH in 3.73 in high yields and excellent regioselectivity.  The 2-O-position is
then treated with CbzCl and DMAP to afford 3.74 in 82% yield.  The presence of excess
DMAP was essential for successful introduction of the Cbz protecting group, as attempts
to do so with catalytic or equimolar amounts of DMAP and/or other organic bases (NEt3,
pyridine, Hunig’s) were considerably less effective.  Because the target required the 3-O-
NAP protection, the benzylidene acetal was exchanged for a 2-naphthylidene acetal using
3.7660 to afford fully protected 3.77 in 81% yield.  Regioselective reductive opening of
the acetal using cobalt chloride and borane-THF61 smoothly provided 3.78 in excellent
yield.  Lastly, a TEMPO/BAIB mediated primary oxidation provided glucuronic acid
3.79, which was subsequently esterified using benzyl bromide to provide target donor
3.68 in 10 steps and an over 30% yield (89% average yield per step) from commercially
available starting material.
3.3.1.2  Synthesis of the GalNAc Acceptor 3.69
The synthesis of acceptor 3.69 was significantly more challenging and lengthy
than that of donor 3.68.  The protecting group strategy was designed such that the
anomeric group could easily be activated or left as a permanent protecting group at the
end of a synthesis.  The amine functionality was masked as a trichloracetamide that
would be converted to the required N-acetatamide when needed.  The free 3-OH position
was required to form the desired glycosidic linkage, and the 4-OH was permanently
protected with a benzyl group.  Also, during the construction of 3.69, the 6-OH required
the introduction of the TCE-protected sulfate moiety.
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The synthesis of acceptor 3.69 began with commercially available glucosamine
hydrochloride (3.80).  Using reliable literature procedures,62,63 3.80 was converted into
tetraacetate 3.84 in four routine, high-yielding transformations (Scheme 3.12).  At this
point in the synthesis, it had not been determined whether the target would be prepared as
a thioglycoside or an OMP-protected glycoside, thus both monomers were synthesized.
Tetraacetate 3.84 was treated with BF3OEt2 in the presence of 4-methoxyphenol or
benzenethiol to yield compounds 3.85 and 3.86, respectively.  Removal of the remaining
acetate protecting groups gave carbohydrate triol compounds 3.87 and 3.88 in near
quantitative yields. The 4-OH group in glucosamine derivatives is known to be
notoriously unreactive.64  Exploiting this well known fact, a slow addition of
trimethylacetyl (pivaloyl, Piv) chloride to triol derivatives 3.87 and 3.8845 allowed for the
selective 3,6-di-O-Piv protected carbohydrates 3.89 and 3.90 to be prepared and isolated

















































3.83 (99%) 3.84 (90%)
R = OMP 3.85 (92%)







R = OMP 3.87 (99%)






R = OMP 3.89 (86%)
R = SPh 3.90 (89%)
(CH3)3CCOCl
Scheme 3.12. Synthesis of 4,6-di-O-Piv monomers 3.89 and 3.90
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From this stage of the synthesis, we envisioned accessing the target acceptor as
shown in Scheme 3.13.  Because galactosamine based starting materials are rare and
relatively expensive, C-4 inversion of configuration to transform glucosamine monomers
3.89 or 3.90 into their galactosamine counterparts is an alternative way to access the
necessary carbohydrate configuration.  The 4-OH of the newly formed galactosamine
monomer would then be benzylated to give 3.91, and the pivaloyl groups would be
removed under Zemplén conditions to provide a partially protected monosaccharide
bearing free hydroxyl groups at the 4- and 6-positions.  Selective primary sulfation at the





R = OMP 3.89 
R = SPh 3.90










HNTCA2) Selective 1o Sulfation
3.91 3.92
Scheme 3.13. Initial route to target acceptor
Unfortunately, the synthesis could not be executed as planned.  In their synthesis
of CS-D, Karst and Jacquinet had reported that upon triflate mediated inversion, the Piv
protecting groups readily migrated to the 4-position of the galactosamine monomer. With
this in mind, we chose to investigate an oxidation/reduction coupled inversion sequence65
in which the equatorial 4-OH in 3.90 was oxidized to the corresponding ketone 3.93, and






































3.90 3.93 3.94 (68% 2 steps)
3.94
Scheme 3.14. Oxidation-reduction mediated C-4 inversion and unsuccessful benzyl
protection
The 4-OH in 3.90 was oxidized to ketone 3.93 using DMSO and acetic anhydride.
Subjecting 3.93 to L-Selectride at low temperatures resulted in the expected equatorial
hydride attack to provide the free axial 4-OH in a 68 % yield over 2 steps (Scheme
3.14a).  Unexpectedly, in this transformation, the N-trichloroacetamide was converted
into a dichloroacetamide moiety, a side reaction which could not be avoided.  This was
not considered to be a problem as the trichloro- or dichloroacetamide would ultimately be
reduced to the N-acetamide at the end of the synthesis.  After work-up and purification of
3.94, there was no evidence of Piv group migration, so attempts were made to benzyl-
protect the axial 4-OH.  Under standard benzylation conditions (NaH, BnBr, DMF),
however, the only product that could be obtained was the 4,6-di-O-piv compound 3.95
resulting from a 3-O- to 4-O- ester migration.  Attempts to install the benzyl protecting
group under acidic conditions resulted in mostly starting material, with no indication that
the target benzylated product was formed (Scheme 3.14b).
We then decided to return to the triflic anhydride/H2O mediated C-4 inversion
used by Karst and Jacquinet.45 Carbohydrates 3.89 and 3.90 were each subjected to triflic
anhydride then H2O to effect the C-4 epimerization to achieve the required galactosamine
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configuration (Scheme 3.15).  Under these conditions, a mixture of the 4,6- and 3,4-di-O-
Piv compounds 3.96 – 3.99 were obtained in good yields.  These compounds can easily
be separated by flash column chromatography; however it is not necessarily required as
removal of the ester protecting groups using catalytic sodium methoxide in methanol
provided the galactosamine triol 3.100 or 3.101 as a single isomer (Scheme 3.15).
Tf2O, Py
0oC, DCE























R = OMP 3.89 
R = SPh 3.90
R = OMP 3.96, 3.97 (94% combined)  
R = SPh 3.98, 3.99 (95% combined)
R = OMP 3.100 (99%)  
R = SPh 3.101 (99%)
Scheme 3.15. Glucosamine to galactosamine C-4 epimerization
The use of benzoyl group for the 3,6-O-protection of glucosamine triol 3.88 was
also examined, to investigate whether the resulting benzoyl esters would be more or less
prone to migration under the C-4 inversion conditions.  In order to prepare the 3,6-di-O-
benzoylated thioglycoside 3.102 several reaction conditions were examined (table 3.1).














Entry Base (eq.) Solvent BzCl (eq.) Temp/Time Result
1a -- Py (0.03 M) 6.0 rt/8 h 3,4,6-tri-OBz
2 -- Py (0.03 M) 3.0 rt/8 h 3,4,6-tri-OBz
3 -- Py (0.03 M) 3.0 0 °C/5h 3,4,6-tri-OBz
4b -- Py (0.03 M) 3.0 0 °C/5h 3,6- and 4,6-di-OBz (1:1)
5b -- Py (0.03 M) 2.5 0 °C/5h 3,6- and 4,6-di-OBz (1:1)
6b -- Py (0.03 M) 2.5 0 °C/5h 3,6- and 4,6-di-OBz (1:1)
7b NEt3 (5.0) CH2Cl2 (0.1 M) 2.5 0 °C/5h 3.102 92%
a) literature conditions66 b) BzCl added via syringe pump over 1h
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Applying the literature conditions66 for the di-O-esterificaton to compound 3.88
with benzoyl chloride substituting for pivaloyl chloride (table 3.1, entry 1) resulted in
complete benzoylation of the triol starting material.  Decreasing the amounts of benzoyl
chloride and cooling the reaction did not yield any selectivity in the introduction of the
benzoyl groups (entries 2 and 3).  Decreasing the addition rate by adding benzoyl
chloride with a syringe pump at low temperatures resulted in a 1:1 mixture of the 3,4- and
4,6-di-O-benzoyl products (entries 4-6).  Finally, changing the base from pyridine to
triethylamine, and performing the reaction in dichloromethane provided the target di-
benzoylated compound 3.102 in a 92% yield (entry 7).
Di-O-benzoylated 3.102 was then subjected to the C-4 inversion conditions as
shown in Scheme 3.16.  Not surprisingly, the benzoyl esters in 3.102 migrated as readily
as the pivaloyl esters in 3.89, and 3.103 was obtained.  A year or so after this result had
been observed, Rosuland and co-workers published an NMR and kinetic study on acyl
group migrations in galactosamine monomers.67 As was observed experimentally, the
authors concluded that the rate of acyl group migration proceeds more slowly for Piv
esters (rate OPiv<OBz<OAc), and that in galactopyranoside monomers, equatorial C-3 to













Scheme 3.16. Observed benzoyl migration after C-4 inversion
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The synthesis of target acceptor 3.69 continued from triol 3.100, and 3.101
(Scheme 3.17).  Selective installation of the 4,6-O-benzylidene acetal was accomplished
using benzaldehyde dimethyl acetal with catalytic p-toluenesulfonic acid (TsOH.H2O) to
afford 3.105 and 3.106 in 95% and 90% yields respectively.  Attempts to perform the
regioselective opening of the benzylidene acetal in 3.106 were not successful (inseparable
mixtures of the 4-OH and 6-OH isomers were obtained), thus the 3-OH was temporarily
protected with an acetate ester.  Fully protected 3.107 and 3.108 were then subjected to
borane-THF and CoCl2 to smoothly afford the desired 6-OH carbohydrates 3.109 and
3.110 in high yields.
R = OMP 3.100  











































R = OMP 3.105 (95%)  
R = SPh 3.106 (90%)
R = OMP 3.107 (99%)  
R = SPh 3.108 (85%)
R = OMP 3.109 (98%)  
R = SPh 3.110 (90%)
R = OMP 3.111 (95%)  
R = SPh 3.112 (0%)
R = OMP 3.69 89%
Scheme 3.17. Completion of acceptor 3.69
With the 1° 6-OH now available, 3.109 and 3.110 were subjected to our standard
sulfation conditions with 2,2,2-trichloroethoxysulfuryl imidazolium triflate 2.40 in the
presence of 1,2-dimethylimidazole, to access the TCE-protected sulfated monomers
3.111 and 3.112.  Surprisingly, the anomeric protecting group had a profound effect on
the outcome of this reaction (Scheme 3.17).  The sulfation reaction progressed very
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smoothly with OMP protected 3.109, providing the 6-O-TCE sulfate 3.111 in a 95%
yield.  Conversely, when thioglycoside 3.110 was subjected to identical conditions, a
complex mixture of products resulted, and 3.112 could not be isolated or even detected in
the reaction mixture.  This result is not unlike that observed for the 2-O-sulfation of 2.51,
discussed in chapter 2. We do not have a clear understanding as to why certain
thioglycoside compounds behave peculiarly under the developed sulfation conditions.
This could be due to a reaction of the sulfur atom with the imidazolium salt or SN2 attack
on C-6 by the sulfur atom resulting in loss of the TCE sulfate and formation of a reactive
sulfonium ion. From this point, the synthesis was carried through with OMP acceptor
3.69, which was finally obtained after cleavage of the 3-O-acetate protecting group under
acidic conditions.  Target acceptor 3.69 was ultimately prepared in 14 steps and an
overall 33% yield (92% average yield per step) from glucosamine hydrochloride.
3.3.1.3  Glycosylation Conditions with Donor 3.68 and Acceptor 3.69
With the synthesis of thioglycoside donor 3.68 and acceptor 3.69 completed, we
set out to prepare the fully protected disaccharide target 3.67 (Scheme 3.18a).  There are
a wide variety of glycosylation methods that can be used for a thioglycoside donors;68 we
chose to investigate the conditions developed by Crich and co-workers which utilizes the
combination of 1-benzenesulfinyl piperidine (BSP) and trifluoromethanesulfonic
anhydride (Tf2O) as a powerful means of activation for both armed and disarmed
thioglycosides.69,70 In this glycosylation reaction, a mixture of thioglycoside donor, BSP,
and 2,4,6-tri-tert-butylpyrimidine (TTBP) in the presence of 3Å molecular sieves are
activated at low temperatures with Tf2O and then treated with the glycosyl acceptor
116
(Scheme 3.18a).  Once again, however, the reaction did not proceed as planned, and
target disaccharide 3.67 was not isolated.  Instead, the major products isolated from the
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Scheme 3.18. Unsuccessful glycosylation using donor 3.68
This type of benzyl group transfer reaction had been previously noted by Montero
and coworkers and so was not entirely unexpected.71 The authors have shown that the
attempted coupling of donor 3.116 with acceptor 3.117 using AgOTf as activator resulted
















- 45 oC, then rt, 3 h
3.117 3.118
Scheme 3.19.  Formation of 3.118 during the coupling of donor 3.116 to acceptor 3.11771
The authors suggested that upon activation, the 2-O-Cbz group of the donor
participates (as expected) in the formation of the oxazolium ion 3.119.  The subsequent
117
nucleophilic attack by the acceptor however, did not occur at the anomeric position as
required, but at the benzylic carbon in the Cbz protecting group, as shown in Scheme






























Scheme 3.20.  Mechanism for cyclic carbonate formation as proposed by Montero and
coworkers71
However, the authors also reported that the desired disaccharide 3.122 could be
obtained in a 65 % yield by using trichloroacetimidate glycosyl donor 3.121, as shown in























- 70 oC, then rt, 1 h
65%
3.122
Scheme 3.21.  Formation of the desired product 3.122 using imidate donor 3.121
On the basis of these results we decided to examine whether trichloroacetimidate
glycosyl donor 3.124 could be used in place of thioglycoside donor 3.68 to get the
desired disaccharide (Scheme 3.22).  Thus, thioglycoside 3.68 was smoothly converted to
its corresponding hemiacetal using NBS/H2O to afford 3.123 in a 96% yield.  Subsequent
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treatment of 3.123 with a catalytic amount of DBU in the presence of trichloroacetonitrile
afforded imidate 3.124 in a 77% yield (Scheme 3.22a).  The newly formed imidate 3.124
and glycosyl acceptor 3.69 were then combined and treated with TMSOTf at -60 °C in an
attempt to produce the target disaccharide 3.67.  After work-up and purification,
however, carbonate 3.114 was isolated in a 90% yield with only trace indication of any
disaccharide formation (Scheme 3.22b). This undesired side reaction could possibly offer
one explanation as to why 2-O-Cbz moieties are not widely used in carbohydrate
synthesis.  This result was somewhat of a disappointment, as changing the 2-O-protecting
group would likely negate the possibility of the global one-pot deprotection at the end of
the synthesis unless another protecting group can be found for this position that can be
removed by hydrogenolysis.  A more detailed discussion of the use of the Cbz group in
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3.68 3.123 (96%) 3.124 (77%)
Scheme 3.22.  Formation of carbonate 3.114 from trichloroacetimidate donor 3.124
3.3.2  Investigations into the synthesis of CS-D based disaccharide 3.65
The following studies on the synthesis of the CS-D disaccharide 3.65 were
concurrent with our studies on the synthesis of the CS-C disaccharide 3.64.  For what is
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considered to be a more challenging synthesis, the retrosynthetic analysis of 3.65 is
presented in Figure 3.5.  The synthesis is once again designed to allow for a global one
pot deprotection of disaccharide 3.125 as the protecting group strategy is designed to
result in a disaccharide bearing only hydrogenolyzable protecting groups, along with the
N-trichloroacetamide which is reduced under the catalytic hydrogenation conditions.  The
synthesis will make use of the previously prepared acceptor 3.69, and will involve the
preparation of the 2-O-sulfated glucuronic acid donor 3.125.  In the synthesis of this
target, the effect of the 2-O-sulfate group on the outcome of a glycosylation reaction will
be studied in order to determine if the 2-O-TCESO3 moiety is sterically demanding
































Figure 3.5. Retrosynthesis of CS-D disaccharide 3.65
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3.3.2.1  Preparation of Sulfated Donor 3.135
The synthesis of donor 3.135  is depicted in Scheme 3.23.  The one pot
regioselective protection chemistry previously shown in Scheme 3.11 was utilized once
again in the preparation of carbohydrate 3.129.  From previous sulfation studies (ex. the
2-O-sulfation of 2.49, chapter 2) it was known that 2-O-sulfation of a thioglycoside was
not an option for the preparation of this target, thus 3.126 was designed to have an
anomeric OMP moiety that could offer versatile protection yet be removed to provide
access to the glycosyl donor.  The literature substrates for the one-pot regioselective
protection methodology contained either an anomeric α-methoxy, or β-thiol moiety;59 but
it was anticipated that the procedure would adapt to the β-OMP glycosides without
complications.  As was predicted, tetrasilylated 3.128 was easily prepared from OMP-
protected tetraol 3.127, and performed as an ideal substrate for the regioselective
preparation of 3.129 in an 80% yield.  2-O-sulfation of 3.129 proceeds smoothly in a 95%
yield using the 2,2,2-trichloroethoxysulfuryl imidazolium triflate sulfating agent 2.40 in
the presence of 1,2-dimethylimidazole to provide fully protected 3.130 in a 95% isolated
yield.  Regioselective reductive opening of the benzylidene acetal using the standard
CoCl2 and BH3•THF conditions progressed very slowly for substrate 3.130, but
substituting the CoCl2 with CuOTf72 provided 3.131, which was subsequently oxidized to
its corresponding glucuronic acid 3.132.  The TCE-sulfate moiety was found to be stable
to both of these manipulations.  Initial attempts to benzyl-protect the glucuronic acid
3.132 resulted solely in lactone 3.133, as under the basic reaction conditions, the 2-O-
TCESO3 group was easily displaced by the carboxylate.  The formation of this undesired
121
side product was, for the most part, circumvented by reversing the addition order of the
reagents such that the NEt3 is added to the reaction mixture after the addition of benzyl
chloroformate. The formation of lactone 3.133 could not be avoided completely, but was
often present in less than a 5-10% yield, and desired carbohydrate ester 3.126 could be
isolated in a 70% yield after the oxidation and protection manipulations.  To convert
3.126 into an activated glycosyl donor, oxidative hydrolysis of the anomeric OMP group
using ammonium cerium nitrate (CAN) provided hemiacetal 3.134, which was
immediately used to prepare 3.135 in an 84% yield.  Overall, trichloroacetimidate donor
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3.70 3.127 (86% 2 steps) 3.128 (95%)
3.129 (80%) 3.130 (95%)
3.131 (78%) 3.132









Scheme 3.23.  Preparation of trichloroacetimidate donor 3.135.
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3.3.2.2  Glycosylation with 2-O-Sulfated Donor 3.135
The stereochemical outcome of a glycosylation reaction using donor 3.135 was
first studied using 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (3.136) as a simple
nucleophilic acceptor, according to Scheme 3.24  The TCEOSO3 moiety does not appear
to participate in the formation of the oxazolium intermediate, and disaccharide 3.137 was

























O3.135 3.136 3.137 (80% 2:1 α:β)
Scheme 3.24. Model glycosylation reaction with donor 3.135
These results are similar to Linhardt and coworkers results during their studies on
the use of trifluoroethyl-protected sulfates in the synthesis of sulfated carbohydrates.24
For example, the authors have shown that the reaction of donor 3.138 and acceptor 3.136
























TMSOTf as activator: 91% yield, α:β 1.2:1
BF3OEt2 as activator: 90% yield , α:β 1:2
OAc
OAc
Scheme 3.25. Linhardt and coworkers synthesis of disaccharide 3.139
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Despite obtaining an α/β mixture of 3.137, the glycosylation reaction between donor
3.135 and acceptor 3.169 was attempted under various conditions (table 3.2).  Under
these circumstances, however, target disaccharide 3.125 could not be detected or isolated.
For each reaction condition, the end result was a complex mixture of carbohydrate-based
products that were very difficult to separate and identify.  It appears that our sulfate
protecting group strategy is not a very practical approach to preparing oligosaccharides
having a sulfate group at the 2-position.

























Acceptor (eq.) Temp. Promoter (eq.) Result
1 1.0 1.0 -40 °C to rt TMSOTf (0.2) Mixture
2 1.0 1.5 -40 °C to rt TMSOTf (0.2) Mixture
3 1.0 1.5 -40 °C to rt BF3OEt2 (0.2) Mixture
4 1.0 2.0 Rt TMSOTf (0.5) Mixture
5 1.0 1.5 Rt BF3OEt2 (0.5) Mixture
6 1.0 1.0 Rt TMSOTf (1.0) Mixture
7 2.0 1.0 Rt BF3OEt2 (1.0) Mixture
3.3.2.3 Preparation of the CS-D Target via Sulfation of a CS-C Disaccharide
While the negative results from the glycosylation attempts with 2-O-sulfated
donor 3.135 were disappointing, they were not entirely unexpected.  Because of this, a
synthetic sequence was designed such that the target di-sulfated CS-D 3.65 would be
obtained from the sulfation of a protected CS-C disaccharide 3.140.  The retrosynthesis
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of both targets is outlined in Figure 3.6. In this approach, monosulfated CS-C
disaccharide 3.141 would be assembled from thioglycoside donor 3.142 and previously
prepared galactosamine acceptor 3.69 The advantage of the MCA protecting group is that
it can be selectively cleaved in the presence of other acyl protecting groups under a
variety of conditions including aqueous ammonia,73 thiourea, 74 and DABCO, 75 among
others.  This is a key factor in the synthesis of CS-D, as the chloroacetate protecting
group will need to be removed from 3.141 in the presence of a benzyl ester, as well as a
TCE-protected sulfate moiety.  Upon successful removal of the 2-O-MCA group, the
second sulfate will be introduced to provide the fully protected CS-D disaccharide 3.125.



















































Figure 3.6. Retrosynthesis of CS-D and CS-C based disaccharides
The 2-O-MCA protecting group was introduced to thioglycoside 3.73 using
chloroacetic anhydride and triethylamine to provide fully protected 3.143 in near
quantitative yields (Scheme 3.26).  At this point, we chose to forego the 4-O-NAP
protection strategy in favor of a shorter synthesis; thus, 3.143 was treated with borane-
THF to effect the regioselective opening of the benzylidene acetal affording the 6-OH
126
3.144  in 95% yield.  Once again, the glucose monomer was converted to its
corresponding glucuronic acid using a BAIB/TEMPO mediated oxidation to provide
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3.144 (95%) 3.145 (88%)
(3.0 eq.)
THF CH2Cl2/H2O
Scheme 3.26.  Modifying the 2-O-protecting group
Initial attempts to benzyl protect the resulting carboxylic acid 3.145 under the
conditions previously described in Scheme 3.11 (i.e. KHCO3, BnBr, TBAI, DMF) were
more complicated when 3.145 was the substrate.  When previously performed on 3.79,
the 2-O-CBz derivative of 3.145, the progression of the reaction was easily monitored by
TLC.  As the spot corresponding to the glucuronic acid substrate disappeared, a faster
running product spot formed, until starting material no longer could no longer be
detected.  In the case of 3.79 isolation of the product spot resulted in pure 3.68 in good
yields. When 3.145 was used as the substrate, the reaction progressed identically by TLC
as expected; however, NMR analysis of the isolated product indicated that two very
similar compounds were produced in the reaction as many of the signals in both the 1H
and 13C spectra were complicated by what appeared to be shadow peaks.  Under no
circumstances could these products be separated by TLC, and because of this the absolute
structure of the contaminating product could not be determined.  Its possible that the
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contaminating product results from an epimerization of the C5 position, but this theory
could not be validated.  A number of conditions were examined in attempts to minimize
the occurrence of this unwanted by-product (table 3.3); however when strong bases were
used for the protection reaction, pure 3.142 could not be isolated (entries 1-4).  To
prepare 3.142 under more mild esterification conditions, a decarboxylative benzylation
procedure developed by Kim and Lee in 1985 was attempted.76  In this reaction, the
carboxylic acid 3.145  is treated with benzyl chloroformate in the presence of
triethylamine to induce the formation of a mixed carboxylic-carbonic anhydride
intermediate.  Addition of a catalytic amount of DMAP then promotes the conversion of
the mixed anhydride into the target benzyl ester 3.145 through a decarboxylative
benzylation reaction.  Fortunately, under these conditions, pure 3.145 could be isolated in
a 73% yield (table 3.3, entry 7).



















Entry Solvent Base (eq.) Reagent (eq.) Result
1 DMF KHCO3 (6.2 eq) BnBr (4.0 eq), TBAI (0,2 eq) Mixture
2 THF KHCO3 (6.2 eq) BnBr (4.0 eq), TBAI (0,2 eq) Mixture
3 THF KHCO3 (1.0 eq) BnBr (4.0 eq), TBAI (0,2 eq) Mixture
4 THF NaH (1.5 eq) BnBr (4.0 eq), TBAI (0,2 eq) Mixture
6 CH2Cl2 NEt3 (1.0 eq) BnOCOCl (1.0 eq) then DMAP (0.2 eq) 64% 3.142
7 CH2Cl2 NEt3 (1.3 eq) BnOCOCl (1.3 eq) then DMAP (0.2 eq) 73% 3.142
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With the preparation of a second derivative of the required donor completed, we
returned to investigate the glycosylation conditions required for the preparation of the
CS-based disaccharide 3.141.  Table 3.4 summarizes the glycosylation conditions
examined for the preparation of disaccharide 3.141 Starting with a set of literature
conditions69 (entry 1) resulted in an encouraging 64% yield of target 3.141.  Decreasing
the reaction temperature (entries 2, 3 and 4) had a negative effect on the isolated yield of
3.141.  Modifying the reaction so that the glycosyl donor 3.142 was present in excess of
glycosyl acceptor 3.69 resulted in a significant increase in the yield of 3.141 to 84-86%
(entries 7 and 8).  Thus it appeared that we were able to obtain disaccharide 3.141 in a
very good yield.
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Acceptor (eq.) Temp. Time Result*
1 1.0 1.5 -60 °C to rt 3 h 64%
2 1.0 1.5 -78 to -40 °C 3 h 41%
3 1.0 1.5 -60 °C 3 h 50%
4 1.0 2.0 -60 °C to rt 5 h 68%
5 1.0 1.5 -60 °C to rt 16 h 54%
6 1.0 1.0 -60 °C to rt 3 h 55%
7 1.5 1.0 -60 °C to rt 3 h 84%
8 2.0 1.0 -60 °C to rt 3 h 86%
* Results for presumed product 3.141.  See structural reassignment section 3.3.2.5.
With the protected CS-C disaccharide fully prepared, we began to examine the
conditions required for the removal of the MCA group.  As previously described in
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Figure 3.6, removal of the 2-O-MCA group from 3.141 would provide 3.160 with the free
2-O-position on the glucuronic acid monomer.  Subjecting 3.140 to the standard sulfation
conditions would provide target 3.125, the fully protected precursor to the target CS-D
disaccharide 3.65. It was not known if the 1° SO3TCE group or the benzyl ester would be
tolerant of the basic and nucleophilic conditions for the removal of the MCA, thus a
comparison study was performed with monosaccharide donor 3.142 and protected
disaccharide 3.141.  For the deprotection to be successful on 3.142, the benzyl ester on
the GlcA monomer must remain intact; and to be successful on 3.141 the TCESO3 group
must not be affected.  It would then be assumed that any conditions that successfully
cleaved the MCA group from 3.142 but failed for 3.141, did so due to complicating
reactions with the 1° SO3TCE moiety.  The results from this study are presented in table
3.5.
Monosaccharide donor 3.142 was subjected to a variety of conditions (Table 3.5)
to remove the MCA protecting group.  Thiourea at 80 °C in ethanol and pyridine (entry
2), DABCO in ethanol (entry 4) and ethylenediamine in ethanol and pyridine (entry 10)
all effectively removed the 2-O-MCA in 3.142 to afford 3.146 in 95-96% yields.
Surprisingly, performing the same transformation on apparent disaccharide 3.141 was
considerably more complex, and desired 3.140 could not be isolated.  Instead, as the
reaction progressed, the mixture got increasingly complicated (as analyzed by TLC), and
subsequent work-up and purification did not produce any major identifiable carbohydrate
based products.  At this point, it was assumed that the 6-O-TCESO3 group was intolerant
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to the conditions required to remove the 2-O-MCA group, thus an alternate approach to
the CS-D disaccharide was investigated.




































Entry Carbohydrate Reagent Eq. Solvent Temp °C Time Result
1 3.142
H2N NH2
S 4.0 EtOH/py RT 24 h NR
2 3.142
H2N NH2
S 4.0 EtOH/py 80 °C 1 h 96 % 3.146
3 3.141
H2N NH2
S 4.0 EtOH/py 80 °C 1 h Mixture
4 3.142
N
N 15.0 EtOH 55 °C 5 h 95% 3.146
5 3.141
N
N 15.0 EtOH 55 °C 5 h Mixture
6 3.142 NH2
NH2
1.5 EtOH/py RT 24 h NR
7 3.142 NH2
NH2
15.0 EtOH/py RT 24 h NR
8 3.141 NH2
NH2
1.5 EtOH/py RT 24 h NR
9 3.141 NH2
NH2
15.0 EtOH/py RT 24 h NR
10 3.142 H2N NH2 1.9 EtOH/py RT 24 h 95% 3.146
11 3.141 H2N NH2 1.9 EtOH/py RT 9 h Mixture
12 3.142 N
N
2 EtOH RT 1h 90% 3.146
13 3.141 N
N
2 EtOH RT 1h Mixture
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3.3.2.4  CS-D via Disulfation of a Partially Protected Disaccharide
The approach to the CS-D target was then modified such that the protected
disaccharide scaffold would be constructed, and then the two TCE-protected sulfate
moieties would be introduced as described in Figure 3.7.  The target disaccharide 3.125
can be accessed through a simultaneous disulfation of diol 3.147, which is obtained from







































Figure 3.7.  Alternative approach to CS-D disaccharide 3.125
The previously prepared glucuronic acid donor 3.142 would serve to prepare
disaccharide 3.148 without requiring any modifications.  The galactosamine acceptor had
to be redesigned with an alternative protecting group strategy so that the 3-OH group
could be independently deprotected in the presence of the 6-O-MCA to provide glycosyl
acceptor 3.149.  The synthesis of 3.149 is described in Scheme 3.27.
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CH2Cl2 0 oC to rt
3.152 (90%)





Scheme 3.27.  Modified glycosyl acceptor 3.149
Starting from intermediate 3.105 (from Scheme 3.17), a t-butyldimethylsilyl
(TBS) group was introduced at the 3-O-position with TBDMSCl in the presence of
imidazole and catalytic DMAP to give 3.150 in a 90 % yield.  Cobalt chloride/borane
THF directed opening of the 4,6-di-O-benzylidene acetal provided partially protected
3.151 in good yields.  Subsequent introduction of the 6-O-MCA group followed by
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3.142 3.149 3.148 (82%)
-60 οC to RT CH2Cl2
Scheme 3.28.  Formation of protected disaccharide 3.149. See structural resassignment in
section 3.3.2.5.
The glycosylation reaction between thioglycoside donor 3.142 and 6-O-MCA
acceptor 3.149 appeared to proceed smoothly to afford what was assumed to be fully
protected disaccharide 3.148 in an 82% yield (The structure of 3.148 is reassigned in
section 3.3.2.5).  The next step in the synthesis was the simultaneous cleavage of the 2-O,
133
and 6’-O-MCA protecting groups to access diol 3.147, the required target for the
disulfation reaction.  Presumably, the 6-O-MCA group is more labile than the 2-O-MCA
protecting group, thus the di-deprotection reaction would likely proceed through
monodeacetylated intermediate 3.153.  It was anticipated that this deprotection reaction
would proceed smoothly, as we had previously demonstrated that the benzyl ester was
tolerant of the conditions required for the dechloroacetylation (table 3.6); the TCESO3
moiety was no longer present in the disaccharide structure; and the remaining benzyl
ethers should not be affected by the basic reaction conditions.  Unfortunately, this was
not the case, as once again, the 2-O-MCA group appeared to be surprisingly difficult to
remove. Table 3.6 summarizes the conditions attempted to remove the 2-O-MCA group
from carbohydrates 3.148 or 3.153.
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Entry Carbohydrate Reagent Eq. Solvent Temp °C Time Result
1 3.148
H2N NH2
S 4.0 EtOH/py 80 °C 5 h 3.153 71%
2 3.153
H2N NH2
S 4.0 EtOH/py 80 °C 8 h NR
3 3.148
N
N 30.0 EtOH 55 °C 5 h 3.153 65%
4 3.153
N
N 30.0 EtOH 55 °C 8 h NR
5 3.148 N
N
2 EtOH RT 10 min 3.153 65%
6 3.153 N
N
2 EtOH RT 8 h NR
7 3.148 N
N
8 EtOH 80 °C 5 h 3.153
8 3.153 N
N
15 EtOH 80 °C 12 h Dec.
Subjecting disaccharide 3.148 to 2 eq. of DBU in EtOH for 10 minutes resulted in
complete removal of the primary MCA protecting group giving disaccharide 3.153,
isolated in a 65% yield (entry 6). Treating the monodeprotected 3.153 with another 2 eq.
of DBU did not result in the second deprotection, despite extended reaction times (entry
2).  The 6-O-MCA group was also successfully removed using DABCO (entry 3) and
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thiourea (entry 5) to provide the monodeprotected 3.153 in low to moderate yields.  Di-
deprotected 3.147 was not detected or isolated in any of the described reactions.
Attempts to use more forcing conditions (entry 8) with a large excess of DBU in EtOH at
elevated temperatures resulted in the formation and then decomposition of 3.153.
From the previous deprotection study (table 3.5), removal of the 2-O-MCA
protecting group from monosaccharide 3.142  was successful under a variety of
nucleophilic and/or basic conditions.  The same transformation on apparent disaccharides
3.141 and 3.148, however, were not successful.  Because of these results, it was assumed
that the 6-O-TCESO3 group was not surviving the dechloroacetylation reaction, and thus
needed to be installed at the disaccharide stage.  The results summarized in table 3.6, now
suggest that this may not be the case.
3.3.2.5  Structural Reassignment of Compounds 3.141 and 3.148
The difficulties encountered in the removal of the 2-OMCA moiety lead us to
analyze the structures of compounds 3.141 and 3.148 more closely.  When 3.141 was first
prepared, it was anticipated that the 2-OMCA group would provide the required
anchimeric assistance to ensure the desired β-linkage.  As the reaction progressed, there
was no evidence of the formation of an α/β mixture, thus it was assumed that the 2-
OMCA participated in the reaction, and the required β-linkage was formed.  Upon
analysis with 1H NMR, the observed coupling constant for JH1-H2 of the glucuronic acid
moiety was calculated to be 3.5 Hz.  While this is on the small side for a β-linked
disaccharide, it was thought that the glucuronic acid ring might not be in the true 4C1
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conformation, and ring distortion could lead to distortion of the observed coupling
constants.
During a discussion with Dr. Auzanneau (Dept. of Chemistry, University of
Guelph), it was suggested that disaccharides 3.141 and 3.148 might in fact not be
disaccharides, but could rather be orthoesters 3.154 and 3.155.  Orthoesters of this type
have been reported by several groups.77  Analysis of the 1H NMR for carbohydrate 3.141
suggests that that theory is likely correct.  Along with the skewed JH1-H2 value for the
glucuronic acid ring, a very notable change in the chemical shift of the H2 proton of the
GlcA ring was observed.  The H2 proton connected to the 2-OMCA moiety in monomer
3.142 occurs at 5.1 ppm.  In what was assumed to be disaccharide 3.141, the proton
corresponding to H2 of the GlcA ring was found at 4.2 ppm, an unexpected upfield shift.
The observed JH2-H3 value for the same proton was also much smaller than expected (JH2-
H3 = 4.0 Hz).  The flattening of the carbohydrate ring through orthoester formation could
account for the unusual values for the observed coupling constants.  Furthermore, what
had gone unnoticed was the appearance of an unusual quaternary carbon at 124 ppm in
the aromatic region of the 13C NMR.  This could easily correlate to the quaternary carbon
of the proposed orthoester.  Unfortunately, the same characteristics were observed for
disaccharide 3.148.  In light of these discoveries, the structures of 3.141 and 3.148 have
been revised to be orthoesters 3.154 and 3.155 (Figure 3.8). In some instances orthoesters
of the type shown in Figure 3.8 have been isomerized under acidic conditions to the
desired β-linked disaccharides in good yield.78 Studies to achieve the isomerization of

























Figure 3.8.  Revised structures of 3.141 and 3.148
3.4 Summary and Future Work
Although the syntheses of the target compounds (3.64-3.66) remain unfinished,
these studies have laid the groundwork for the completion of these three syntheses. For
target 3.64, it appears that having a Cbz group at the 2-position of the donor (i.e.
compound 3.68) is not going to work due to cyclic carbonate formation.  It is very likely
that we could readily prepare 3.64 by putting an acetyl, chloroacetyl or benzoyl group at
the 2-position of the donor.  However, we would still prefer to install a protecting group
at this position that will provide the desired β-stereochemistry yet be removed by
hydrogenolysis so that we could demonstrate that all of the protecting groups could be
removed in a single step.  Very few protecting groups meet these criteria.  The 2,2,2-
trichloroethylcarbonate (Troc) group is one possibility.  This group has not been widely
employed as a protecting group in carbohydrate chemistry.  Nevertheless, Saulnier and
coworkers have used this protecting group for installation of the carbohydrate portion of
etoposide analogs.79 Glucopyranose donors bearing the Troc group at positions 2 and 3
were employed (bis-Troc protected at positions 2 and 3) and the desired β-sterochemistry
in the coupled products were obtained.79 The Troc groups were removed by
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hydrogenolysis.  Thus monomer 3.156 will be prepared with a Troc group at the 2-
position and coupled to monomer 3.69 (Scheme 3.29).  Hydrogenolysis will provide the
CSC-disaccharide 3.64 .  Disaccharide 3.157  will be used to prepare the CS-C
































































































Scheme 3.29.  Proposed route to CS-C disaccharide 3.64.
The studies described in this chapter also provided some insight as to the
limitations of our sulfate protecting group approach to the synthesis of sulfated
oligosaccharides.  One limitation is that thioglycosides bearing a TCE-protected sulfate at
the 6-position (i.e. compound 3.112) appear to be unstable.  Another, and perhaps the
most significant limitation of our approach, is that it is not a very practical tactic for
preparing oligosaccharides having a sulfate group at the 2-position as glycosidation
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reactions employing donors bearing a TCE-protected sulfate at the 2-position yield
coupled products as α/β mixtures.  Consequently, the CS-D disaccharide 3.65 will be
prepared by isomerizing 3.154 to 3.141 using acid, followed by removal of the MCA
group to get 3.140, sulfation using imidazolium salt 2.40 and then global deprotection








































Scheme 3.30.  Proposed route to CS-D disaccharide 3.65.
In spite of the above-mentioned limitations of our approach most of the
difficulties encountered in the syntheses of the target compounds presented in this chapter
were not a direct result of the presence of the TCE-protected sulfate group but instead
stem from the inherently challenging synthesis of carbohydrates in general.  While there
still remains a great deal of research to be done, we are confident that the synthesis of
sulfated carbohydrates using TCE-protected sulfate moieties will become a feasible
approach in the future.
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3.5  Experimental
3.5.1  General Considerations
For general information regarding solvents, NMR, MS, refer to section 2.5.1 in
Chapter 2.  All commercially available reagents in chapter 3 were purchased from either
Sigma Aldrich or Alfa Aesar with the exception of BSP80 and TTBP, 81 which were
prepared exactly as reported in the literature.
3.5.2  Experimental Syntheses and Characterization
Benzyl (4-Tolyl 3-O-benzyl-2-O-carbobenzyloxy-4-O-(2
naphthyl)methylene-1-thio-β-D-glucopyranoside) uronate (3.68).
The crude acid 3.79 (0.624 g, crude) was dissolved in THF (9.0 mL).  KHCO3 (0.56 g,
5.5 mmol), TBAI (0.06 g, 0.17 mmol) and BnBr (0.6 mL, 5.0 mmol) were added
sequentially.  The reaction was stirred overnight for 16 hours, until no starting material
remained by TLC.  The reaction was quenched with MeOH, diluted with EtOAc, and
washed with H2O.  The organic layer was separated, dried over Na2SO4 and concentrated
to a crude solid.  Purification by flash chromatography (100% CH2Cl2) afforded 3.68 as a
white solid (0.554 g, 80% over 2 steps). 1H NMR (300 MHz, CDCl3) δ 2.31 (s, 3H, CH3),
3.72 (tapp, 1H, J3,2 = J3,4 = 8.8 Hz, H3), 3.90 (tapp, 1H, J4,3 +J4,5 = 18.3 Hz, H4), 3.98 (d,
1H, J5,4 = 9.7 Hz, H5), 4.58-4.82 (m, 6H, H1, H2, CH2Ph, CH2NAP), 5.13 (s, 2H,
CO2CH2Ph), 5.18, 5.22 (AB, 2H, J = 12.2 Hz OCO2CH2Ph), 7.04 (d, 2H, J = 8.0 Hz,








(s, 1H, ArH), 7.70-7.73 (m, 2H, ArH), 7.77-7.80 (m, 1H, ArH); 13C NMR (75 MHz,
CDCl3) δ 21.9, 67.4, 70.2, 75.5, 75.6, 78.2, 79.0, 83.5, 86.7, 125.8, 126.0, 126.1, 126.6,
127.6, 127.7, 127.78, 127.81, 127.9, 128.0, 128.36, 128.44, 128.5, 128.58, 128.61,
129.64, 133.0, 133.2, 133.9, 134.98, 135.03, 135.1, 137.7, 138.6, 154.3, 160.7, 168.1;
HRMS (+ESI) m/z =  772.2932, C46H46NO8S (M+NH4)+ requires 772.2944.
4-Methoxyphenyl 4-O-benzyl-2-deoxy-2-trichloroacetamido-6-O-
(2,2,2-trichloroethoxysulfo)-β-D-galactopyranoside (3.69). A 1.5 M
solution of acidic methanol was prepared by dissolving acetyl chloride (0.6 mL) in
reagent grade methanol (6.0 mL) at 0 °C.  This solution was then added to fully protected
3.111 (0.2 g, 0.258 mmol), and the reaction was stirred for 4 h at room temperature until
no starting material was detected by TLC.  The reaction was concentrated to
approximately half volume (without heat), then diluted with CH2Cl2.  The resulting
solution was washed with H2O, sat. aq. NaHCO3 then H2O and dried over MgSO4.  The
reaction was then concentrated under reduced pressure (heat must be avoided in this
process) to a white foam (0.158 g, 84%).  This product decomposes very rapidly, thus is
used immediately in the glycosylation reaction without any purification. 1H NMR (300
MHz, CDCl3) δ 2.82 (d, 1H, JOH,3 = 7.9 Hz, OH), 3.77 (s, 3H, CH3), 3.91 (d, 1H, J4,3 =
2.4 Hz, H4), 3.94-3.96 (m, 1H, H3), 4.08-4.13 (m, 1H, H2), 4.24 (dd, 1H, J6,6’ = 10.6 Hz,
J6,5 = 4.3 Hz, H6), 4.25-4.30 (m, 1H, H5), 4.54 (dd, 1H, J6’,6 = 10.6 Hz, J6’,5 = 7.7 Hz,
H6’), 4.59, 4.62 (AB, 2H, J = 1.0.9 Hz, CH2CCl3), 4.73, 4.91 (AB, 2H, J = 11.6 Hz,






ArH), 7.03 (d, 1H, JNH,2 = 7.1 Hz, NH), 7.36-7.43 (m, 5H, ArH); 13C NMR (125 MHz,
CDCl3) δ 55.7, 56.7, 70.9, 72.0, 72.3, 74.9, 75.6, 79.6, 92.3, 92.4, 99.4, 114.7, 118.6,
128.4, 128.6, 128.8, 137.1, 150.7, 155.8, 163.0.
4-Tolyl 2,3,4,6-tetra-O-trimethylsilyl-1-thio-β-D-glucopyranoside
 (3.72). Prepared according to literature procedure. 59 To the tetraol
3.7128 (6.3 g, 22.0 mmol) in pyridine (22.0 mL) was added TMSCl (14.0 mL, 110.3
mmol) dropwise over 30 mins.  The reaction quickly forms a thick white paste, and was
stirred at rt for 3h.  The slurry was diluted with Et2O, washed with water, and
concentrated to a crude oil. The crude product was taken up in toluene and re-
concentrated (3x) under high vacuum to remove residual traces of pyridine; and left on
the high vacuum pump until a white solid (3.72) formed (12.2 g, 96%). All spectra are in
agreement with literature data for this compound.
4-Tolyl 3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-
glucopyranoside (3.73).  Prepared according to a modified
literature procedure.59 To a solution of the tetrasilylated 3.72 (5.0 g, 8.68 mmol) in
CH2Cl2 at 0 °C was added benzaldehyde (2.5 mL, 23.9 mmol) followed by solution of
freshly dried CuOTf in CH3CN (0.0289 g in 1.0 mL , 0.080 mmol).  The reaction was
stirred for 2 h at 0 °C, and then triethylsilane (1.4 mL, 8.76 mmol) was added.  After an
additional 1 h at 0 °C, the reaction was concentrated with no heat to a crude slurry.  The













concentrate to a white solid.   The resulting crude solid was washed with EtOH, and
filtered.  Flash chromatography of the filtrate (100% CH2Cl2) and combination of the
solids resulted in pure 3.73 (3.48 g, 85%). 1H NMR (300 MHz, CDCl3) δ  2.38 (s, 3H,
CH3), 2.60 (br-s, 1H, OH), 3.48-3.55 (m, 2H, H2, H5), 3.63-3.74 (m, 2H, H3, H4), 3.81
(tapp, 1H, J6,6’ = J6,5 = 10.2 Hz, H6), 4.41 (dd, 1H, J6’,6 = 10.4 Hz, J6’,6 = 4.8 Hz, H6’),
4.60 (d, 1H, J1,2 = 9.6 Hz, H1), 4.82, 4.97 (AB, 2H, J = 11.5 Hz, CH2Ph), 5.59 (s, 1H,
CHPh), 7.16 (d, 1H, J = 7.9 Hz, ArH), 7.28 – 7.51 (m, 12H, ArH); All spectra are in
agreement with literature data for this compound.59
4-Tolyl 3-O-benzyl-4,6-O-benzylidene-2-O-carbobenzyloxy-1-
thio-β-D-glucopyranoside (3.74). To a solution of 3.73 (2.0 g, 4.31
mmol) and DMAP (1.9 g, 15.5 mmol) in CH2Cl2 (30 mL) at room temperature was added
benzyl chloroformate (1.2 mL) dropwise over 30 min.  The reaction was stirred for 12 h,
and then a second portion of DMAP (0.5 g, 4.1 mmol) and benzyl chloroformate (0.6 mL,
4.30 mmol) were added.  After an additional 8 h, no starting material remained by TLC.
The reaction was quenched with cold MeOH, diluted with CH2Cl2 and washed with
water.  The organic layers were collected, dried over MgSO4 and concentrated to a crude
yellowish solid.  Purification by flash chromatography (100% CH2Cl2) afforded 3.74 as a
white solid (2.40 g, 93%). 1H NMR (300 MHz, CDCl3) δ 2.33 (s, 3H, CH3), 3.45 (ddd,
1H, J5,6 = 9.6 Hz, J5,4 = 9.4 Hz, J5,6’ = 5.0 Hz, H5), 3.70 (tapp, 1H, J4,5 = J4,3 = 9.2 Hz, H4),
3.74-3.81 (m, 2H, H3, H6ax), 4.37 (dd, 1H, J6,6’ = 10.5 Hz, J6’,5 = 5.0 Hz, H6eq), 4.65 (d,








= 18.5 Hz, H2), 5.23 (s, 2H, CO2CH2Ph), 5.55 (s, 1H, CHPh), 7.09 (d, 2H, J = 8.0 Hz,
ArH), 7.19-7.23 (m, 5H, ArH), 7.34-7.48 (m, 12H, ArH); 13C NMR (75 MHz, CDCl3) δ
21.2, 68.5, 70.1, 70.5, 74.6, 75.8, 79.9, 81.1, 86.8, 101.2, 126.0, 127.7, 127.8, 127.9,
128.3, 128.4, 128.61, 128.63, 129.1, 129.7, 133.8, 135.1, 137.1, 137.9. 138.7, 154.2;
HRMS (+ESI) m/z = 599.2105 (M+H)+ C35H35O7S requires 599.2104.
4-Tolyl 3-O-benzyl-2-O-carbobenzyloxy-1-thio-β-D-
glucopyranoside (3.75). Carbohydrate 3.74 (3.0 g, 5.01 mmol) was
dissolved in 2:1 MeOH: CH2Cl2 (150 mL).  p-Toluenesulfonic acid monohydrate (0.6 g,
3.13 mmol) was added, and the reaction was heated at 45 °C for 5 h until no starting
material remained by TLC.  The reaction was neutralized with NEt3, and, concentrated to
approximately half-volume, and then diluted with CH2Cl2.  The resulting solution was
washed with H2O, and sat. aq. NaHCO3, and the organic layer was collected and dried
over Na2SO4.  Purification of the crude solid by flash chromatography (1:99 to 5:95
MeOH:CH2Cl2) afforded 3.75 as a white solid (2.20 g, 86%). 1H NMR (300 MHz,
CDCl3) δ 2.31 (s, 3H, CH3), 2.31-2.33 (m, 1H, OH), 2.87 (d, 1H, JOH,4 = 3.3 Hz, 4-OH),
3.29-3.35 (m, 1H, H5), 3.40 (tapp, 1H, J3,2 + J3,4 = 17.6 Hz, H3), 3.61 (ddd, 1H, J4,3 = 9.1
Hz, J4,5 = 9.2 Hz, J4,OH = 3.1 Hz, H4), 3.69-3.76 (m, 1H, H6), 3.81-3.88 (m, 1H, H6’),
4.58-4.78 (m, 4H, H1, H2, CH2Ph), 5.20, 5.21 (AB, 2H, J = 12.1 Hz, CO2CH2Ph), 7.08
(d, 2H, J = 8.0 Hz, ArH), 7.21-7.39 (m, 12H, ArH); 13C NMR (75 MHz, CDCl3) δ 21.2,
62.3, 70.05, 70.15, 74.9, 76.1, 79.3, 83.8, 86.4, 127.9, 128.0, 128.4, 128.5, 128.56,








2-(dimethoxymethyl)naphthalene (3.76). Prepared according to the
literature procedure.60 Trimethylorthoformate (8.0 mL, 0.077 mol) and p-
toluenesulfonic acid (0.025g) were added to a solution of 2-naphthaldehyde (8.0 g, 0.051
mol) in methanol (15.3 mL).  The reaction was stirred overnight for 16 h, then diluted
with CH2Cl2, washed with sat. aq. NaHCO3 and H2O.  The organic layer was dried over
Na2SO4 and concentrated.  The resulting orange-yellow viscous liquid (10.7 g) was used
without any further purification.  All spectra were in agreement with the literature data.60
4 Tolyl 3-O-benzyl-2-O-carbobenzyloxy-4,6-O-(2-
naphthyl)methylene-1-thio-β-D-glucopyranoside (3.77). Diol
3.75 (4.3 g, 8.42 mmol) was dissolved in CH3CN (85 mL).  2-napthaldehyde dimethyl
acetal 3.76 (2.04 g, 10.1 mmol) and p-toluenesulfonic acid (0.10 g, 0.53 mmol) were
added.  The reaction was stirred at room temperature for 30 min, until a clear gel-like
precipitate formed and no starting material was detected by TLC.  The resulting slurry
was concentrated, taken up in CH2Cl2 washed with H2O, sat. aq. NaHCO3 and dried over
Na2SO4.  Flash chromatography of the crude solid provided 3.77 as a waxy solid (4.68 g,
86%). 1H NMR (300 MHz, CDCl3) δ 2.34 (s, 3H, CH3), 3.51 (ddd, 1H J5,4 = J5,6ax = 9.2
Hz, J5,6eq = 4.9 Hz, H5), 3.73-3.88 (m, 3H, H3, H4, H6ax), 4.42 (dd, 1H, J6eq,6ax = 10.5
Hz, J6eq,5 = 4.9 Hz, H6eq), 4.66-4.70 (m, 3H, H1, 1/2 CH2Ph), 4.82-4.88 (m, 2H, H2, 1/2
CH2Ph), 5.26 (s, 2H, CO2CH2Ph), 5.70 (s, 1H, CHNAP), 7.12 (d, 2H, J = 7.9 Hz, ArH),
7.23 (s, 1H, 5H), 7.36-7.41 (m, 7H, ArH), 7.48-7.51 (m, 2H, ArH), 7.58 (d, 1H, J = 8.4










21.2, 68.6, 70.1, 70.5, 74.6, 75.8, 79.9, 81.2, 86.8, 101.4, 123.6, 125.5, 126.3, 126.5,
127.69, 127.73, 127.8, 127.9, 128.1, 128.3, 128.37, 128.4, 128.7, 129.8, 132.9, 133.7,




carbohydrate 3.77 (3.0 g, 4.62 mmol) in freshly distilled THF (15 mL) at rt was added
CoCl2 (1.8 g, 13.9 mmol) followed by BH3THF (1.0 M soln. in THF, 14.4 mL, 1.4.
mmol).  When no starting material remains by TLC,  (approximately 8 hours, subject to
change drastically with quality of BH3THF) the reaction was diluted with EtOAc, and the
unused CoCl2 is filtered off.  The remaining filtrate was treated with aq. NaBH4 (0.2 eq),
and a second filtration was performed to remove the black precipitate.  The resulting two
phases were separated, the organic phase was washed with sat. aq. NaHCO3, dried over
MgSO4 and concentrated to a crude solid.  Flash chromatography (99:1 CH2Cl2:MeOH)
provided 3.78 as a white waxy solid (2.76 g, 92%). 1H NMR (300 MHz, CDCl3) δ 1.88
(br-s, 1H, OH), 2.32 (s, 3H, CH3), 3.38-3.44 (m, 1H, H5), 3.61-3.78 (m, 3H, H3, H4,
H6), 3.87-3.91 (m, 1H, H6’), 4.61 (d, 1H, J1,2 = 9.8 Hz, H1), 4.67-4.84 (m, 4H, H2,
CH2Nap, 1/2 CH2Ph), 4.95 (d, 1H, J =1 1.1 Hz, 1/2 CH2Ph), 5.19, 5.23 (AB, 2H, J = 12.1
Hz, CO2CH2Ph), 7.07-7.10 (m, 2H, ArH), 7.18-7.26 (m, 5H, ArH), 7.31-7.40 (m, 8H,
ArH), 7.44-7.47 (m, 2H, ArH), 7.67 (s, 1H, ArH), 7.75-7.82 (m, 3H, ArH); 13C NMR (75








126.2, 126.8, 127.7, 127.77, 127.83, 128.0, 128.26, 128.33, 128.37, 128.40, 128.6, 129.8,
133.0, 133.2, 133.5, 135.10, 135.13, 137.9, 138.6, 154.3; HRMS (+ESI) m/z = 668.2663,
C39H42NO7S (M+NH4)+ requires 668.2682.
4-Tolyl 3-O-benzyl-2-O-carbobenzyloxy-4-O-(2-
naphthylmethylene)-1-thio-β-D-glucopyranosyluronic acid
 (3.79). To carbohydrate 3.78 (0.60 g, 0.92 mmol) in 2:1 CH 2Cl2:H2O (4.5 mL) was
added TEMPO (0.029 g, 0.18 mmol) followed by iodobenzene diacetate (BAIB, 0.89 g,
2.7 mmol). The biphasic reaction was vigorously stirred at rt for 45 min, then diluted with
CH2Cl2 then quenched with 10 % Na2S2O3 in H2O (30 mL).  The layers were separated,
and the organic layer was dried over Na2SO4 and concentrated to a crude yellow solid
(0.624 g, crude).  The crude material was directly applied in the synthesis of 3.69 with no
purification or characterization.
4-Methoxyphenyl 3,4,6-tri-O-acetyl-2-deoxy-2-trichloroacetamido-
β-D-glucopyranoside (3.85). To tetraacetate 3.8462,63 (15.0 g, 30.4
mmol) in freshly distilled CH2Cl2 at 0 °C was added 4-methoxy phenol (15.0 g, 120.8
mmol) follwed by a dropwise addition of BF3OEt2 (15.0 mL, 118.0 mmol).  The reaction
was allowed to gradually warm to room temperature and stir overnight for 16 h.  The
solution was then cooled, diluted with CH2Cl2 and carefully quenched with sat. aq.
NaHCO3.  The resulting layers were separated, and the organic layer was washed with













Recrystallization (EtOAc/Hexanes) afforded 3.85 as fine white needles (15.1 g, 92%).
All spectra agree with literature data for this compound.82
Phenyl 3,4,6-tri-O-acetyl-2-deoxy1-thio-2-trichloroacetamido-β-D-
glucopyranoside (3.86). Synthesis performed exactly as described for
3.85.  Tetraacetate 3.84 (15.0 g, 30.4 mmol), benzene thiol (15.0 mL, 136 mmol),
BF3OEt2 (15.0 mL, 118 mmol).  After work-up and recrystallization, 3.86 is isolated as a
white solid (15.7 g, 95%). All spectra agree with literature data for this compound.83
4-Methoxyphenyl 2-deoxy-2-trichloroacetamido-β-D-
glucopyranoside (3.87) or Phenyl 2-deoxy-1-thio-2-
trichloroacetamido-β-D-glucopyranoside (3.88). Na° metal (0.3 eq.) was added to the
appropriate starting material (3.85 or 3.86) in reagent grade MeOH (0.12 M solution).
The reaction was stirred for 12 h, neutralized with Dowex H+ resin, filtered and
concentrated to a white solid.  The resulting crude triols were used directly in the next
step without any purification or characterization.
4-Methoxyphenyl 2-deoxy-3,6-di-O-pivaloyl-2-trichloroacetamido-β-
D-glucopyranoside (3.89) or Phenyl 2-deoxy-3,6-di-O-pivaloyl-1-thio-
2-trichloroacetamido-β-D-glucopyranoside (3.90). Prepared according to a modified
literature procedure.66 To the appropriate crude triol (3.86 or 3.87) in pyridine (1.2 M)














reaction was then removed from the ice bath, and stirred at room temperature for 5 h.
The slurry was then cooled, quenched with MeOH and concentrated to dryness.  The
resulting solid was dissolved in CH2Cl2, washed with H2O, 5% aqueous HCl, and sat. aq.
NaHCO3, dried over MgSO4 and re-concentrated to dryness.  Recrystalization of the
crude solid and flash chromatography purification of the filtrate (EtOAc/Hexanes)
provided pure 3.88 or 3.89. All spectra for 3.8982 and 3.9083 were in agreement with
literature data for these compounds.
Phenyl 2-deoxy-3,6-di-O-pivaloyl-1-thio-2-trichloroacetamide-β-D-
glucopyranosid-4-ulose (3.93). Acetic acid (11.3 mL) was added to a
solution of carbohydrate 3.89 (2.0 g, 3.42 mmol) in dry DMSO (79 mL).  The reaction
flask was covered with aluminum foil, and stirred at room temperature for 16 h.  The
solution was then diluted with Et2O and washed with H2O.  The aqueous layer was
extracted 2x with Et2O, and the combined organic phases were dried over MgSO4 and
concentrated to a crude oil.  Purification by flash chromatography afforded impure 3.93
as a yellow solid (1.91 g, 96% incl. impurities).  HRMS (+ESI) m/z = 582.0883,
C24H31Cl3NO7S (M+H)+ requires 582.0887.  The compound was used directly in the next
reaction without any further characterization.
Phenyl 2-deoxy-2-dichloroacetamido-3,6-di-O-pivaloyl-1-thio-β-D-
galactopyranoside (3.94). To a solution of 3.93 (1.91 g, 3.28 mmol) in












dropwise via syringe pump over 45 min.  The reaction was stirred at –78 °C for 4 h, at
which point no starting material could be detected by TLC.  The reaction was quenched
with H2O, diluted with Et2O, and washed with sat. aq. NaHCO3.  The aqueous layer was
extracted with Et2O, and the organic portions were collected, dried over MgSO4 and
concentrated to a crude oil.  Purification by flash chromatography (25:75
EtOAc/Hexanes) afforded 3.94 as a slightly yellow foam (1.23 g, 68%). 1H NMR (300
MHz, CDCl3) δ 1.14 (s, 9H, 3xCH3), 1.17 (s, 9H, 3xCH3), 2.63 (br-s, 1H, OH), 3.83-3.83
(m, 1H, H5), 4.01 (br-s, 1H, H4), 4.27-4.42 (m, 3H, H2, H6, H6’), 4.90 (s, 1H, J1.2 = 10.5
Hz, H1), 5.20 (dd, 1H, J3,2 = 10.7 Hz, J3,4 = 3.0 Hz, H3), 5.84 (s, 1H, CHCl2), 6.94 (d,
1H, JNH,2 = 9.4 Hz, NH), 7.22-7.26 (m, 3H, ArH), 7.46-7.49 (m, 2H, ArH); 13C NMR (75
MHz, CDCl3) δ  27.06, 27.10, 30.7, 39.0, 49.9, 63.4, 66.2, 67.3, 72.7, 76.4, 87.9, 127.9,
128.9, 129.0, 132.0, 133.5, 164.4, 178.3, 178.4.  HRMS (+ESI) m/z = 550.1420
C24H34NO7SCl2 (M+H)+ requires 550.1433.
4-Methoxyphenyl 2-deoxy-4,6-di-O-pivaloyl-2-
trichloroacetamido-β-D-galactopyranoside (3.96) and 4-
Methoxyphenyl 2-deoxy-3,4-di-O-pivaloyl-2-trichloroacetamido-β-D-
galactopyranoside (3.97) or Phenyl 2-deoxy-4,6-di-O-pivaloyl-2-trichloroacetamido-
1-thio-β-D-galactopyranoside (3.98) and Phenyl 2-deoxy-3,4-di-O-pivaloyl-2-
trichloroacetamido-1-thio-β-D-galactopyranoside (3.99). Compounds prepared
according to a modified literature procedure.66 The appropriate glycoside (3.89 or 3.90),












dropwise addition of triflic anhydride (1.2 eq.).  The reaction was stirred for 1 h at 0 °C
until no starting material is detected by TLC.  H2O (50 eq.) was then added, and the
reaction was heated at 85 °C for 3 hours.  The resulting solution was cooled, diluted with
1,2-dichloroethane, washed with sat. aq. NaHCO3 and dried over MgSO4.  Purification by
flash column chromatography (33:67 to 50:50 EtOAc/Hexanes) provided the appropriate
separated 3,4- and 4,6-di-O-Piv compounds 3.96/3.97 (94% combined yield) or 3.98/3.99
(95 % combined yield).  All spectra for these compounds are in agreement with literature
characterization data.82,83
4-Methoxyphenyl 2-deoxy-2-trichloroacetamido-β-D-
galactopyranoside (3.100) or Phenyl 2-deoxy-2-trichloroacetamido-1-
thio-β-D-galactopyranoside (3.101). Na metal (0.3 eq.) was added to the appropriate
starting material (3.85 or 3.86) in reagent grade MeOH (0.12 M solution). The reaction
was stirred for 12 h, neutralized with dowex H+ resin, filtered and concentrated to a white
solid.  The resulting crude triols 3.100 and 3.101 were used directly in the next step
without any further purification or characterization.
4-Methoxyphenyl 4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-
D-galactopyranoside (3.105) or Phenyl 4.6-O -2-deoxy-1-thio-2-
trichloroacetimido-β-D-galactopyranoside (3.106). A solution of 3.100













were stirred overnight (16 h) at room temperature.  The solution was neutralized by
addition of triethylamine, and concentrated to a crude yellow solid.  For 3.105: The
resulting solid was washed with methanol, and the white precipitate was filtered and
collected.  Flash chromatography of the resulting filtrate (98:2 CH2Cl2/MeOH) afforded a
white solid. 3.105  (96%).  For 3.106 : The crude solid was purified by flash
chromatography (1:1 EtOAc/Hexanes) to afford 3.106 (90%).  All spectra for 3.105 and
3.106 were in agreement with literature data.82
4-Methoxyphenyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside (3.107). To carbohydrate
3.105 (6.6 g, 12.7 mmol) in CH2Cl2 (70 mL) at 0 °C was added pyridine
(5.3 mL, 61.6 mmol) followed by a dropwise addition of acetic anhydride (6.0 mL, 63.5
mmol).  The reaction was removed from the ice bath and stirred until no starting material
was detected by TLC (5 h).  The solution was quenched with methanol and concentrated.
The resulting residue was dissolved in CH2Cl2, washed with sat. aq. NaHCO3 and H2O,
the organic layer was dried over MgSO4 and concentrated to a crude foam.  Purification
by flash chromatography (99:1 CH2Cl2/MeOH) provided 3.107 as a white solid (7.0 g,
98%). 1H NMR (300 MHz, CDCl3) δ 2.08 (s, 3H, CH3), 3.62 (br-s, 1H, H5), 3.73 (s, 3H,
OCH3), 4.06 (dd, 1H, J6,6’ = 12.4 Hz, J6,5 = 1.2 Hz, H6), 4.31-4.42 (m, 3H,H6’, H4, H2),
5.27 (d, 1H, J1,2 = 8.3 Hz, H1), 5.47 (dd, 1H, J3,2 = 11.3 Hz, J3,4 = 3.4 Hz, H3), 5.51 (s,
1H, CHPh), 6.74-6.78 (m, 2H, ArH), 6.90 (d, 1H, JNH,2 = 8.1 Hz, NH), 6.96-7.00 (m, 2H,








20.8, 53.0, 55.6, 66.5, 69.0, 69.5, 73.0, 92.4, 100.1, 100.9, 114.5, 119.4, 126.3, 128.2,
129.2, 137.4, 151.1, 155.7, 162.0, 170.8.
 4-Methoxyphenyl 3-O-acetyl-4-O-benzyl-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside (3.109). To the fully
protected 3.107 (4.3 g, 7.67 mmol) in freshly distilled THF (43 mL) at rt was added
CoCl2 (3.0 g, 23.1 mmol) followed by BH3THF (1.0 M soln. in THF, 24.0 mL, 1.4.
mmol).  When no starting material remains as indicated by TLC analysis,  (approximately
6 hours) the reaction is diluted with EtOAc, and the unused CoCl2 is filtered off.  The
remaining filtrate is treated with aq. NaBH4 (0.2 eq), and a second filtration is performed
to remove the black precipitate.  The resulting two phases are separated, the organic
phase is washed with sat. aq. NaHCO3, dried over MgSO4 and concentrated to a crude
solid.  Flash chromatography (99:1 CH2Cl2:MeOH) provides 3.109 as a white solid (4.19
g, 98%). 1H NMR (300 MHz, CDCl3) δ 1.81 (br-s, 1H, OH), 2.03 (s, 3H, CH3), 3.56-3.61
(m, 1H, H5), 3.64-3.68 (m, 1H, H6), 3.71 (s, 3H, OCH3), 3.82 (dd, 1H, J6’,6 = 10.7 Hz,
J6’,5 = 6.3 Hz, H6’), 3.90 (d, 1H, J4,3 = 2.7 Hz, H4), 4.45-4.52 (m, 1H, H2), 4.56, 4.76
(AB, 2H, J = 11.7 Hz, CH2Ph), 5.04 (d, 1H, J1,2 = 8.3 Hz, H1), 5.29 (dd, 1H, J3,2 = 11.3
Hz, J3,4 = 2.9 Hz, H3), 6.71-6.76 (m, 2H, ArH), 6.84-6.94 (m, 3H, NH, ArH), 7.26-7.37
(m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 20.8, 53.5, 55.6, 61.4, 72.3, 72.9, 74.9, 75.3,








galactopyranoside  (3.111). To 3.109 (2.853 g, 5.07 mmol) in CH2Cl2 (20 mL, 0.25 M)
at 0 °C was added 1,2-DMI (1.25 g, 13.0 mmol) followed by 2.42 (4.75 g, 10.4 mmol).
The reaction was stirred at 0 oC, gradually warmed to room temperature, and then stirred
overnight.  After 24 h, the system applied directly to a silica gel column, and 3.111 was
obtained after flash chromatography (33:67 EtOAc/Hexanes) as a white solid (3.70 g,
95%). 1H NMR (300 MHz, CDCl3) δ 2.13 (s, 3H, CH3), 3.76 (s, 3H, CH3), 4.01 (d, 1H,
J4,3 = 2.3 Hz, H4), 4.05 (br-dd, 1H, J5,6’ = 6.9 Hz, J5,6 = 4.9 Hz, H5), 4.28 (dd, J6,6’ = 10.6
Hz, J6,5 = 4.6 Hz, H6), 4.49-4.63 (m, 5H, H6’, H2, 1/2 CH2Ph, CH2CCl3), 4.90 (d, 1H, J
= 11.4 Hz, 1/2 CH2Ph), 5.19 (d, 1H, J1,2 = 8.3 Hz, H1), 5.45 (dd, 1H, J3,2 = 11.3 Hz, J3,4 =
2.7 Hz, H3), 6.81 (d, 2H, J = 9.0 Hz, ArH), 6.88 (d, 1H, JNH,2 = 8.6 Hz, NH), 6.96 (d, 2H,
J = 9.0 Hz, ArH), 7.35-7.43 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ  20.8, 53.3,
55.6, 71.6, 71.7, 72.1, 72.7, 75.1, 79.7, 92.31, 92.35, 100.0, 114.7, 118.6, 128.4, 128.5,
128.8, 136.8, 150.9, 155.8, 162.2, 170.6; HRMS (+ESI) m/z = 788.9805,
C26H31Cl6N2O11S (M+NH4)+ requires 788.9780.
Carbonate (3.114). To a solution of 3.117 (0.285 g, 0.359 mmol), 3.69
(0.180 g, 0.246 mmol), and 4A molecular sieves (0.75 g) in CH2Cl2 at
–40 °C was added TMSOTf (0.1 mL of a 1.0 M soln. in CH2Cl2, 0.1
mmol).  The reaction was stirred for 30 min at –40 °C and then quenched with NEt3 (0.1












yellow foam.  Purification by flash chromatography (33/67 EtOAc/Hexanes) afforded
3.114 as a white foam (0.186 g, 90%).  1H NMR (300 MHz, CDCl3) δ 3.90 (tapp, 1H, J3,4
+ J3,2 = 7.0 Hz, H3), 4.06 (tapp, 1H, J4,5 + J4.3 = 9.3 Hz, H4), 4.38 (s, 2H, CH2Ar), 4.57 (d,
1H, J5,4 = 5.1 Hz, H5), 4.61 (dd, 1H, J2,1 = 6.2 Hz, J2,3 = 2.8 Hz, H2), 4.68 (s, 2H,
CH2Ar), 5.07, 5.13 (AB, 2H, J = 12.2 Hz, CO2CH2Ph), 6.18 (d, 1H, J1,2 = 6.3 Hz, H1),
7.07-7.35 (m, 2H, ArH), 7.23-7.34 (m, 9H, ArH), 7.47-7.51 (m, 2H, ArH), 7.63 (s, 1H,
NAPH1), 7.76-7.84 (m, 3H, ArH); 13C NMR (75 MHz, CDCl3) δ 67.6, 72.1, 72.6, 72.86,
72.93, 73.2, 73.8, 95.7, 125.8, 126.2, 126.3, 127.0, 127.7, 127.9, 128.0, 128.35, 128.37,
128.5, 128.6, 128.7, 133.2, 134.2, 134.8, 136.3, 152.2, 168.3; LRMS (+ESI) m/z =
558.2247, C32H32NO8 (M+NH4)+ requires 558.1784.
Benzyl (3-O-benzyl-2-O-carbobenzyloxy-4-O-(2-
naphthyl)methylene-D-glucopyranosyl)uronate (3.123). NBS (0.38
g, 2.12 mmol) was added to 3.68 (0.4 g, 0.530 mmol) in acetone/CH2Cl2/H2O (5:5:1, 11
mL) at 0 °C. The reaction was stirred for 30 min at 0 °C then concentrated until turbidity
developed.  The remaining residue was dissolved in EtOAc, washed with H2O, dried over
MgSO4 and concentrated to a yellow foam.  Purification by flash chromatography (100%
CH2Cl2) afforded 3.123 as a white foam (0.3129, 94%). HRMS (+ESI) m/z = 666.2679,
C39H40NO9 (M+NH4)+ requires 666.2703.  3.123 was used directly in the next reaction










glucopyranosyl)uronate (3.124). To carbohydrate 3.123 (0.3291 g, 0.507 mmol) in
CH2Cl2 (3.0 mL) at –40 oC was added trichloroacetonitrile (0.8 mL, 7.98 mmol),
followed by DBU (0.10 mL of 1.0 M solution in CH2Cl2, 0.10 mmol).  The reaction was
stirred for approximately 4 hours then concentrated to a brown crude oil.  Purification by
flash chromatography (25:75 EtOAc/hexanes) afforded 3.123 as a white foam (0.3096,
77%).  1H NMR (300 MHz, CDCl3) δ 3.98 (tapp, J3,4 = J3,.2 = 9.7 Hz, H3), 4.13 (tapp, J4,5
+J4,3 = 19.0 Hz, H4), 4.51 (d, 1H, J5,4 = 9.9 Hz, H5), 4.61, 4.86 (AB, 2H, J = 10.9 Hz,
CH2NAP), 4.80 (s, 2H, CO2CH2Ph), 5.00 (dd, 1H, J2,3 = 9.8 Hz, J2,1 = 3.5 Hz, H2), 5.08-
5.19 (m, 4H, CH2Ph), 6.66 (d, 1H, J1,2 = 3.5 Hz, H1), 7.21-7.26 (m, 12H, ArH), 7.34 (s,
5H, ArH), 7.45-7.48 (m, 2H, ArH), 7.55 (s, 1H, NapH1), 7.71-7.74 (m, 2H, ArH), 7.78-
7.82 (m, 1H, ArH), 8.57 (s, 1H, NH); 13C NMR (75 MHz, CDCl3) δ 67.6, 70.1, 72.9,
75.5, 75.70, 75.74, 78.8, 78.9, 90.7, 93.4, 125.9, 126.0, 126.1, 126.8, 127.7, 127.8, 127.9,
128.0, 128.1, 128.36, 128.40, 128.48, 128.51, 128.58, 128.62, 128.7, 133.1, 133.2, 134.8,
135.0, 137.8, 154.3, 160.7, 168.1.
Benzyl (4-Methoxyphenyl 3,4-di-O-benzyl-2-O-
trichoroethoxysulfo-β-D-glucopyranoside)uronate (3.126).  To the
glucuronic acid 3.132 (0.230 g, 0.332 mmol) in CH2Cl2 (1.2 mL) at 0 °C was added
benzyl chloroformate (0.07 mL, 0.490 mmol) followed by a dropwise addition of NEt3
















mmol) was added and the system was stirred for an additional 30 min at 0 °C.  The
reaction was concentrated to approximate half volume without the use of heat, and
applied directly to a silica gel column.  Flash chromatography (100% CH2Cl2) provided
3.126 as a white solid (0.188 g, 70%). 1H NMR (300 MHz, CDCl3) δ 3.76 (s, 3H, CH3),
3.85 (br-t, 1H, J3,4 + J3,2 = 15.6 Hz, H3), 4.02-4.10 (m, 2H, H4, H5), 4.52 (d, 1H, J = 10.7
Hz, 1/2 CH2Ph), 4.65-4.74 (m, 3H, CH2CCl3, 1/2 CH2Ph), 4.80-4.92 (m, 3H, H2,
CH2Ph), 5.07 (d, 1H, J1,2 = 7.3 Hz, H1), 5.14 (s, 2H, CO2CH2Ph), 6.80 (d, 2H, J = 8.9 Hz,
ArH), 7.03 (d, 2H, J = 8.9 Hz, ArH), 7.13-7.35 (m, 14H, ArH); 13C NMR (75 MHz,
CDCl3) δ 55.6, 67.6, 74.7, 75.0, 75.5, 78.8, 80.0, 80.8, 83.8, 92.6, 99.4, 114.7, 118.9,
127.8, 128.0, 128.1, 128.4, 128.49, 128.54, 128.6, 134.8, 137.0, 137.2, 150.1, 156.1,
167.3; HRMS (+ESI) m/z = 798.1285, C36H39Cl3NO11S (M+NH4)+ requires 798.1309.
4-Methoxyphenyl 2,3,4,6-tetra-O-trimethylsilyl-β-D-
glucopyranoside (3.128).  TMSCl (7.9 mL, 60.7 mmol) was added
dropwise to a solution of carbohydrate 3.127 (3.4 g, 11.9 mmol) in pyridine (20 mL).
The reaction was stirred for 2 h at room temperature, diluted with Et2O, and washed H2O.
The resulting organic layer was dried over MgSO4 and concentrated to dryness.  The
resulting oil was co-evaporated (2x) with toluene and left under vacuum overnight.  Pure








glucopyranoside (3.129). Tetrasilylated 3.128 (1.0 g, 1.74 mmol)
was dissolved in CH2Cl2 (2.0 mL) at 0 °C.  Benzaldehyde was added, and after 10 min a
solution of freshly dried CuOTf in CH3CN (0.023 M, 0.75 mL, 0.017 mmol) was added.
After 1 h, triethylsilane (0.28 mL, 1.75 mmol), and the reaction was stirred for an
additional 30 min at 0 °C.   The reaction was then concentrated to a crude paste without
the use of heat, redissolved in CH2Cl2 (45 mL) and was treated with a 1.0 M solution of
TBAF in THF (3.0 mL, 3.0 mmol) at room temperature.  The reaction was stirred for an
additional hour and then concentrated to a crude solid.  Purification by flash
chromatography (100% CH2Cl2 to 98:2 CH2Cl2:MeOH for solubility reasons) afforded




carbohydrate 3.129 (0.2 g, 0.431 mmol) in freshly distilled CH2Cl2 (2.7 mL) at 0 °C was
added 1,2-DiMeIm (0.1 g, 1.0 mmol) follwed by 2.40 (0.4 g, 0.847 mmol).  The reaction
was stirred for 16 h, and then additional 1,2-DiMeIm (0.1 g, 1.0 mmol) and 2.40 (0.4 g,
0.847 mmol) were added.  After an additional 8 h, the reaction was quenched with H2O.
The aqueous layer was extracted with CH2Cl2 and the organic layer was collected, dried
over MgSO4 and concentrated to a crude brown syrup.  Purification by flash














1H NMR (300 MHz, CDCl3) δ 3.57 (ddd, 1H, J5,6ax = 9.7, J5,4 = 9.5, J5,6eq = 5.0 Hz, H5),
3.80 (s, 3H, CH3), 3.86 (tapp, 1H, J6eq,6ax =  J6ax,5 = 10.4 Hz, H6ax), 3.88 (tapp, 1H, J4,5 = J4,3
= 9.2 Hz, H4), 3.98 (tapp, 1H, J3,4 = J3,2 = 9.1 Hz, H3), 4.43 (dd, 1H, J6eq,6ax = 10.5, J6eq,5 =
5.0 Hz, H6eq), 4.68, 4.71 (AB, 2H, J = 11.1 Hz, CH2CCl3), 4.85 (tapp, 1H, J2,3 +J2,1 =16.2
Hz, H2), 4.87, 5.01 (AB, 2H, J = 11.2 Hz, CH2Ph), 5.02 (d, 1H, J1,2 = 7.8 Hz, H1), 5.61
(s, 1H, CHPh), 6.85-6.88 (m, 2H, ArH), 7.06-7.09 (m, 2H, ArH), 7.33-7.50 (m, 10H,
ArH); 13C NMR (75 MHz, CDCl3) δ 55.54, 66.19, 66.30, 74.61, 77.87, 79.86, 81.21,
83.89, 92.57, 99.89, 101.36, 114.59, 118.77, 125.88, 127.92, 128.09, 128.11, 128.25,
128.27, 128.28, 128.38, 129.13, 136.63, 137.12, 150.16, 155.99; Melting point 105-107
oC; HRMS (EI) m/z = 674.0546, C29H29Cl3O10S requires 674.0547.
4-Methoxyphenyl 3,4-di-O-benzyl-2-O-(2,2,2-
trichloroethoxysulfo)-β-D-glucopyranoside (3.131). Carbohydrate
3.130 (1.0 g, 1.48 mmol) was dissolved in 1.0 M BH3.THF solution (7.4 mL, 7.4 mmol).
CuOTf (0.027 g, 0.075 mmol) was added, and the reaction was stirred at room
temperature for 10 h.  Upon completion, the system was diluted with EtOAc, the black
precipitate was filtered off, and the filtrate was washed with H2O, sat. aq. NaHCO3, dried
over MgSO4 an concentrated to a white foam.  Purification by flash chromatography
provided 3.131 (0.780 g, 78%) as a white solid. 1H NMR (300 MHz, CDCl3) δ 1.85 (br-s,
1H, OH), 3.45-3.51 (m, 1H, H5), 3.68-3.77 (m, 2H, H4,H6), 3.75 (s, 3H, CH3), 3.82-3.88
(m, 2H, H3, H6’), 4.63-4.87 (m, 6H, H2, CH2CCl3, CH2Ph, 1/2CH2Ph), 4.98 (d, 1H, J =








(m, 2H, ArH), 7.24-7.40 (m, 10H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 61.3, 75.2,
75.6, 75.8, 77.4, 80.0, 81.8, 84.2, 92.7, 98.9, 114.8, 118.3, 128.02, 128.05, 128.12, 128.2,
128.5, 128.6, 137.1, 137.3, 150.1, 155.9; HRMS (+ESI) m/z = 694.1028, C-
29H35NO10SCl3 (M+NH4)+ requires 594.1047.
4-Methoxyphenyl 3,4-di-O-benzyl-2-O-(2,2,2-
trichloroethoxysulfo)-β-D-glucopyranosyluronic acid (3.132). To
carbohydrate 3.131 (0.3 g, 0.442 mmol) in 1:1 CH2Cl2:H2O (2.5 mL) was added TEMPO
(0.014 g, 0.090 mmol) followed by iodobenzene diacetate (BAIB, 0.310 g, 0.962 mmol).
The biphasic reaction was vigorously stirred at rt for 3 h. The resulting layers were
separated, and the organic layer was dried over Na2SO4 and concentrated to a crude
yellow solid.  Purification by flash chromatography (99:1 CH2Cl2/MeOH) afforded 3.132
as a yellow foam (0.271 g, 88%). The crude acid was used directly in the next reaction
with no further characterization.
Lactone (3.133). Isolated as a by-product in the preparation of 3.126.
1H NMR (300 MHz, CDCl3) δ 3.74, (s, 4H, H3, CH3), 3.84 (s, 1H,
H5), 4.47-4.67 (m, 5H, H4, 2xCH2Ph), 4.97 (s, 1H, H2), 5.48 (s, 1H, H1), 6.80 (d, 2H, J
= 9.02 Hz, ArH), 6.97 (d, 2H, J = 9.02 Hz, ArH), 7.24-7.37 (m, 10H, ArH); 13C NMR (75
MHz, CDCl3) δ 55.7, 71.05, 71.14, 76.6, 77.4, 79.4, 94.7, 114.7, 118.2, 128.0, 128.1,
128.3, 128.4, 128.66, 128.69, 136.50, 136.52, 149.7, 155.5, 168.0; HRMS (+ESI) m/z
















Glucopyranosyl)uronate (3.134).  Ceric ammonium nitrate (0.933 g,
0.96 mmol) wad added to carbohydrate 3.126 (0.250 g, 0.319 mmol) in
CH3CN/H2O/PhCH3 (4.2 mL:28 mL:0.3 mL).  The reaction was stirred for 20 min, then
poured into an ice/H2O mixture.  The resulting solution was extracted with EtOAc, and
the resulting organic phase was collected and dried over MgSO4.  Purification by flash
chromatography (99:1 CH2Cl2/MeOH) provided 3.134 as a slightly yellow foam (0.158 g,
73%). For the α-anomer. 1H NMR (300 MHz, CDCl3) δ 3.50 (br-s, 1H, OH), 3.86 (tapp,
1H, J4,3 + J4.5 = 18.3 Hz, H4), 4.11 (tapp, 1H, J3,4 + J3,2 = 18.3 Hz, H3), 4.47-4.63 (m, 5H,
H2, H5, CH2CCl3, 1/2 CH2Ph), 4.68-4.78 (m, 2H, 2x 1/2 CH2Ph), 4.85 (d, 1H, J = 11.0
Hz, 1/2 CH2Ph), 5.14, 5.16 (AB, 2H, J = 12.1 Hz, CO2CH2Ph), 5.68 (br-s, 1H, H1), 7.11-
7.13 (m, 2H, ArH), 7.25-7.31 (m, 13H, ArH); 13C NMR (75 MHz, CDCl3) δ 60.5, 67.7,
70.3, 75.1, 76.0, 77.8, 79.56, 79.64, 81.5, 90.2, 92.3, 127.8, 127.9, 128.0, 128.1, 128.4,




To carbohydrate 3.134 (0.172 g, 0.255 mmol) in CH2Cl2 (1.5 mL) at
–40 oC was added trichloroacetonitrile (0.41 mL, 4.09 mmol), followed by DBU (0.05
















4 hours as the temperature increased to rt, then concentrated to a brown crude oil.
Purification by flash chromatography (25:75 EtOAc/hexanes) afforded 3.135 as a white
foam (0.175, 84%).  1H NMR (300 MHz, CDCl3) δ 3.94 (tapp, 1H, J4,5 = J4,3 =9.5 Hz, H4),
4.13 (tapp, 1H, J3,2 = J3,4 = 9.5 Hz, H3), 4.41-4.48 (m, 2H, H5, 1/2 CH2Ph), 4.55 (s, 2H,
CH2CCl3), 4.69 (d, 1H, J = 10.6 Hz, 1/2 CH2Ph), 4.90 (d, 1H, J1,2 = 3.5 Hz, H1), 7.06-
7.09 (m, 2H, ArH), 7.24-7.31 (m, 13H, ArH), 8.85 (s, 1H, NH); 13C NMR (75 MHz,
CDCl3) δ 67.8, 72.6, 75.5, 76.1, 78.0, 79.4, 79.7, 80.1, 92.6, 128.04, 128.06, 128.14,
128.2, 128.5, 128.6, 128.7, 134.7, 136.87, 136.92, 160.3, 167.6; HRMS (+ESI) m/z =
817.9717, C31H30Cl6NO10S (M+H)+ requires 817.9722.
Benzyl 3,4-di-O-benzyl-2-O-(2,2,2-trichloroethoxysulfo)-α,β-
D-glucopyronosyluronate-(16)-1,2:3,4-di-O-isopropylidene-
α-D-galactopyranoside (3.137). A mixture of imidate 3.135
(0.170 g, 0.207 mmol) and acceptor 3.136 (0.043 g, 0.165 mmol) and 4A molecular
sieves were stirred in dry CH2Cl2 (2.0 mL) under rgon for 1 h at room temperature.  A
solution of 0.1 M TMSOTf (0.040 mL) was added, and the reaction was allowed to stir at
rt for 30 min.  The system was then treated with triethylamine (0.05 mL), filtered through
celite and concentrated.  Purification by flash chromatography (25:75 EtOAc/Hexanes)
afforded in order of elution the α-anomer (0.085 g, 54%) and the β anomer (0.042 g,
27%).  α anomer:  1H NMR (300 MHz, CDCl3) δ 1.31 (s, 3H, CH3), 1.32 (s, 3H, CH3),
1.40 (s, 3H, CH3), 1.52 (s, 3H, CH3), 3.76-3.91 (m, 3H, H4’, H5, H6), 3.98-4.09 (m, 2H,













5H, H2’, H4’, CH2CCl3, 1/2 CH2Ph), 4.65-4.74 (m, 2H, 2x1/2CH2Ph), 4.87 (d, 1H,
J=11.0 Hz, 1/2 CH2Ph), 5.17 (s, 2H, COCH2Ph), 5.33 (d, 1H, J1’,2’ = 3.5 Hz, H1’), 5.47
(d, 1H, J1,2 =5.0 Hz, H1), 7.08-7.10 (m, 2H, ArH), 7.22-7.29 (m, 13H, ArH); 13C NMR
(75 MHz, CDCl3) δ 24.3, 24.9, 25.9, 26.1, 65.9, 67.5, 70.4, 70.5, 70.6, 75.0, 75.9, 78.2,
79.6, 80.0, 81.1, 92.4, 96.2, 96.4, 108.6, 109.5, 127.78, 127.82, 127.9, 128.0, 128.4,
128.48, 128.51, 128.60, 128.64, 134.9, 137.26, 137.31, 168.8.  β anomer: 1H NMR (300
MHz, CDCl3) δ 1.29 (s, 6H, 2xCH3), 1.41 (s, 3H, CH3), 1.52 (s, 3H, CH3), 3.80-3.86 (m,
2H, H3’, H6), 3.94-4.07 (m, 4H, H4, H4’, H5, H6), 4.24 (d, 1H, J5’,4’ = 8.0 Hz, H5’),
4.31-4.33 (m, 1H, H2), 4.44, 4.68 (AB, 2H, J= 10.8 Hz, CH2Ph), 4.55-4.65 (m, 2H, H2’,
H3),  4.74-4.81 (m, 2H, H1’, 1/2 CH2Ph), 4.86 (s, 2H, CH2CCl3), 4.93 (d, 1H, J1,2 =5.0
Hz, H1), 7.07-7.09 (m, 2H, ArH), 7.24-7.31 (m, 13H, ArH); : 13C NMR (75 MHz, CDCl3-
) δ 24.4, 24.9, 25.0, 67.46, 67.54, 68.9, 70.2, 70.7, 71.3, 74.9. 75.4, 79.3, 80.1, 81.0, 83.5,
93.2, 96.2, 99.7, 108.8, 109.4, 127.8, 127.9, 128.0, 128.2, 128.4, 128.5, 128.56, 128.60,
128.63, 134.8, 137.1, 137.2, 167.8; HRMS (+ESI) m/z = 917.1796, C41H48Cl3O15S
requires 917.1780.
4-Tolyl 3-O-benzyl-4,6-O-benzylidene-2-O-chloroacetyl-thio-β-
D-glucopyranoside (3.143). To carbohydrate 3.73 (1.7 g, 3.66
mmol) in CH2Cl2 (20 mL) at 0 °C was added NEt3 (1.6 mL, 11.49 mmol) followed by
chloroacetic anhydride (1.84 g, 10.76 mmol).  The reaction was stirred for 1h at 0 °C then
removed from the ice bath and allowed to stir at rt for 8 h.  Methanol (20 mL) was slowly








chromatography (99:1 CH2Cl2:MeOH)  afforded 3.143 as a white solid (1.960 g, 99%).
1H NMR (300 MHz, CDCl3) δ 2.33 (s, 3H, CH3), 3.43-3.52 (m, 1H, H5), 3.66-3.81 (m,
3H, H3, H4, H6ax), 3.83, 3.94 (AB, 2H, J = 14.9 Hz, CH2Cl), 4.38 (dd, 1H, J6az,6eq = 10.8
Hz, J6eq,5 = 4.9 Hz, H6eq), 4.59-4.63 (m, 2H, H1, 1/2 CH2Ph), 4.86 (d, 1H, J = 12.0 Hz,
1/2 CH2Ph), 4.98 (d, 1H, J2,1 = J2,3 = 9.0 Hz, H2), 5.56 (s, 1H, CHPh), 7.12 (d, 2H, J =
8.0 Hz, ArH), 7.23-7.48 (m, 12H, ArH); 13C NMR (75 MHz, CDCl3) δ 21.2, 40.7, 68.5,
70.5, 72.8, 74.4, 79.5, 81.2, 86.4, 101.2, 125.9, 127.5, 127.9, 128.1, 128.3, 128.4, 129.1,
129.7, 133.8, 137.0, 137.9, 138.8, 165.7.
4 Tolyl 3,4-di-O-benzyl-2-O-chloroacetyl-thio-β-D-
glucopyranoside (3.144).  To carbohydrate 3.143 (1.6 g, 2.96 mmol)
in freshly distilled THF (16 mL) at rt was added CoCl2 (1.15 g, 8.86 mmol) followed by
BH3THF (1.0 M soln. in THF, 8.80 mL, 8.8. mmol).  The reaction was stirred at room
temperature for 15 h, then was diluted with EtOAc, and the unused CoCl2 was filtered
off.  The remaining filtrate was treated with aq. NaBH4 (0.2 eq), and a second filtration
was performed to remove the black precipitate.  The resulting two phases were separated,
the organic phase was washed with sat. aq. NaHCO3, dried over MgSO4 and concentrated
to a crude solid.  Flash chromatography (99:1 CH2Cl2:MeOH) provides 3.143 as a white
solid (1.53 g, 95%). 1H NMR (300 MHz, CDCl3) δ 1.96 (br-s, 1H, OH), 2.32 (s, 3H,
CH3), 3.37-3.43 (m, 1H, H5), 3.61 (tapp, 1H, J3,2 = J3,4 = 9.3 Hz, H3), 3.67-3.76 (m, 3H,
H6, H4, 1/2 CH2Cl), 3.87-3.93 (m, 2H, H6’, 1/2 CH2Cl), 4.56-4.69 (m, 3H, H1, 2x1/2








4.94 (tapp, 1H, J2,1 +J2,3 = 18.9 Hz, H2), 7.09-7.12 (d, 2H, J = 9.0 Hz, ArH), 7.23-7.41 (m,
12H, ArH); 13C NMR (75 MHz, CDCl3) δ 21.2, 40.7, 61.8, 73.3, 75.2, 75.4, 77.6, 79.5,
83.8, 85.8, 127.9, 127.99, 128.10, 128.5, 128.6, 128.8, 133.3, 137.6, 138.0, 138.7, 165.9.
4-Tolyl 3,4-di-O-benzyl-2-O-chloroacetyl-1-thio-β-D-
glucopyranosyluronic acid (3.145). To carbohydrate 3.144 (1.0 g,
1.84 mmol) in 1:1 CH2Cl2:H2O (10 mL) was added TEMPO (0.060 g, 0.38 mmol)
followed by iodobenzene diacetate (BAIB, 1.31 g, 4.07 mmol). The biphasic reaction was
vigorously stirred at rt for 1 h. The resulting layers were separated, and the organic layer
was dried over Na2SO4 and concentrated to a crude yellow solid.  Purification by flash
chromatography (99:1 CH2Cl2/MeOH) afforded 3.120 as a slightly yellow solid (0.902 g,
88%).  The crude acid was used without any further characterization.
Benzyl (4-Tolyl-3,4-di-O-benzyl-2-O-chloroacetyl-1-thio-β-D-
glucopyranoside)uronate (3.142).  To the glucuronic acid 3.145
(3.30 g, 5.93 mmol) in CH2Cl2 (26 mL) at 0 °C was added NEt3 (1.1 mL, 7.90 mmol)
followed by a dropwise addition of  benzyl chloroformate (1.1 mL, 7.71 mmol).  The
reaction was stirred for 10 min, then DMAP (0.21 g, 1.72 mmol) was added and the
system was stirred for an additional 30 min at 0 °C.  The reaction was concentrated to
approximate half volume without the use of heat, and applied directly to a silica gel
















76%).  1H NMR (500 MHz, CDCl3) δ 2.37 (s, 3H, CH3), 3.72 (tapp, 1H, J3,2 = J3,4 = 9.2
Hz, H3), 3.90, 3.93 (AB, 2H, J=14.8 Hz, CH2Cl), 3.91 (tapp, 1H, J4,3 + J4,5 =  18.7 Hz,
H4), 4.00 (d, 1H, J5,4 = 9.7 Hz, H5), 4,54, 4.72 (AB, 2H, J = 10.7 Hz, CH2Ph), 4.59 (d,
1H, J1,2 = 9.0 Hz, H1), 4.64, 4.83 (AB, 2H, J = 11.6 Hz, CH2Ph), 5.00 (tapp, 1H, J2,1 +J2,3
= 10.1 Hz, H2), 5.23 (s, 2H, CO2CH2Ph), 7.10 (d, 2H, J = 8.0 Hz, ArH), 7.17-7.19 (m,
2H, ArH), 7.25-7.40 (m, 16H, ArH); 13C NMR (125 MHz, CDCl3) δ  21.2, 40.7, 67.5,
72.6, 75.1, 75.4, 78.2, 79.3, 81.2, 86.3, 127.4, 127.97, 127.99, 128.0, 128.1, 128.4, 128.5,
128.57, 128.59, 128.7, 129.7, 132.8, 137.5, 137.8, 138.9, 165.8, 167.5;
4-Methoxyphenyl 4,6-O-benzylidene-2-deoxy-3-O-tert-
butyldimethylsilyl-2-trichloroacetamido-β-D-galactopyranoside
(3.150).  To 3.105 (0.500 g, 0.990 mmol) in dry THF (5.0 mL) was
added TBSCl (0.49 g, 3.25 mmol) followed by imidazole (0.27 g, 3.97 mmol) and DMAP
(0.05 g, 0.41 mmol).  The reaction was stirred for 3 h at room temperature, then was
quenched with sat. aq. NaHCO3 and diluted with EtOAc.  The aqueous layer was
extracted three times with EtOAc, and the oranic layers were combined, dried over
Na2SO4 and concentrated to a waxy crude compound.  Purification by flash
chromatography (99:1 CH2Cl2/MeOH) afforded 3.150 as a white waxy solid (0.560 g,
91%).  1H NMR (300 MHz, CDCl3) δ 0.085 (s,3H, CH3), 0.104 (s, 3H, CH3), 0.88 (s, 9H,
C(CH3)3), 3.56 (br-s, 1H, H5), 3.73 (s, 3H, OCH3), 3.84-3.93 (m, 1H, H2), 4.08 (dd, 1H,
J6,6’ = 12.4 Hz, J6,5 = 1.5 Hz, H6), 4.12 (d, 1H, J4,3 = 3.6 Hz, H4), 4.36 (br-d, 1H, J6’,6 =








H1), 5.54 (s, 1H, CHPh), 6.74-6.79 (m, 2H, ArH), 6.93-7.02 (m, 3H, ArH, NH2), 7.33-
7.36 (m, 3H, ArH), 7.52-7.55 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3) δ -4.5, 18.1,
25.7, 55.6, 56.8, 66.7, 68.7, 69.2, 76.0, 98.8, 100.7, 114.4, 119.7, 126.1, 128.1, 128.8,




 To carbohydrate 3.150 (1.50 g, 2.37 mmol) in freshly distilled THF (7.5 mL) at rt was
added CoCl2 (0.90 g, 6.93 mmol) followed by BH3THF (1.0 M soln. in THF, 7.1 mL, 7.1
mmol).  When no starting material remains by TLC,  (approximately 4 hours) the reaction
is diluted with EtOAc, and the unused CoCl2 is filtered off.  The remaining filtrate is
treated with aq. NaBH4 (0.2 eq), and a second filtration is performed to remove the black
precipitate.  The resulting two phases are separated, the organic phase is washed with sat.
aq. NaHCO3, dried over MgSO4 and concentrated to a crude solid.  Flash
chromatography (98:2 CH2Cl2:MeOH) afforded pure 3.151 as a white waxy solid (1.21 g,
80%).  1H NMR (300 MHz, CDCl3) δ 0.13 (s, 3H, CH3), 0.19 (s, 3H, CH3), 0.93 (s, 9H,
3xCH3), 1.71-1.75 (m, 1H, OH), 3.56-3.66 (m, 2H, H5, H6), 3.70 (s, 3H, OCH3), 3.74-
3.78 (m, 2H, H4, H6’), 4.05-4.14 (m, 1H, H2), 4.36 (br-d, 1H, J3,2 = 8.0 Hz, H3), 4.56,
5.02 (AB, 2H, J = 11.4 Hz, CH2Ph), 5.35 (d, 1H, J1,2 = 8.2 Hz, H1), 6.70-6.73 (m, 2H,






δ -5.0, -3.5, 17.9, 25.8, 55.6, 56.9, 61.9, 71.2, 74.9, 75.1, 76.2, 98.9, 114.5, 118.7, 127.9,
128.0, 128.5, 138.2, 151.2, 155.4, 161.2.
4-Methoxyphenyl 4-O-benzy-2-deoxy-6-O-chloroacetyl-3-O-tert-
butyldimethylsilyl-2-trichloroacetamido-β-D-galactopyranoside
(3.152).  To carbohydrate 3.151 (0.780 g, 1.23 mmol) in CH2Cl2 (7.3 mL) at 0 °C was
added NEt3 (0.25 mL, 1.80 mmol) followed by chloroacetic anhydride (0.313 g, 1.83
mmol).  The reaction was stirred for 30 min at 0 °C, then quenched with cold MeOH and
concentrated to a crude brown solid.  Purification by flash chromatography (99:1
CH2Cl2/MeOH) provided 3.152 as a white waxy solid (0.785 g, 90%).  1H NMR (300
MHz, CDCl3) δ 0.13 (s, 3H, CH3), 0.20 (s, 3H, CH3), 0.93 (s, 9H, 3xCH3), 3.72 (brs, 4H,
OCH3, H4), 3.80-3.82 (m, 1H, H5), 3.94 (s, 2H, CH2Cl), 4.00-4.09 (m, 1H, H2), 4.17 (dd,
1H, J6,6’ = 11.1 Hz, J6,5 = 5.3 Hz, H6), 4.36-4.42 (m, 2H, H3, H6’), 4.56, 5.04 (AB, 2H, J
= 11.3 Hz, CH2Ph), 5.38 (d, 1H, J1,2 = 8.1 Hz, H1), 6.72-6.75 (m, 2H, ArH), 6.93-6.96
(m, 3H, ArH, NH), 7.23-7.34 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ -5.0, -3.5,
17.9, 25.8, 40.6, 55.6, 56.9, 64.6, 71.4, 72.0, 75.1, 75.9, 92.4, 98.6, 114.4, 119.0, 127.9,
128.0, 128.5, 138.0, 151.2, 155.6, 161.9, 166.8; HRMS (+ESI) m/z = 727.1537,
C30H43Cl4N2O8Si (M+NH4)+ requires 727.1543.
4-Methoxyphenyl 4-O-benzy-2-deoxy-6-O-chloroacetyl-2-










3.152 (0.500 g, 0.703 mmol) in dry THF (10 mL) was added 1.0 M TBAF in THF (0.77
ml, 0.77 mmol) dropwise.  The reaction was stirred at room temperature for 2 h, then
concentrated to a crude oil using minimal heat. Purification by flash chromatography
(98:2 CH2Cl2/MeOH) afforded 3.149 as a white solid (0.311 g, 74%).  1H NMR (500
MHz, CDCl3) δ 3.76 (d, 1H, JOH,3 = 8.4 Hz, OH), 3.78 (s, 3H, OCH3), 3.84 (br-t, J5,6 +
J5,6’ = 12.6 Hz, H5), 3.90 (brd, J4,3 = 2.03 Hz, H4), 4.02 (s, 2H, CH2Cl), 4.04-4.09 (m,
1H, H2), 4.20-4.27 (m, 2H, H3, H6), 4.48 (dd, 1H, J6’,6 = 11.0 Hz, J6’,5 = 7.0 Hz, H6’),
4.79,4.85 (AB, 2H, J = 11.6 Hz, CH2Ph), 5.09 (d, 1H, J1,2 = 8.3 Hz, H1), 6.80-6.84 (m,
2H, ArH), 6.98-7.02 (m, 3H, NH, ArH), 7.36-7.41 (m, 5H, ArH); 13C NMR (125 MHz,
CDCl3) δ 40.6, 55.6, 57.0, 64.2, 70.9, 72.5, 75.1, 75.6, 92.4, 99.8, 114.6, 119.0, 128.37,
128.43, 128.8, 137.4, 151.0, 155.8, 162.9, 166.8;
Orthoester (3.155). A suspension of thioglycoside donor
3.142 (0.354 g, 0.547 mmol), BSP (0.126 g, 0.602
mmol), TTBP (0.272 g, 1.09 mmol) and freshly activated
3A MS (0.40 g) was stirred under argon in freshly
distilled CH2Cl2 (3.7 mL) for 1 h at room temperature.  The reaction mixture was cooled
to –60 °C and stirred for an additional 30 min.  Tf2O (0.1 mL, 0.602 mmol) was added,
and after 10-12 min, a solution of acceptor 3.69 (0.200 g, 0.273 mmol) in CH2Cl2 (0.5
mL) was added dropwise.  The reaction was stirred for 3 h, while the temperature
gradually rose to 0 °C, until no starting acceptor 3.69 was detected using TLC.  The













organic layer was dried over Na2SO4 and concentrated to a greenish crude oil.  Flash
chromatography performed twice, (99:1 CH2Cl2/MeOH then 25:57 EtOAc/Hexanes)
provided 3.141 as a white foam (0.299 g, 86%).  1H NMR (500 MHz, CDCl3) δ 3.78 (s,
3H, CH3), 3.82, 3.90 (AB, 2H, J = 12.0 Hz, CH2Cl), 3.81-3.91 (m, 3H, H2’, H5’, H5),
4.00-4.03 (m, 2H, H3, H4), 4.21 (dd, 1H, J3’,2’ = 10.5 Hz, J3’,4 = 4.3 Hz, H3’), 4.28 (br-s,
1H, H2), 4.50-4.53 (m, 3H, CH2CCl3, H4’), 4.57-4.65 (m, 5H, H6’, H6’, 3x1/2 CH2Ph),
4.70-4.64 (m, 2H, 2x1/2 CH2Ph), 4.94, 5.01 (AB, 2H, J = 12.1 Hz, CO2CH2Ph), 5.12 (d,
1H, J1’,2’ = 8.3 Hz, H1’), 6.16 (d, 1H, J1,2 = 3.4 Hz, H1), 6.99 (d, 2H, J = 9.0 Hz, ArH),
7.12 (d, 1H, JNH,H2’ = 6.8 Hz, NH), 7.28 (d, 2H, J = 9.0 Hz, ArH), 7.34-7.24 (m, 20H,
ArH); 13C NMR (125 MHz, CDCl3) δ 47.0, 54.9, 55.6, 67.3, 69.9, 72.1 72.3, 72.5, 72.8,
72.9, 73.2, 73.8, 74.0, 74.9, 78.2, 79.6, 92.3, 92.4, 94.7, 98.5, 114.6, 119.1, 122.7, 128.0,
128.19, 128.21, 128.3, 128.5, 128.56, 128.58, 128.6, 128.7, 134.8, 136.8, 137.0, 137.6,
151.0, 155.8, 162.3, 169.3; HRMS (+ESI) m/z = 1269.1132, C53H56Cl7N2O17S (M+NH4)+
requires 1269.1119.
Orthoester (3.156). Prepared and isolated according to the
procedure described for 3.155.  1H NMR (500 MHz, CDCl3)
δ 3.78 (s, 3H, OCH3), 3.80-3.93 (m, 4H, CH2Cl, H5, H2’),
3.95-3.96 (m, 2H, CH2Cl), 3.99-4.02 (m, 2H, H3, H4), 4.14 (dd, 1H, J6’,6’’ = 11.3 Hz, J6’,5
= 5.3 Hz, H6’), 4.29 (br-t, 1H, J2,1+J2,3 = 6.2 Hz, H2), 4.40 (dd, 1H, J6’’,6’ = 11.3 Hz, J6’’,5’
= 7.2 Hz, H6’’), 4.54 (s, 2H, CH2Ph), 4.58 (dd, 1H, J3’,2’ = 10.8 Hz, J3’,4’ = 2.6 Hz, H3’),













(AB, 2H, J = 11.6 Hz, CH2Ph), 4.95, 5.01 (AB, 2H, J = 12.1 Hz, CO2CH2Ph), 5.57 (d,
1H, J1’,2’ = 8.3 Hz, H1’), 6.14 (d, 1H, J1,2 = 3.5 Hz, H1), 6.80 (d, 2H, J = 9.0 Hz, ArH),
7.01 (d, 2H, J = 9.0 Hz, ArH), 7.14 (d, 1H, JNH,2 = 6.8 Hz, NH), 7.22-7.24 (m, 3H, ArH),
7.28-7.29 (m, 4H, ArH), 7.34-7.40 (m, 16H, ArH), 7.41-7.44 (m, 2H, ArH); 13C NMR
(125 MHz, CDCl3) δ 40.6, 47.1, 55.1, 55.6, 64.5, 67.3, 70.2, 72.3, 72.7, 72.87, 72.94,
73.8, 73.9, 74.0, 74.7, 78.6, 92.3, 94.9, 98.7, 114.4, 119.5, 122.7, 127.7, 127.9, 127.98,
128.0, 128.17, 128.19, 128.2, 128.4, 128.49, 128.55, 128.59, 128.7, 128.8, 134.8, 136.8,
137.0, 137.9, 151.2, 155.8, 162.6, 166.8, 169.3; HRMS (+ESI) m/z = 1135.2122, C53H56-
Cl5N2O15 (M+NH4)+ requires 1135.2123.
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Chapter 4 – Studies on the Selective Introduction and
Isomerization of the Carbobenzyloxy Carbonyl group in 2,3-
diols of 4,6-O-Benzylidene Galactose Derivatives
4.1  Introduction
In addition to the synthesis of the chondroitin sulfate fragments described in
chapter 3, the Taylor group is working towards the synthesis of another multisulfated
oligosaccharide using the sulfate protecting group strategy, namely the synthesis of the
tetrasaccharide portion of SB1A. SB1A (4.1, Figure 4.1), is glycosphingolipid carbohydrate
antigen with a disulfated tetrasaccharide moiety that has shown to accumulate in both
cultured and tissue-extracted human hepatocellular carcinoma (HCC) cell lines.
Carbohydrate antigens are often expressed specifically to a certain type of tumor, and are
not overexpressed or recognized by the immune system in normal tissues; thus
oligosaccharide based antigens show a great deal of potential for application towards
tumor immunotherapy.84  It has been suggested that SB 1A is one of the most important











































Figure 4.1.  SB1A (4.1) and its synthetic analog 4.2.
In 2002, Zhong-Jun Li and coworkers reported the first synthesis of the disulfated
tetrasaccharide moiety of SB1A (4.2, Figure 4.1).84 The authors used a [2+1+1] stepwise
synthetic approach to assemble the fully protected target tetrasaccharide.  The protecting
group strategy was designed such that benzyl ethers were used for permanent protection
until the end of the synthesis; 2-N-phthalimido and 2-O-benzoyl protected donors were
used to direct the required β-glycosidic linkages, and the locations that would ultimately
be sulfated were orthogonally protected using p-methoxybenzyl (PMB) and
monochloroacetate (MCA) moieties.
The synthesis of SB1A began with the preparation of a previously reported85
lactose derivative 4.3 (Scheme 4.1) which was coupled to the trichloroacetimidate donor
4.4 in the presence of TMSOTf to give trisaccharide 4.5 in an 83% yield.  A series of
protecting group manipulations on trisaccharide 4.5 including dephthaloylation and N-
acetylation to give 4.6, and subsequent O-deacetylation and installation of the 4,6-O-
























































   n-butanol, 75 oC






















Scheme 4.1.  Preparation of SB1A trisaccharide acceptor.
The trisaccharide acceptor 4.7 was then glycosylated with the glycosyl bromide
donor 4.8 (several other donors were examined but only donor 4.8 gave the desired
product) using AgOTf as a promoter at low temperature which gave the fully protected
tetrasaccharide 4.9  in an 89% yield (Scheme 4.2).  Selective removal of the
monochloroacetate protecting group followed by oxidative cleavage of the PMB group
provided diol 4.10 which was treated with the sulfur trioxide-pyridine complex to furnish
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the disulfated tetrasaccharide 4.11 in a 95% yield.  Removal of the benzyl groups in 4.11
was achieved in an 88% yield by catalytic hydrogenolysis in the presence of HCl (0.011
M in MeOH-H2O, 10:1) over three days.  These are somewhat unusual conditions for this
reaction since sulfate monoesters are quite acid labile; however, there was no mention
that any loss of the sulfate groups occurred during this step.  Some difficulties were
encountered in removing the benzoyl groups.  Subjecting the debenzylated product to
0.012 M NaOMe in MeOH at room temperature only resulted in loss of the benzoyl
group at the 6-position while the one at the 2-position was retained.  Increasing the base
concentration and prolonging the reaction time led to decomposition. Ammonia in MeOH
resulted in desulfation.  Nevertheless, they were eventually able to obtain target





















































    CH2Cl2, EtOH (76%)
















































1. H2, Pd/C, MeOH/H2O, 1 M HCl
2. 0.012 M NaOMe/MeOH, rt






















Scheme 4.2.  Completed synthesis of the SB1A tetrasaccharide.
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We reasoned that the SB1A tetrasaccharide would be a good target to evaluate the
sulfate protecting group strategy for the preparation of sulfated oligosaccharides. While
Li and coworkers’ synthesis is an accomplishment in the preparation of sulfated
oligosaccharides, it does have some shortcomings.  The total number of steps was 33 if
one takes into account the steps required to prepare the protected monosaccharides (not
discussed).  Over 8 different protecting group manipulations are required at the tri- and
tetrasaccharide stage.  Although the removal of the benzoyl groups at the end of the
synthesis was eventually achieved in good yield considerable difficulties were
encountered in this step.  By designing a synthesis that incorporates a protected sulfate
moiety at the beginning of the synthetic sequence, and by using a protecting group
strategy in which all protecting groups are removed by hydrogenolysis, this step would
no longer be required and some of protecting group manipulations would be avoided
which would in turn decrease the number of synthetic steps in the preparation of the
target.
We envisioned the target tetrasaccharide 4.12 being prepared from the fully
protected precursor 4.13 (Figure 4.2).  The target was designed to be fully protected with
groups (including the TCE-protected SO3 moieties) that can be removed under catalytic
hydrogenation conditions in the last step of the synthesis.  This includes the use of the
carbobenzyloxy (Cbz) group, which we discussed to a limited extent, in chapter 3, at the
2-position of the galactose units.  Tetrasaccharide 4.13 would ultimately be assembled
































































4.14 R = OMP or STol 4.15 4.16
Figure 4.2. Retrosynthesis of SB1A
This particular route was very appealing for several reasons.  First of all,
monomer 4.15 with either an SPh (3.106, chapter 3) or OMP group (3.105, chapter 3) at
the anomeric position had already been prepared during our synthesis of chondroitin
sulfate fragments that were discussed in chapter 3.  Secondly, two of the residues could
be derived for a single monomer (monomer 4.14).  Finally, we had anticipated that
monomer 4.14 could be easily prepared via selective sulfation methodology recently
developed in our laboratory by Ahmed Desoky, a colleague in the Taylor laboratory.
While performing studies on the selective sulfation of partially protected gluco- and
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galactopyranosides, Ahmed Desoky had discovered that diol 4.17 could be selectively
sulfated in 88% yield with 2.0 equivalents of SIS 2.40 in the presence of 2.5 equivalents
of 1,2-dimethylimidazole to prepare 3-O-sulfate 4.18 (Scheme 4.3a).  This finding was
quite exciting, as in just one further synthetic step, the required sulfated monomer 4.14
could, in principle, be prepared.  Unfortunately, once the TCESO3 moiety had been
installed, the 2-OH of 4.18 appeared to be extremely unreactive, and, at the time we
began these studies, no conditions had been found to install the desired 2-O-Cbz group to
prepare 4.19.  Interestingly, Ahmed Desoky had also observed that selective O-




























































Scheme 4.3.  Selective sulfation and benzoylation of diol 4.17 and 4.20.
A literature search quickly revealed that other researchers had noted this
selectivity pattern with 2,3-diols of 4,6-O-benzylidene-protected galactose derivatives.
For example, in 2004, Jacquinet and co-workers reported the same selectivity pattern
with OMP protected galactopyranoside 4.20.  The authors were able to selectively
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introduce a benzoyl protecting group at the 3-position of 4.20 and then migrate the








0.05 M NaOH, Acetone

















4.20 4.21 (75%) 4.22 (82%)
Scheme 4.4.  Selective benzoylation and benzoyl migration as reported by Jacquinet86
Jacquinet’s work lead us to investigate an alternative route to the desired SB1A
galactopyranoside donor, as described in Scheme 4.5. We proposed the possibility of
selectively introducing a Cbz protecting group to the 3-O-position of 4.17 giving 4.23,
and then migrate the Cbz group to the 2-O-position to provide 4.24.  Although 32
migration of a Cbz group in a carbohydrate had never been demonstrated before we
anticipated that it should be achieveable using conditions that had already been developed



































Scheme 4.5.  Proposed route to donor 4.14
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4.2  Objectives
The objectives of the work described in this chapter was to determine if a Cbz
group could be introduced selectively into the 3-position of 2,3-diols of 4,6-O-
benzylidene-protected galactose derivatives and if the Cbz group of the resulting 3-
carbobenzyloxy carbonyl derivatives could be isomerized to the 2-position.
4.3  Results and Discussion
4.3.1  Selective Introduction and Isomerization of the Cbz group
Diol 4.17 was prepared in an overall 84% yield in three high yielding steps
starting from commercially available galactose tetraacetate (4.25) as described by
Scheme 4.6.  An anomeric protecting group exchange using 4-methylbenzenethiol and
BF3OEt2 provided tetraacetate 4.26. Removal of the acetate esters under Zemplén

























(84% over 3 Steps)
4.25 4.26 4.17
Scheme 4.6.  Preparation of diol 4.17
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We next examined whether the Cbz protecting group could be selectively
installed, and if it would follow the same selectivity patterns previously observed for
sulfation and benzoylation of monomers 4.17 and 4.20.  Diol 4.17 was treated with
benzyl chloroformate under a variety conditions as shown in table 4.1.  Initial attempts to
selectively install the Cbz group using triethylamine as a base (entries 1 and 2) were very
sluggish, and after extended periods of time the conversion of 4.17 to product was very
low.  Under these conditions, a mixture of 2-O-Cbz and 3-O-Cbz compounds were
obtained, with the latter being the major product.  Changing the base to pyridine lead to
better selectivity, with 4.23 being the only observed product (entry 3); however with only
1.2 eq. of CbzCl the conversion of starting material to product was again, quite low.
Increasing the equivalents of CbzCl (entry 4), and drastically decreasing the rate of
addition (entry 6) resulted in the preparation and isolation of target compound 4.23 in an
easily reproducible 84% yield.
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Entry Solvent Base (eq.) CBzCl (eq.) Results
1 CH2Cl2 NEt3 (5.0) 1.2 Mostly 4.17, trace 4.23 (major) + 2-O-CBz
2 CH2Cl2 NEt3 (5.0) 3.0 Mostly 4.17, trace 4.23 (major) + 2-O-CBz
3 CH2Cl2 Py (5.0) 1.2 Mostly 4.17, trace 3.23 (only)
4 CH2Cl2 Py (5.0) 2.0+2.0 78 % 4.23
5 -- Py (40.0) 2.0+2.0 60% 4.23 + unreacted 4.17
6 CH2Cl2 Py (5.0) 2.0+1.0 84 % 4.23
With 4.23 in hand we then set out to examine various conditions to see if the
protecting group would undergo successful alkoxycarbonyl group migration to produce
the 2-OCbz 4.24 (table 4.2). We began by attempting to migrate the Cbz protecting group
under the same conditions which Jacquinet was able to migrate the 3-OBz in 4.21 to give
4.24 as previously shown in Scheme 4.4.  Under the basic conditions, a mixture of 3-O-
CBz 4.23, migrated product 4.24 and diol 4.17 was observed (table 4.2, entry 1).   The
concentration and molar equivalents of NaOH were varied along with temperature and
time (entries 2-6); however it appeared that an equilibrium between 4.23 and 4.24 was
rapidly established that consisted of considerable quantities of both 4.23 and 4.24.  DBU
was also examined in a variety of solvents (entries 7-12), and although some migration
was observed, we could not find conditions that gave 4.24 as the dominant product.
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Entry Migration Conditions Results
1 0.05 M NaOH (0.5 eq) / Acetone, 5 min, RT 4.23 (major) 4.24 (minor)
4.17 (trace)
2 0.05 M NaOH (0.05 eq) / Acetone, 15 min, RT 4.23 (major)4.24 (minor)
4.17 (trace)
3 0.05 M NaOH (0.05 eq) / Acetone, 24 h, 0 oC to RT 4.23 (major)4.24 (minor)
4.17 (trace)
4 0.05 M NaOH (0.05 eq x 3) / Acetone, 9 h, 0 oC 4.23 (major) 4.24 (minor)
4.17 (trace)
5 0.05 M NaOH (0.5 eq) / Acetone, 10 h, 0 oC 4.23 (major)4.24 (minor)
4.17 (trace)
6 0.5 M NaOH (5.0eq) / Acetone, 5 min, RT 4.17
7 DBU (0.5 eq) / Acetone, 4 h, RT 4.23 (major) 4.24 (minor)
8 DBU (1.0 eq) / Acetone 24 h, RT 4.23 (major) 4.24 (minor)
9 DBU (1.0 eq) / DCM, 24 h, RT 4.23 (major) 4.24 (minor)
10 DBU (1.0 eq) / Et2O, 24 h, RT 4.23 (major) 4.24 (minor)
11 DBU (1.0 eq) / H2O, 24 h, RT 4.17
12 DBU (1.0 eq) / MeOH, 24 h, RT 4.17
13 Silica Gel (0.05g/mg sugar), 16 h, RT 4.23
When Jacquinet performed the acyl group migration of the benzoyl protecting
group on galactopyranoside 4.21 (Scheme 4.4) the process took just 3 minutes.  The
completely migrated 4.22 product precipitated out of solution and was isolated in good
yields.  It is possible that this product precipitation resulted in pushing the equilibrium to
the 2-O-acyl side.  With our system the migrated product did not precipitate out of
solution.  In our attempts, two variables differed from Jacquinet’s.  The acyl protecting
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group was changed to a Cbz group, and the anomeric protecting group was changed from
an OMP to a thioether.  This brings up the question:  Are the migration difficulties we
encountered related to the Cbz protecting group itself, or are they a result of the
thioglycoside function?  In order to determine which variable was hindering the
migration, the thioglycoside derivative of the 3-O-benzoylated 4.21, compound 4.27, was
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4.17 4.27 (85%) `
CH2Cl2
R1 = Bz, R2 = H 4.27 (major)
R1 = H, R2 = Bz 4.28 (minor)
Scheme 4.7.  Benzoyl migration with thioglycoside 4.27
As previously observed with 4.23, only trace amounts of the migrated product
4.28 were observed.  The migrated thioglycoside product 4.28 did not precipitate out of
solution as was reported for 4.22.  Presumably then, it is the product precipitation that
shifts the equilibrium towards the migrated product, and above migration issues with 4.23
could be due to the anomeric thioglycoside, and are not necessarily a result of the 3-O-
Cbz protecting group.  To prove this, the OMP derivative of 4.23, compound 4.30, was
prepared according to Scheme 4.8.  The selective introduction of the Cbz group into




























(84% over 3 Steps)
4.20
CbzCl (3.0 eq.)









Scheme 4.8.  Preparation of 3-OCbz derivative 4.30
Compound 4.30 was then subjected to the literature migration conditions (table
4.3).  The solubility of this compound was found to be quite poor, so the literature
migration conditions had to be modified to ensure that the 4.30 was in solution before the
base catalyst was added.  Fortunately, under these conditions, the 3-O-Cbz quickly
migrated to the 2-position of the carbohydrate ring, and the resulting product 4.31
precipitated out of solution and was isolated in an 89% yield (table 4.3, entry 3).


















Entry Migration Conditions Results
1 0.05 M NaOH (0.5 eq) / Acetone (0.1 M), 5 min, 0 °C All 4.30 precipitate
2 0.05 M NaOH (0.5 eq) dropwise / Acetone (0.1 M), 5 min, 0 °C 4.31   75%
3 0.05 M NaOH (0.5 eq) dropwise / Acetone (0.07 M), 5 min, 0 °C 4.31   89%
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4.3.2  Installation of the Sulfate and Trichloroacetimidate group into monomer 4.31
With the desired 2-O-Cbz compound 4.31 in hand, we next looked at the sulfation
of the 3-OH to provide fully protected 4.32.  As anticipated, the sulfation reaction using


























4.31 4.32  (86%)
(2.0 eq.)
Scheme 4.9.  3-O-Sulfation of 4.31
Because the target SB1A donor had been modified from a thioglycoside to an
OMP protected glycoside, the next steps to complete the synthesis include hemiacetal
formation followed by installation of the trichloroacetimidate.  When attempting to
prepare hemiacetal 4.33 (table 4.4), using the standard CAN, CH3CN/H2O conditions,
difficulties were encountered due to the insolubility of 4.32 (table 4.4, entries 1-7).  In
many situations, when a starting material is partially insoluble in a reaction medium, the
material will slowly go into solution as the reaction progresses.  In all water-acetonitrile
solvent systems we examined however, 4.32 was extremely insoluble to the point where
no reaction was even occurring.  Starting carbohydrate 4.32 was soluble in CH3CN;
however as soon as any aqueous media was introduced into the reaction mixture 4.32
precipitated out of solution and no reaction occurred.  A variety of reactant
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concentrations and temperatures were examined using both H2O and aqueous pH 7
buffer; however 4.32 would not remain in solution to allow for the reaction to proceed.
Decomposition of 4.32 was observed when the CAN reagent was introduced to the
reaction system before the aqueous media (entry 8).  It was finally discovered that if
carbohydrate 4.32 was dissolved acetonitrile at 30 °C, and then CAN was added as an
aqueous solution, the target hemiacetal could be isolated in a 76 % yield (entry 12).
















Entry Solvent Conditions CAN (eq.) Result
1 CH3CN/pH7 Buffer (1:1.5  0.04 M) 1h, 0oC 1.0 then 3.0 4.32 ppt. (NR)
2 CH3CN/pH7 Buffer (1:1  0.03 M) 1h, 0 oC 4.0 portionwise 4.32 ppt. (NR)
3 CH3CN/H2O (1:1.5  0.04 M) 1h, 0 oC 4.0 portionwise 4.32 ppt. (NR)
4 CH3CN/H2O (1:1.5  0.04 M) 1h, RT 4.0 at once 4.32 ppt. (NR)
5 CH3CN/pH7 Buffer (1:1  0.03 M) 1h, RT 4.0 at once 4.32 ppt. (NR)
6 CH3CN (0.03 M) then
pH7 Buffer (0.04 M)
30oC 2.0 at once 4.32 ppt. (NR)
7 CH3CN (0.03 M) then H2O (0.04 M) 30 oC 2.0 at once 4.32 ppt. (NR)
8 CH3CN (0.03M)
then CAN then H2O (0.04M)
30 oC 4.0 at once Complex
mixture
9 CH3CN (0.03M) then H2O (0.01M) 30 oC 4.0 at once 4.32 ppt. (NR)
10 CH3CN (0.03M) 30 oC 4.0 (0.55M aq.) 4.33 67%
11 CH3CN (0.03M) 30 oC 4.0 (1.1M aq.) 4.33 67%
12 CH3CN (0.02M) 30 oC 4.0(1.1M aq.) 4.33 76%
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With hemiacetal 4.33 finally prepared, it was converted smoothly to the
corresponding trichloroacetimidate donor 4.34 in an 86% yield (Scheme 4.10).  Overall,
the target 3-O-sulfated donor 4.34 was prepared in 8 steps and an overall 38% yield (89%




















Scheme 4.10.  Synthesis of trichloroacetimidate 4.34 from hemiacetal 4.33.
4.4  Summary and Future Work
In this chapter we demonstrated that selective introduction of the Cbz group into
the 3-position of 2,3-diols of 4,6-O-benzylidene-protected galactose derivatives can be
achieved in high selectivity and yield.  We also demonstrated that the Cbz group of the
resulting 3-carbobenzyloxy derivatives could be isomerized to the 2-position under basic
conditions.  However conditions that allow the precipitation of the migrated product
appear to be necessary for good yields.  Future studies on this subject will be to
determine if the selective introduction and subsequent isomerization can also be achieved
using glucose-based substrates.
The complete total synthesis of SB1A is now under investigation by Ahmed
Desoky in the Taylor group.  Subsequent to the work described in this chapter Mr.
Desoky eventually developed conditions for the introduction of the Cbz group into
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monomer 4.18 to give monomer 4.19 (Scheme 4.11) a reaction that we had previously








1. NBS, Acetone H2O
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Scheme 4.11.  Synthesis of monomer 4.19 and donor 4.34 starting from thioglycosides
4.18.
Of particular note is that he has found that the coupling of monomer to 4.34 to
monomer 4.15 proceeds in good yield (73 %, unoptimized) and no cyclic carbonate
product was formed nor was any product obtained resulting from benzyl group migration
(Scheme 4.12).  Thus, the problems that we encountered in chapter 3 with the Cbz group
during glycosidic bond formation do not seem to be an issue with our synthesis of SB1A at
least so far.  Further studies to determine the factors that effect cyclic carbonate



























CH2Cl2, 4 A MS, 
- 40 oC, 1h then rt, 3h
4.35
(73%)
Scheme 4.12.  Coupling of 4.34 to 4.15.
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4.5  Experimental
4.5.1  General Considerations
For all general considerations, see section 2.5.1 in Chapter 2.
4.5.2  Experimental Syntheses and Characterization
p-Tolyl 4,6-O-benzylidene-3-O-carbobenzyloxy-1-thio-β-D-
galactopyranoside (4.23). Pyridine (2.3 mL, 28.5 mmol) was added to
a solution of carbohydrate 4.1787 (2.0 g, 5.76 mmol) in CH2Cl2.  Benzyl
chloroformate (1.6 mL, 11.4 mmol) was added dropwise using a syringe pump over 1.5
h.  After 3 h, additional benzyl chloroformate (0.8  mL, 5.68 mmol) was added dropwise
over 30 minutes.  After an additional hour, no starting material was detected using TLC.
The reaction was quenched with methanol and concentrated to a crude yellow oil.
Purification by flash chromatography (99:1 CH2Cl2/MeOH) afforded 4.18 as a clear,
colourless glassy compound (2.45 g, 84%). 1H NMR (300 MHz, CDCl3) δ 2.32 (s, 3H,
CH3), 2.44 (br-s, 1H, OH), 3.55 (s, 1H, H5), 3.89 (br-t, J2,3 = J2,1 = 9.6 Hz, H2), 3.99 (d,
1H, J6,6’ = 12.4 Hz, H6), 4.34 (d, 1H, J6’,6  = 12.4 Hz, H6’), 4.40 (d, 1H, J4,3 = 2.9 Hz,
H4), 4.51 (d, 1H, J1,2 = 9.5 Hz, H1), 4.76 (dd, 1H, J3,2 = 9.7 Hz, J3,4 =3.1 Hz, H3), 5.14
(s, 2H, CO2CH2Ph), 5.44 (s, 1H, CHPh), 7.03 (d, 2H, J = 7.9 Hz, ArH), 7.24-7.33 (m,
10H, ArH), 7.54 (d, 2H, J = 7.9 Hz, ArH).  13C NMR (75 MHz, CDCl3) δ  21.2, 65.5,
69.1, 69.6, 70.0, 73.3, 78.3, 87.1, 100.9, 125.9, 126.5, 128.0, 128.2, 128.5, 129.0, 129.8,










galactopyranoside (4.27). To carbohydrate 4.1787 (0.5 g, 1.44 mmol)
in CH2Cl2 (6.3 mL) was added pyridine (0.58 mL, 7.19 mmol) followed
by a dropwise addition of benzoyl chloride (0.33 mL, 2.84 mmol).  The reaction was
stirred for 3h, then quenched with methanol and concentrated to a crude syrup.
Purification by flash chromatography (99:1 CH2Cl2/MeOH) provided 4.27 as a white
solid (0.599 g, 85%). 1H NMR (300 MHz, CDCl3) δ 2.34 (s, 3H, CH3), 2.43 (s, 1H, OH),
3.65 (s, 1H, H5), 4.00-4.11 (m, 2H, H2, H6), 4.41 (dd, 1H, J6’,6 = 12.4 Hz, J6’,5 = 1.4 Hz,
H6’) 4.47 (d, 1H, J4,3 = 3.2 Hz, H4), 4.60 (d, 1H, J1,2 = 9.4 Hz, H1), 5.16 (dd, 1H, J3,2 =
9.8 Hz, J3,4 = 3.3Hz, H3), 5.46 (s, 1H, CHPh), 7.06 (d, 2H, J = 7.9 Hz, ArH), 7.31-7.53
(m, 7H, ArH), 7.48-7.53 (m, 3H, ArH), 8.01 (d, 2H, J = 7.1 Hz, ArH); 13C NMR (75
MHz, CDCl3) δ 21.3, 65.8, 69.2, 69.9, 73.9, 75.3, 87.9, 100.8, 126.4, 126.6, 128.0, 128.4,
129.0, 129.7, 129.8, 130.0, 133.3, 134.0, 137.9, 138.5, 166.4.
4-Methoxyphenyl 4,6-O-benzylidene-3-O-carbobenzyloxy-β-D-
galactopyranoside (4.30). To a suspension of carbohydrate 4.2088 (1.0
g, 2.67 mmol) in CH2Cl2 was added pyridine (1.0 mL, 12.4 mmol)
followed by a slow addition of benzyl chloroformate (1.2 mL, 8.53 mmol) via syringe
pump over 2.5 h.  The reaction was stirred for an additional 2 h, quenched with MeOH
and concentrated to a crude syrup.  Purification by flash chromatography (99:1
CH2Cl2/MeOH) provided 4.30 as a white solid (1.28 g, 94%). %). 1H NMR (300 MHz,
















(dd, 1H, J6,6’ = 12.5 Hz, J6,5 =1.6 Hz, H6), 4.23-4.33 (m, 2H, H2, H6’), 4.46 (d, 1H, J4,3 =
3.5 Hz, H4), 4.79-4.82 (m, 1H, H3), 4.82 (d, 1H, J1,2 = 7.8 Hz, H1), 5.18 (s, 2H,
CO2CH2Ph), 5.49 (s, 1H, CHPh), 6.78-6.82 (m, 2H, ArH), 7.02-7.07 (m, 2H, ArH), 7.29-
7.38 (m, 7H, ArH), 7.46-7.49 (m, 2H, ArH);  13C NMR (75 MHz, CDCl3) δ 55.6, 66.4,
68.3, 68.9, 70.1, 73.1, 77.1, 100.9, 102.6, 114.5, 119.3, 126.3, 128.1, 128.3, 128.6, 129.0,
143.9, 137.5, 151.0, 154.8, 155.7.
4-Methoxyphenyl 4,6-O-benzylidene-2-O-carbobenzyloxy-β-D-
galactopyranoside (4.31). To carbohydrate 4.30 (0.60 g, 1.18 mmol) in
acetone (15 mL) was added NaOH (0.05 M sol’n, 11.8 mL, 0.590
mmol).  Within 5 minutes, 4.31 precipitated out of solution.  The product was dissolved
in EtOAc, washed with H2O and the resulting organic layer was dried over MgSO4.
Purification by flash chromatography (99:1 CH2Cl2/MeOH) provided 4.31 as a white
solid (0.531 g, 89%). 1H NMR (300 MHz, CDCl3) δ 2.57 (br-s, 1H, OH), 3.52 (s, 1H,
H5), 3.74 (s, 3H, CH3), 3.84 (m, 1H, H3), 4.08 (d, 1H, J6,6’ = 12.6 Hz, H6), 4.48 (d, 1H,
J4,3 = 3.7 Hz, H4), 4.63 (d, 1H, J6’,6 = 12.8 Hz, H6’), 4.82 (d, 1H, J1,2 = 8.0 Hz, H1), 5.09-
5.26 (m, 3H, H2, CO2CH2Ph), 5.56 (s, 1H, CHPh), 6.75 (d, 2H, J = 8.9 Hz, ArH), 6.90
(d, 2H, J = 8.9 Hz, ArH), 7.32-7.48 (m, 8H, ArH), 7.49-7.53 (m, 2H, ArH). 13C NMR (75
MHz, DMSO-d6) δ 55.8, 66.7, 68.6, 69.3, 76.2, 99.6, 100.3, 114.8, 114.9, 118.1, 126.7,











carbohydrate 4.31 (0.300 g, 0.590 mmol) in CH2Cl2 (4.8  mL) at
room temperature was added 1,2-DiMeIm (0.145 g, 1.51 mmol) followed by 2.40 (0.540
g, 1.18 mmol).  After 4 h, the reaction was concentrated to a yellow crude oil and applied
directly to a silica gel column.  Purification by flash chromatography afforded 4.32 as a
white solid (0.364 g, 85%). 1H NMR (300 MHz, CDCl3) δ 3.57 (s, 1H, H5), 3.74 (s, 3H,
OCH3), 4.08 (d, 1H, J6,6’ = 12.4 Hz, H6). 4.35 (d, 1H, J6’,6 = 12.4 Hz, H6’), 4.57-4.67 (m,
3H, H4, CH2CCl3), 4.84 (dd, 1H, J3,2 = 10.3 Hz, J3,4 = 3.6Hz, H3), 4.88 (d, 1H, J1,2 = 7.9
Hz, H1), 5.19, 5.26 (AB, 2H, J= 12.1 Hz, CH2CO2Ph), 5.44 (dd, J2,3 = 10.3 Hz, J2,1 = 8.1
Hz, H2), 5.57 (s, 1H, CHPh), 6.74 (d, 2H, J = 9.0 Hz, ArH), 6.85 (d, 2H, J = 9.0 Hz,
ArH), 7.24-7.51 (m, 10H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 65.9, 68.6, 70.5,
71.9, 72.9, 80.0, 81.3, 92.4, 100.8, 101.4, 114.5, 119.3, 126.5, 128.4, 128.5, 128.69,
128.74, 129.6, 134.8, 136.7, 150.9, 153.9, 155.9.
4,6-O-benzylidene-2-O-carbobenzyloxy-3-O-(2,2,2-
trichloroethoxysulfo)-β-D-galactose (4.33). Carbohydrate 4.32
(0.500 g, 0.694 mmol) was stirred in a solution of CH3CN (37 mL) at
30 °C until all starting material had gone into solution.  An aqueous solution of CAN (1.5
g in 2.5 mL H2O, 2.74 mmol) was then added in one portion.  The reaction was
immediately removed from heat and allowed to stir at rt for 4 h.  Upon completion, the
















layer was collected, dried over MgSO4 and concentrated to an orange crude syrup.
Purification by flash chromatography (50/50 EtOAc/Hexane) followed by a short silica
gel gravity column (75:25 benzene/EtOAc) yielded 4.33 as a white foam (0.324 g, 76%).
The product was used directly in the preparation of 4.34 with no further characterization.
4,6-O-benzylidene-2-O-carbobenzyloxy-3-O-
(2,2,2-trichloroethoxysulfo)-β-D-galactose trichloroacetimidate
(4.34).  To hemiacetal 4.33 (0.2 g, 0.326 mmol) in CH2Cl2 (2.0
mL) at –35 °C was added trichloroacetonitrile (0.52 mL, 5.16 mmol) followed by a 1.0 M
solution of DBU in CH2Cl2 (0.065 mL, 0.065 mmol).  The reaction was stirred for 2 h
and gradually warmed to –10 °C.  The reaction mixture was then directly applied to a
silica gel column, and 4.34 (0.212 g, 86%) was isolated as a white foam after purification
by flash chromatography (100% CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 4.04 (s, 1H,
H5), 4.13 (d, 1H, J6,6’ = 11.8 Hz, H6), 4.35 (d, 1H, J6’,6 = 11.8 Hz, H6’), 4.68, 4.81 (AB,
2H, J = 10.7 Hz, CH2CCl3), 4.84 (d, 1H, J4,3 = 3.0 Hz, H4), 5.18-5.24 (m, 3H, H2,
CO2CH2Ph),  5.43 (dd, 1H, J3,2 = 10.5 Hz, J3,4 = 3.0 Hz, H3), 5.66 (s, 1H, CHPh),  6.89
(d, 1H, J1,2 = 3.2 Hz, H1), 7.28-7.45 (m, 2H, ArH), 7.54-7.57 (m, 2H, ArH), 8.61 (s, 1H,
NH);  13C NMR (75 MHz, CDCl3) δ  64.7, 68.5, 70.2, 70.6, 73.3, 78.1, 79.9, 92.4, 94.1,
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